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ABSTRACT 
The neural crest (NC) is multipotent population of cells that has been 
very useful in studying several developmental processes including 
specification, proliferation and differentiation. Its derivatives include amongst 
others craniofacial cartilage, glial cells of the peripheral nervous system and 
of particular importance to us the pigment cells. Defects in the NC are 
responsible for several clinically important diseases. We report here the 
development of a permanent labelling system for the NC, and of a new 
zebrafish NC culture system. Plus one gene study of function for id2a and a 
new method for testing receptor tyrosine kinase inhibitors in vivo.  
We have generated a -4725sox10:cre transgenic line that permanently 
labels the NC and derivatives: migrating NC cells of the head, craniofacial 
cartilage, cranial ganglia, iridophores, xanthophores, enteric neurons, 
Schwann cells of the PLLn, of the DRG and of the ventrally and dorsally 
projecting spinal nerves and sox10+ populations such as  oligodendrocytes 
and the ear epithelium  
By testing different attachment substrates, media compositions and 
methods to obtain NC cells in vitro we have achieved a set of culture 
conditions that we believe are suitable for zebrafish NC cells and culturing 
total disaggregated embryos in these culture conditions has allowed us to 
identify several NC derivatives. 
We injected embryos with two different constitutive RTKs that are able 
to generate ectopic and/or extra iridophores in vivo, using the TAE684 ALK 
inhibitor, we were able to inhibit this process. Treatment with TAE684 also 
inhibited production of endogenous Ltk, we used this to our advantage to 
study iridophore development to distinguish a role for Ltk early in 
specification and later in proliferation of iridophores. 
 ii 
We characterised the id2a expression pattern in NC in WT and two NC 
mutants. Using knockdown of id2a we show a role for id2a in NC pigment cell 
and craniofacial cartilage development. 
 
Keywords: 
ALK, cell culture, Cre, chromatoblast, in vitro, id2a, inhibitors of 
differentiation, iridophores, Leukocyte Tyrosine Kinase, LTK, melanophores, 
Midkine, neural crest, permanent labelling, receptor tyrosine kinases, RTK, 
shady, sox10, Zebrafish. 
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ABBREVIATIONS 
°C   Degrees Celsius 
µ    micro 
aa   amino acids 
ALK   Anaplastic Lymphoma Kinase 
BMP    Bone Morphogenetic Protein 
bp   base pairs 
BSA    Bovine serum albumin 
CaCl2    Calcium chloride 
cDNA   complementary DNA 
c-kit   kit oncogene 
cls    colourless 
CNS   Central nervous system 
C-terminus  Carboxyl-terminus 
dct   dopachrome tautomerase 
DIG    Digoxigenin 
DMSO   Dimethyl Sulfoxide 
DNA     Deoxyribonucleic acid 
Dom     Dominant megacolon 
dpf     days post fertilization 
DRG   Dorsal root ganglia 
DS               dorsal stripe 
ednrb1   endothelin receptor 1b  
EDTA     Ethylenediaminetetra-acetic acid 
EM   embryo media 
ENU     N-ethyl-N-nitrosourea 
EST   Expressed Sequence Tag 
ET3   endothelin 3  
EtOH   ethanol 
FACS   Fluorescent activated cell sorting 
FBS   Foetal Bovine Serum 
FEE   fish embryo extract 
FGF   Fibroblast Growth Factor 
FN   Fibronectin 
G   gravitational constant 
g    gram 
GFP   Green Fluorescent Protein 
 v 
GMP synthetase  Guanine Monophosphate synthetase 
h    hours 
water   water 
H2O2     Hydrogen peroxide 
HCl   Hydrochloric acid 
hpf     hours post fertilization 
HM   Hybridization mixture 
id     inhibitor of differentiation 
inh   inhibitor 
kb   kilo base pairs 
KCl   potassium chloride 
KO   Knock-out 
KOD   Thermococcus kodakaraensis 
KOH     Potassium hydroxide 
LB   Luria Broth 
LTK   Leukocyte Tyrosine Kinase 
M   Molar units 
Mdk   Midkine 
MetOH   Methanol 
MgSO4   Magnesium sulfate 
min   minutes 
mitf     microphthalmia related transcription factor 
MO   morpholino 
NaOAc   Sodium acetate 
nac     nacre 
NaCl   Sodium chloride 
NC   Neural crest 
NCC   Neural crest cell 
NT   Neural tube 
N-terminal  amino-terminal 
O/N   over-night 
pA   poly- Adenylation signal 
P/S   penicillin/streptomycin 
PBS     Phosphate Buffered Saline 
PCR   Polymerase Chain Reaction 
PFA     Paraformaldehyde 
PI   Propidium iodide 
PLLn     Posterior lateral line nerve 
PNS     Peripheral nervous system 
PTU     1-phenyl-2-thiourea 
 vi 
RNA     Ribonucleic acid 
Rpm   revolutions per minute 
RT   reverse transcriptase or room temperature 
RTK   Receptor tyrosine kinase 
s    seconds 
shd   shady 
SMA   Smooth muscle actin 
sox10   SRY-box containing gene 10  
Sry   sex-determining region of Y chromosome 
SSC   saline sodium citrate 
TAE   Tris-Acetate-EDTA 
TE     Tris EDTA 
TGFβ     Transforming Growth Factor β 
TILLING   Targeting Induced Local Lesions in Genomes 
RTK   receptor tyrosine kinase 
tyr    tyrosinase 
VS     ventral stripe 
WT   wild-type 
xdh     xanthine dehydrogenase 
ZFIN   Zebrafish Information Network 
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I.1 THE NEURAL CREST 
The neural crest (NC) is a transient structure that arises at the border of 
the neural plate and the non-neural ectoderm in vertebrates. Neural crest 
cells (NCC) are highly migratory and initially multipotent, before becoming 
specified to diverse cell fates, including non-ectomesenchymal fates such as 
peripheral neurons (e.g. sensory and sympathetic), glia (e.g. Schwann and 
satellite cells), pigment cells, and ectomesenchymal derivatives such as  
mesenchymal cells from head and neck (e.g. cartilage, bones and vascular 
smooth muscle cells), fin mesenchyme (Dupin et al., 2007; Dutton et al., 
2001b; Kelsh et al., 2004; Le Douarin et al., 2004) and adipocytes (Billon et 
al., 2007). 
Defects in NC development or in its differentiated derivatives are 
associated with several tumours and a number of degenerative diseases 
called neurocristopathies, these include for example Hirschsprung’s disease, 
neuroblastomas, Waardenburg’s syndrome and albinism (Bolande, 1997) 
(Cossais et al., 2010). The understanding of how NC is formed and how 
different NC derivatives are specified is therefore of medical importance. 
NC induction starts around late gastrulation in the neural plate, a 
signalling event between the non-neural ectoderm (presumptive epidermis), 
the neural plate and the paraxial mesoderm are required for its induction. 
There are several signalling pathways involved in NC induction from the 
neural plate border such as BMPs, Notch, Wnts and FGFs (Monsoro-Burq et 
al., 2005). After a complex induction process NC cells start delaminanting 
from the neural tube in a classical epithelial to mesenchymal conversion 
(Garcia-Castro et al., 2002) NCCs briefly rest in a dorsal or dorsolateral 
position to the neural tube (NT) before migrating along defined pathways to 
populate various regions of the embryo (Le Douarin and Kalcheim, 1999). 
Trunk NCCs in mammalian and avian models migrate through two different 
pathways, a ventral pathway comprised between the NT and somites and a 
lateral pathway between the dermis and the dermomyotome. In zebrafish 
there are also two pathways but due to the embryo shape both move 
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ventrally, the medial pathway corresponding to the mammalian and avian 
ventral pathway and the lateral pathway (Eisen and Weston, 1993). 
 
To study any population of cells it is important to have markers that 
allow their identification and characterization, the NC is no exception. It has 
been established in mice and chicken that undifferentiated NC progenitors 
express HNK-1 and p75, both cell surface markers (Morrison et al., 1999; 
Real et al., 2006). These markers are not found in zebrafish, but other exist 
that are expressed in all models such as: Sox10 (Kelsh, 2006), foxd3 (Lister 
et al., 2006) and crestin (Luo et al., 2001).  
 
I.1.1 NC SPECIFICATION 
A major question of medical importance is how do multipotent neural 
crest stem cells generate diverse individual fates, i.e.how specification of NC-
derived fates occurs. Neural crest development is considered to involve a 
process of progressive fate restriction in which pluripotent cells become 
limited in their potencies over time (for a review Delfino-Machin et al., 2007). 
The molecular mechanisms underlying NCC fate restriction remain poorly 
understood. Some extracellular signals such as Wnt signals and transcription 
factors have been described as necessary for the specification of one or 
more NCC fates (eg. Dorsky et al., 2000; Takeda et al., 2000). For example, 
melanocyte specification via transcriptional activation of Mitf requires Wnt 
signals. Mitf is essential for melanocyte specification (Lister et al., 1999) (see 
I.3.1). Sox10 is required to drive transcription of Mitf and other transcription 
factors in multipotent NCCs (eg. Elworthy et al., 2003; Lee et al., 2000), while 
Pax3 acts synergistically with Sox10 to regulate mouse Mitf promoter (eg. 
Girard and Goossens, 2006). Other examples include Phox2b that seems to 
be important for the development of autonomic ganglia (Pattyn et al., 1999), 
whereas Ltk has been shown to be involved in iridophore specification from a 
common multipotent precursors (Lopes et al., 2008) (see I.3.2 and I.7.2). 
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Further signals remain to be identified, and for some NC-derived fates, no 
fate specification factors have yet been identified. The receptors mediating 
these signals are also unknown in most cases (Delfino-Machin et al., 2007). 
 
I.1.2 NEUROCRISTOPATHIES 
Neurocristopathy is the generic term for any congenital malformation, 
syndrome, tumour or dismorphology of the neural crest. Neurocristopathies 
include for example albinism, Hirschsprung’s disease and the related 
Waardenburg’s syndrome, neurofibromatosis and neuroblastoma (Bolande, 
1997; Dutton et al., 2001b; Le Douarin and Kalcheim, 1999) 
Albinism is characterized mainly by its deficiency in pigmentation but 
can be accompanied by many more serious conditions such as abnormal 
crossings of the temporal fibres in the optic chiasm, nystagmus, photophobia, 
variable visual acuity and, frequently, strabismus. Hundreds of mutations can 
cause this disease with the most common in tyrosinase and P gene, both 
present in melanocytes (Summers, 2009). This is a case were only some of 
the NC derivatives are affected, other diseases can have a more systemic 
effects if the mutation occurs in genes responsible for earlier development of 
the NC, such is the case of Hirschsprung’s disease. 
In Hirschsprung’s disease individuals have few or no enteric ganglia in 
(usually) the distal colon. It affects approximately 1 in 4500 newborns and 
almost invariably requires surgical intervention to alleviate the consequences 
of acute obstruction. Despite considerable surgical improvements post-
operative morbidity is still high (Laranjeira and Pachnis, 2009). Waardenburg 
syndrome is characterized by association of pigmentation abnormalities, 
such as depigmented patches of the skin and hair, vivid blue eyes or 
heterochromia iridis, with sensorineural hearing loss. Several genes are 
involved in this syndrome; these include PAX3, MITF, EDN3, EDNRB, 
SOX10 and SNAI2. In the Waardenburg-Shah syndrome individuals combine 
the defects of the Waardenburg syndrome with those of the Hirschsprung’s 
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disease, and it is mostly associated with SOX10 mutations, although some 
EDN3 and Tyrosine mutations have been found to cause it (Pingault et al.; 
Southard-Smith et al., 1998). Several models for this disease have been 
described, including mouse and zebrafish sox10 mutants (Dutton et al., 2009; 
Dutton et al., 2001b; Southard-Smith et al., 1998). The fact that a single gene 
mutation can cause these syndromes reflects the importance of knowing how 
these genes regulate NC development, in particular Sox10. 
 
I.2 SOX10 
SOX10 (or Sry bOX10 transcription factor) is a key factor in neural crest 
development. SOX10 is a member of the high-mobility group (HMG) domain 
SOX family of transcription factors. SOX family members are related to the 
mammalian testis determination factor SRY. SOX10 belongs to the E group 
of SOX proteins, together with SOX8 and SOX9, based on pairwise 
comparisons of HMG-domain sequences (Mollaaghababa and Pavan, 2003; 
Southard-Smith et al., 1998). Homologues of Sox10 have been identified in 
several vertebrate species including zebrafish (Dutton et al., 2001b), and also 
in non-vertebrates such as Drosophila (Mollaaghababa and Pavan, 2003). 
Similarly to other HMG proteins, SOX10 binds DNA through the HMG 
domain; it then activates transcription through a classical transactivation 
domain at the C-terminus (Mollaaghababa and Pavan, 2003). 
SOX10 mutations underlie several neurocristopathies such as 
Waardenburg-Shah Syndrome and Hirschsprung’s disease (Dutton et al., 
2001b; Kelsh, 2006; Pingault et al.) At least four distinct functions have been 
suggested for SOX10, it may be critical for formation of NCCs, maintain their 
multipotency, specification and differentiation of derivative cell types of the 
NC (Kelsh, 2006). 
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In mouse a mutant allele with a single frameshift mutation has been 
described: SOX10Dom. Heterozygous SOX10Dom/+ mice display regional 
deficiencies of neural crest-derived enteric ganglia in the distal colon 
whereas homozygous mutants are embryonic lethal (Southard-Smith et al., 
1998). SOX10Dom/Dom mice have also lack of Schwann cells and satellite glia 
within the DRG (Mollaaghababa and Pavan, 2003). The sensory neuron 
phenotype is weaker than that of other derivatives (Kapur, 1999). In this 
model NCC form correctly but then fail to become specified and eventually 
die.  
 
In Zebrafish sox10 is also known as colourless (cls). several sox10 
mutant alleles have been described including sox10tw2, sox10tw11, sox10t2, 
sox10baz1 and sox10m618(Carney et al., 2006; Dutton et al., 2001b; Kelsh et 
al., 1996; Kelsh et al., 2000). Zebrafish sox10 mutants show a phenotype 
strikingly similar to that of mouse null homozygotes (Carney et al., 2006). 
Zebrafish sox10 mutants have severe defects in most crest-derived cell 
types, including loss of all three pigment cell types and enteric neurons as 
well as reduction in sensory and sympathetic neurons and putative satellite 
glia and Schwann cells. Sox10 mutants have although no defects in 
ectomesenchymal derivatives such as craniofacial skeleton and fin 
mesenchyme (Dutton et al., 2001b; Kelsh and Eisen, 2000; Kelsh et al., 
2000). Premigratory NC forms in normal numbers and DRG precursor cells 
migrate normally, but NCC die before they become specified (between 35 
and 45 hours hpf) (Carney et al., 2006; Dutton et al., 2001b; Kelsh and Eisen, 
2000). It has been proposed that the defects in NC derivatives of sox10 
mutants are consistent with a role of Sox10 in specification, proliferation or 
survival of progenitors for all non-ectomesenchymal crest derivatives (Dutton 
et al., 2001b). More recently sox10 function has been established to be a role 
in NCC fate specification, specifically in all neuronal, glial and pigment cell 
(Carney et al., 2006; Dutton et al., 2001a; Elworthy et al., 2005). It has been 
suggested that the defects in the melanocyte and enteric neuron lineages, in 
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sox10 mutants can largely be explained by disruption of mitf and phox2b 
expression (respectively) (Dutton et al., 2001b; Elworthy et al., 2005). 
In zebrafish sox10baz1 mutant allele has a unique phenotype compared 
with other sox10 mutants, like other mutants it lacks melanophores, PNS 
Schwann cells and enteric neurons. Most strikingly they have an increase in 
DRG sensory neurons (Carney et al., 2006). This difference suggests 
different functions for the sox10 protein. 
 
I.3 NEURAL CREST DERIVED PIGMENT CELLS 
Up to six types of NC-derived pigment cells have been described in fish, 
including melanophores (black, melanocytes in mammals), xanthophores 
(yellow), erythrophores (red), iridophores (iridescent, blue, silver or gold), 
leucophores (dull, whitish) and cyanophores (electric blue)(Kelsh et al., 
2004). In zebrafish there are 3 only three types: melanophores, xanthophores 
and iridophores although leucophores might be present in adult tail fin (Kelsh 
et al., 2004). 
 
Before becoming pigmented, pigment cell precursors are called 
chromatoblasts. In fish, contrary to humans, these cells differentiate relatively 
early, and thus migrating pigment precursors are partially pigmented. Unlike 
mammals, fish melanophores migrate through both the lateral (under 
developing epidermis) and the medial pathway (between the somites and 
NT). Xanthophores are restricted to the lateral pathway, and iridophores are 
restricted to the medial pathway (Kelsh et al., 2004). 
 
I.3.1 PIGMENT CELL SPECIFICATION AND DIFFERENTIATION 
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How cells become specified to their final fates is one of the most 
interesting questions of Developmental Biology. The NC-derived pigment 
cells are a great tool to answer this question. In the zebrafish embryo 
melanophores are present in a striped pattern with four longitudinal stripes: 
dorsal stripe dorsal to the neural tube, lateral stripe in the horizontal 
myoseptum, the ventral stripe dorsal to the gut, and the yolk sac stripe 
ventral to the yolk (Kimmel et al., 1995); iridophores are present in the dorsal 
stripe, the ventral stripe, the yolk patch and the eye. Xanthophores don’t 
have a stripy pattern but instead cover the whole surface of the embryo. 
Several molecules are known to be involved in the development and 
specification of NC-derived pigment cells. In melanocytes/melanophores it is 
widely accepted that mitf (microphthalmia-associated transcription factor) or 
the zebrafish homologue mitfa/nacre is critical for melanocyte differentiation 
and is required for melanoblast formation (Kelsh et al., 2000). 
Mitf is a basic HLH-leucine zipper transcription factor and it has been 
shown to be required for transcription of many melanocyte genes such as 
tyrosinase and at least indirectly dct (Steingrimsson et al., 2004). Mitfa/nacre 
mutants lack melanophores, but have extra numbers of iridophores (Lister et 
al., 1999). 
Dct (dopachrome tautomerase) is a melanogenic protein and is 
considered as one of the first markers of the melanocyte lineage (Kelsh et al., 
2000). Dct expression in zebrafish starts around 19 hpf, and is thought to be 
a marker for melanoblasts, but it continues to be expressed after 
melanogenesis begins at 24 hpf (Kelsh et al., 2000). SOX10 regulates the 
expression of the Dct gene. Dct functions in melanin biosynthesis. In 
Sox10Dom/+ heterozygous embryos, Dct expression is severely reduced in the 
trunk and cranial regions. Intriguingly, Dct expression is significantly restored 
later in development. It has been suggested that this could be either due to 
SOX10 regulation being only transient or that a gradual accumulation of the 
wild-type SOX10 protein partially overcomes the effect of the SOX10Dom 
allele with restoration of Dct expression (Mollaaghababa and Pavan, 2003). 
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I.3.2 IRIDOPHORES 
Iridophores are iridescent under incident light (Kelsh et al., 1996). This 
iridescent property results from specially orientated organelles. These consist 
of flat reflecting platelets usually arranged in highly orientated stacks, that are 
rich in purines (primarily guanine) (Le Douarin and Kalcheim, 1999). Since 
guanine is one of the main components of these reflective platelets, it is 
interesting to notice that that addition of guanosine to axolotl embryos alters 
the pigmentation pattern by suppressing melanisation and increasing the 
number of xanthophores and iridophores (Frost et al., 1987). This was also 
true in cell cultures from axolotls (Thibaudeau and Holder, 1998). It is 
possible that guanosine might be the precursor used to form these guanine 
platelets. 
Whilst it is partially understood how NCCs generate melanophores, little 
is known of iridophore specification. There are only two known iridoblast 
markers, ednrb1 (Parichy et al., 2000) and ltk (Lopes et al., 2008). I will 
discuss ltk in detail in section I.7.2. Apart from these, Müller (2007) has 
identified cb632 and id2a as iridophore markers. Sb:cb632 or gmp (guanine 
monophosphate synthetase) was found to be expressed in the eye, tectum 
and premigratory NC by 24 hpf. By 48 hpf expression is localised in small 
spots along the DS and VS in a pattern reminiscent of iridophores. Further to 
this ltkty82 mutants lacked these spots whereas mitfaw2 (that have extra 
iridophores), had more of these cells, suggesting these are iridophores. Gmp 
synthetase is involved in the de novo synthesis of purines (Müller, 2007; 
Lister, 1999). Id2a is an inhibitor of differentiation protein and will be 
discussed further in section I.5. 
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I.4 LABELLING THE NEURAL CREST 
One of the problems with studying the NC is determining exactly what 
its derivatives are, where they are formed, how they migrate and whether or 
not different subsets of NC with different pluripontencies exist. 
Several methods to label the NC and its progeny have been extensively 
used in chicken, frog and zebrafish. These include vital dyes such as DiI 
injected in the lumen of the neural tube or directly into the neural folds, NC 
cell specific antibodies, retroviral-mediated gene transfer and chick-quail 
chimeras (Eisen and Weston, 1993; Fraser and Bronner-Fraser, 1991; 
Osumi-Yamashita et al., 1997; Weston, 1991). 
The quail-chick chimeras have been particularly useful in the study of 
neural crest morphogenesis and differentiation. Due to different histological 
properties, quail and chick cells can be distinguished one from the other. In 
this system part of the neural primordium of one species is replaced by the 
other species counterpart. This allows following these cells from migration till 
their final fate. They have confirmed the NC origin of facial skeleton, the 
contribution of the NC to the endocrine system, the A-P localisation of the 
various derivatives and the pathways and chronology of their migration as 
well as their plasticity (for a review Le Douarin, 2008). 
 
I.4.1 SOX10 TRANSGENIC LINES 
In zebrafish several transgenic reporter lines have been generated 
using the sox10 promoter (Carney, 2003; Carney et al., 2006; Dutton et al., 
2008). These lines differ in the length of the promoter used, but all use eGFP 
as a reporter. 
Carney et al. (2006) describe a transgenic line containing 4.9 kb of the 
sox10 promoter. In this line GFP expression in pre-migratory NCCs replicates 
that of the endogenous sox10, being visible from the one somite stage; 
subsequently GFP expression is seen in both pre-migratory and migratory 
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NCCs. By 24 hpf cranial GFP-expressing cells include migrating CNC, NC in 
branchial arches, glia precursors surrounding cranial ganglia and otic 
epithelium. GFP was found in migrating cells of both the the lateral and 
medial pathway. 
By 24 hpf putative neurons of the olfactory bulb also start to express 
GFP. GFP expression was also seen in the central CNS (particularly in the 
brain and anterior spinal cord). By 48 hpf GFP is still seen in migrating NCCs 
in both pathways, Expression in satellite cells of the cranial ganglia, otic 
epithelium and branchial arches is still maintained. Other cranial crest cells 
such as melanophores and xanthophores have weaker expression. GFP 
expression persists in all peripheral glia, including DRG statelite glia, 
Schwann cells of the PLL and spinal nerves at least until 5 dpf (Carney et al., 
2006). 
Authors describe that the clear GFP expression seen within the 
branchial arches by 24 hpf. In the CNS expression can still be seen in cells of 
the ventral fore, mid and hindbrain (possibly oligodendrocyte precursors and 
neurons), olfactory bulb expression is still active and NCC associated with 
PLL ganglia and nerve (Schwann cells) still remain GFP+ (Carney et al., 
2006). 
At 56 hpf GFP+ spinal nerve associated glial cells are seen in a 
segmental arrangement medial to each somite, also satellite glia surrounding 
the neurons of the DRGs are GFP+. At 3 dpf expression in cartilage elements 
of the jaw and pectoral fin are GFP+. Putative interneurons with ventrally and 
laterally projecting axons can be seen in the NT. By 5 dpf the only NC cells to 
retain GFP expression are those of the jaws and PNS Schwann cells, and 
enteric nervous system expression starts to be seen. At 24 and 48 hpf 
ectopic muscle expression is seen (Carney et al., 2006). 
Carney (2003) describe another transgenic line sox10(6.1):GFP, in this 
transgenic line migrating NC cells can be seen at 28 hpf and cranial NC and 
olfactory bulb expression is similar to that of 4.9 line. At 2 dpf GFP 
expression can be seen in Schwann cells in the PLL ganglia and surrounding 
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the DRGs. Ear and hindbrain are also positive. In the NT strongest 
expression is seen in putative oligodendrocytes, predominantly ventrally and 
dispersed in more dorsal parts, faint expression is also seen in putative 
interneurons. 
Expression pattern is very similar to 4.9 line although slightly weaker. 
But this line additionally expresses GFP in cell surrounding the heart at 5 dpf. 
No ectopic muscle expression was seen (Carney, 2003; Carney, 2006). 
The other published lines Tg(-4725sox10:gfp)ba4 and Tg(-
1252sox10:gfp)ba5 show a similar GFP expression pattern, although with 
stronger otic vesicle expression and melanophores are still GFP+ at 48 hpf in 
the -4725sox10:gfp line. The line -1252sox10:gfp does not show expression 
in premigratory NC at 1 somite stage like the other lines (Dutton et al., 2008). 
 
Despite their great usefulness NC labelling methods are either transient 
or restricted only to a few NCCs at a time (Yamauchi et al., 1999) This 
prevents following these cells for the whole of their development. It would 
therefore be extremely useful to the field to have a tool for permanent 
labelling of the crest. One of such system could be the Cre/Lox system. 
 
I.4.2 PERMANENT LABELLING AND CRE/LOX 
The Cre/Lox system was first described in 1981 due to its involvement 
in several aspects of the P1 life-cycle (Hamilton and Abremski, 1984). The 
Cre recombinase is a Type I topoisomerase from P1 bacteriophage that 
belongs to the integrase family of site-specific recombinases, that catalyse 
site-specific recombination of DNA between loxP sites. The loxP sites consist 
of consensus 34 bp DNA recognition sites (Nagy, 2000). When Cre is 
activated, it mediates molecular recombination between two loxP sites. Two 
Cre molecules bind to two loxP sites and binding them close together, 
forming a circular protein-DNA complex. They then catalyse the 
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recombination. This recombination can result in excision or inversion of the 
loxP flanked region (Hamilton and Abremski, 1984; Nagy, 2000). The choice 
between excision and inversion depends on the relative orientation of the two 
loxP sites. Several other integrases exist and have been described and used, 
e.g. the FLP and Int systems (Lee and Saito, 1998). 
The Cre-lox system has been used for several different approaches, 
particularly in mice, such as conditional knock-out, chromosomal 
rearrangements for human disease modelling and more importantly for us 
cell lineage tracing (Branda and Dymecki, 2004; Livet et al., 2007; Seok et 
al., 2010). Conditional knock-out in mice relies on a binary system, mice 
carry two different constructs, one expresses Cre in a specific domain, 
usually by using tissue specific promoters, the other construct flanked by 
loxP sites replaces all or part of the an endogenous gene. This allows for 
endogenous gene expression to occur normally with exception of the Cre 
domain, thus allowing study of the effect of a specific gene in a restricted 
population of cells (Branda and Dymecki, 2004). 
This same binary approach is used for gene over-expression or 
permanent lineage cell labelling. As an example Seok et al. (2010) have 
generated a transgenic zebrafish line that conditionally expresses an 
oncogene when injected with Cre mRNA.  
An increasing number of mouse and zebrafish models are being 
created that allow for permanent cell labelling of specific cell lineages or 
populations, particularly in the study of neural development (Livet et al., 
2007; Merkle et al., 2004; Zovein et al., 2008). Generally, a constitutive 
promoter such as the Ef1α, β-catenin or the ROSA26 locus (Soriano, 1999), 
drive the expression of a particular fluorescent protein, or other reporter such 
as lacZ, only where Cre has been activated. Generally Cre removes a poly-
Adenylation signal (pA) flanked by the lox sites (with or without a selection 
marker) allowing the expression of the downstream reporter. Since this 
recombination happens at the chromosomal level it is permanent and 
transmitted to the progeny. This method has allowed for identification of 
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origin of specific cell types derivatives (Lepper and Fan, 2010), as well as 
help in understanding origin of stem cells (Merkle et al., 2004; Zovein et al., 
2008). 
Several mutated versions of the loxP sites have been developed that 
like loxP can be recognised by Cre but that do not recombine with loxP or 
within themselves (Lee and Saito, 1998). Recently researchers have used 
three of these different versions to generate a transgenic mouse model, 
Brainbow, with 3 possible recombination outcomes (Livet et al., 2007). This 
mouse expresses one of three different fluorescent proteins depending on 
which lox site recombines; recombination of one site prevents further 
recombination of the others by removing the remaining lox sites. Livet et al. 
refer that this model has several copies of the transgene, leading to 
expression of several fluorescent proteins in each cell. Since the choice of 
recombination events is random, cells can express different coloured proteins 
in different quantities, upon fluorescent combination these can lead to up to 
90 differently coloured cells. This model allows not only the identification of 
individual cells but also tracing of their progeny (Livet et al., 2007). 
 
I.4.3 THE NEURAL CREST AND THE CRE/LOX SYSTEM 
The origin of neural crest derived cells and its full derivatives are 
surrounded in controversy, mainly due to limited markers that allow for the 
limeted tracing. The mouse model has recently taken use of the Cre/lox 
system to solve this issue. Several transgenic lines have been produced that 
express Cre using the promoter or enhancer of a NC marker. Such examples 
include the Wnt1-Cre/R26R (Chai et al., 2000; Danielian et al., 1998; 
Poelmann et al., 2004), Cx43-lacZ (Waldo et al., 1999), Pax3-Cre/R26R 
(Epstein et al., 2000) and the P0-cre (Yamauchi et al., 1999) lines. 
Pietri et al. (2003) have using the Cre/loxP system generated a mouse 
line that exclusively labels NC derivatives through the Ht-PA-Cre/R26R. 
Using a Wnt1-Cre line researchers have been able to demonstrate that the 
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NC contributes to tooth and mandibular morphogenesis and that NC is 
contiguous with the cardiac conduction system (Chai et al., 2000; Poelmann 
et al., 2004). Using the same model researchers have also shown the 
contribution of NCCs to the development of the mammalian eye (Gage et al., 
2005). These findings would have been difficult to prove, particularly in mice, 
had it not been for the permanent labelling of the NC. 
 
Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) 
The Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) transgenic line was 
kindly given to us by Dr. Laure Bally-Cuif. This line contains the Elongation 
factor 1 alpha (EF1alpha) promoter, which is a ubiquitous promoter, followed 
by the egfp gene flanked by two loxP sites and the DsRed gene (Yoshikawa 
et al., 2008). In the absence of Cre the EF1alpha promoter constitutively 
produces eGFP in every cell of the embryo (Figure I.1). The egfp gene 
contains a SV40 polyadenylation site (pA), thus preventing the translation of 
the downstream dsred gene. Upon production, Cre recombinase recognizes 
the two loxP sites and mediates the intramolecular recombination resulting in 
the excision of the egfp gene in-between, this leads to the constitutive 
expression of the downstream DsRed gene; DsRed expression is now 
permanent in these cells and their progeny as this excision occurs at the 
DNA level. 
 
I.4.4 PRODUCTION OF ZEBRAFISH TRANSGENIC LINES 
Production of transgenic animal lines as long been used in research. 
Whereas in mouse models several systems exist to produce these transgenic 
models, in zebrafish this invariably involves injection of circular or linear, 
foreign DNA into the egg. Production of a stable line implies that the injected 
DNA must stably integrate into the germline genome (Allende, 2001). This 
foreign DNA can either be integrated randomly in the DNA or with the aid of I-
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SceI meganuclease (Thermes et al., 2002) or transposon systems (Suster et 
al., 2009). In fish random integration of DNA is a rare event and is reported to 
produce between 5 – 20 % of F0 injected with the integration in the germ-line 
and germ-line transmission of 0.5 % to 50 %  (Thermes et al., 2002). This 
integration normally consists of tandem arrays of the original injected 
construct, as shown by southern analysis. And can also occur independently 
in different regions within the same carrier, leading to possible Mendelian 
segregation in the next generations (Culp et al., 1991). I-SceI meganuclease 
has been reported in Medaka embryos to produce higher rates of 
transgenesis. This system involves flanking the construct of interest with 
recognition sites for a restriction endonuclease and co-injecting them with the 
endonuclease. The endonuclease recognition site is rare in the endogenous 
genome so it is reported that it acts solely to digest the injected DNA 
(Thermes et al., 2002). The greatest advantages reported for this system 
were the much higher F1 transmission rates (closer to 50 %) suggesting 
early integration events, and the reduction in the number of concatemers 
(Thermes et al., 2002). 
More recently transposon systems have been applied to produce 
transgenic zebrafish. Such examples include the Tol2 transposon from 
Medaka and the Sleeping beauty from Salmon. These are binary systems 
composed by the construct of interest flanked with the transposase 
recognition sites, and the transposase. To generate transgenics, fish are co-
injected with the construct and the respective transposase mRNA. 
Transposase is then transduced by the cellular machinery and mediates the 
insertion of the construct into the genome. These systems have reported a 
higher efficiency of transgenesis ranging from ~30 % to 70 %, and higher 
percentages of F1 transmission (Davidson et al., 2003; Kawakami, 2004; 
Kawakami, 2007; Kawakami et al., 1998). 
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Figure I.1 – Ubiquitous GFP in reporter line. Transgenic Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) 
4 dpf embryo. Overlay of Brightfield and green fluorescence. This embryo expresses eGFP constitutively in 
all cells under a ubiquitous promoter (EF1alpha). 
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I.5 INHIBITORS OF DIFFERENTIATION PROTEINS 
ID proteins or inhibitors of differentiation proteins are bHLH proteins that 
lack the characteristic basic domain. BHLH proteins are a family of 
transcription factors that contain a helix-loop-helix domain (HLH); this domain 
comprises two alpha helices separated by a small intervening loop. The 
helix-loop-helix domain allows HLH proteins to form homo- or hetero-dimers, 
which is essential for DNA binding and transcriptional activation. BHLH 
domains also contain a region of highly basic residues that composes the 
basic domain. The basic domain facilitates binding to DNA sequences 
containing the canonical ‘E box’. ID proteins lack this domain and thus 
function only by dimerizing with other bHLH proteins. The ID-bHLH 
heterodimers are unable to bind DNA, thus ID proteins act as negative 
regulators of their bHLH partners (for a review, Norton, 2000). 
Due to the fact that most bHLH regulate cell fate determination and 
differentiation ID proteins were traditionally viewed as negative regulators of 
differentiation. More recent works have show that ID proteins have several 
other roles. ID proteins are involved in regulating lineage commitment and 
cell fate determination, promote cell growth and arrest differentiation, are 
required for cell cycle progression, apoptosis, angiogenesis, function as 
oncoproteins and promote tumour invasiveness (Jung et al., 2010; Martinsen 
and Bronner-Fraser, 1998; Norton, 2000; Tokuzawa et al., 2010). 
 
Drosophila has one ID-like gene, extramacrochaetae (emc); null 
mutants for this gene an embryonic lethal. Emc is responsible for several 
developmental processes of which sensory organ development, wing 
morphogenesis and sex determination have been the most extensively 
studied. EMC seems to regulate cell commitment, differentiation and cell 
proliferation  (Jan and Jan, 1993; Norton, 2000). ID proteins have also been 
linked to the Notch signalling pathway. Emc gene or protein is regulated by 
Notch to control Drosophila wing vein differentiation (Norton, 2000). 
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Mammals possess four Id family members, Id1-Id4, with overlapping 
expression patterns and functional redundancy. Double knockout 
combinations of Id1 – Id3 are embryonic lethal (Norton, 2000; Sikder et al., 
2003). Id1-/-Id3-/- embryos have aberrant neurogenesis with premature cell 
cycle withdrawal of neuroblasts and expression of neural-specific 
differentiation markers. In addition, they exhibit vascular malformations 
(Lyden et al., 1999). Id2-/- are embryonic viable but have defects in peripheral 
lymphoid organs and natural killer cells (Yokota et al., 1999). Id2 is not the 
only ID protein involved in lymphogenesis, Id3-/- mice also display defective 
immune response in vivo, and in vitro mature B cells display defective 
proliferative response (Norton, 2000). Id2-/- also exhibit a defect in lactation: 
during pregnancy mammary glands fail to expand and remain small in size 
(Yokota et al., 1999).  
 
During neural development, pro-neuronal bHLH proteins such as 
Mash1 or Ngn form heterodimers with ubiquitous E-proteins and bind to the 
E-box regulating other bHLH genes such as NeuroD. NeuroD then activates 
cell cycle-dependent kinase inhibitor causing cell cycle exit. This causes 
precursor cells to arrest proliferation stage and terminally differentiate into 
neurons. ID mediated regulation of these bHLH factors is critical for a 
balance between expansion of progenitor cells and differentiation (Jung et 
al., 2010). In vitro assays have shown that id2 protein prevents NeuroD 
binding to its target sequence, inhibiting the stimulatory activity of NeuroD in 
HeLa cells, and suggesting that Id proteins might negatively regulate 
NeuroD-induced tissue specific gene expression (Ghil et al., 2002). Mutations 
of Id1 in conjunction with Id3 or Id4, produce a small brain phenotype in mice, 
this suggests a critical role in the cell cycle regulation of neural precursor 
cells (Jung et al., 2010). Jung et al. have shown that in cortical neural stem 
cells isolated from mouse telencephalon, Id1, Id2, and Id3 increase self-
renewing and the proliferating potential of those. Id proteins interfere with 
binding of NeuroD/E47 complexes to the E-box sequences, thus inhibiting 
neuronal differentiation. Conversely persistent Id protein expression 
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stimulates astrocyte differentiation (Jung et al., 2010). In Id4-/- several areas 
of the CNS showed reduction in mitotic neural precursor cells, and a thicker 
neocortex due to premature neuronal differentiation. Consequently late-born 
neurons in adult brains were decreased and brains are smaller, putatively 
due to the depletion of the neural precursor cell pool (Bedford et al., 2005).  
 
In both fish and mammals ID proteins seem to be important for muscle 
development, due to their binding muscle bHLH proteins such as myoD, 
myogenin, Myf5 and MRF4 (Ghil et al., 2002). In trout TId1 and TId2, 
homologous to human ID1 and ID2 respectively, are expressed in slow 
oxidative muscle fibres (Rescan, 1997). During development trout TId6a, 
TId6b and TId1 were expressed in paraxial mesoderm and the ventral and 
dorsal domains of neoformed somites. TId2 transcripts were only found 
transiently in dorsal domains of neoformed somites. Their location in dorsal 
and ventral domains of somites suggests that ID positive cells might 
correspond to proliferative somitic cells involved in somite growth (Ralliere et 
al., 2004). In trout TId6a, TId6b and TId1 are also expressed in the dorsal 
side of the neural keel, neural tube, cerebellum, optic tectum, telencephalon, 
tail bud, lens and retina. TId2 is expressed in the lens of eye rudiment and 
strongly accumulated in the pronephros (Ralliere et al., 2004). 
 
In Xenopus id3 is expressed in the neural plate border during 
gastrulation and neurulation overlapping the domain of neural crest induction, 
as well as in migrating neural crest. Its expression significantly precedes that 
of genes affecting NCC specification, such as slug or C-myc. Knock-down 
(KD) of id3 resulted in the absence of neural crest precursors and 
consequent loss of neural crest derivatives (Kee and Bronner-Fraser, 2005). 
Kee and Bronner-Fraser (2005) suggest that rather than a cell fate switch, 
this is mediated by cell cycle inhibition followed by cell death of the neural 
crest progenitor pool. Overexpression of Id3 increased cell proliferation and 
resulted in expansion of the neural crest domain. Authors suggest that Id3 
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mediates a decision of NC precursors to proliferate or die; a novel 
mechanism independent of cell fate determination (Kee and Bronner-Fraser, 
2005). In zebrafish, id3 is expressed in the germ ring and embryonic shield, 
by the end of gastrulation id3 is highly expressed in the anterior prechordal 
plate and hypoblast. At later stages, id3 expression is turned on and off in a 
large variety of tissues within short periods of time. These include, lateral 
mesoderm, cornea, lens, brain, cranial and trunk neural crest, retina and fins 
(Dickmeis et al., 2002). 
Id1 in zebrafish (previously known has id6) is expressed at the borders 
of the axial mesoderm and in the paraxial mesoderm until the end of 
gastrulation. From late gastrulation onwards id1 is most conspicuous within 
the developing CNS, in the ventral region and floor plate of the spinal cord. 
During late stages it is expressed in zones of intense proliferative activity, 
such as the ventricular zone. It is also weakly expressed in the anlage of the 
trigeminal ganglion and during somitogenesis in the presomitic and paraxial 
mesoderm (Sawai and Campos-Ortega, 1997). The function of both id1 and 
id3 during zebrafish development is not known yet. Id4 in zebrafish has not 
been studied but data from Thisse et al. shows expression of id4 mostly in 
CNS (Thisse and Thisse, 2004). 
In chick and Xenopus, Id2 is expressed in cranial neural folds and 
cranial neural crest. Id2 is also expressed in the developing heart in the 
cardiac neural crest, secondary heart field, outflow tract, inflow tract, anterior 
parasympathetic plexus (chick) and splanchnic mesoderm (Xenopus) 
(Martinsen and Bronner-Fraser, 1998; Martinsen et al., 2004). Ectopic 
expression of id2 in chick converted ectodermal cells to NC. Overexpression 
also resulted in overgrowth and premature neurogenesis of the dorsal neural 
tube, suggesting a role of Id2 in shifting ectodermal cells to a neural fate 
(Martinsen and Bronner-Fraser, 1998). Physical ablation of cardiac crest in 
chick results in a significant loss of Id2 expression in the outflow tract 
whereas ablation of the premigratory neural crest in Xenopus embryos 
results in abnormal formation of the heart and a loss of Id2 expression in the 
heart and splanchnic mesoderm. These results suggest that Id2 is expressed 
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in NC-derived cells of the heart in both chick and Xenopus heart 
development (Martinsen et al., 2004). Involvement of Id2 in pigment cell 
development in Xenopus or chick has however not been studied yet. 
 
I.5.1 ID2 IN ZEBRAFISH 
When mapping clone sb:cb321 in zebrafish Jeannette Müller, a PhD 
student in the Kelsh lab, identified it as being id2a (Müller, 2007). Both Müller 
(Müller, 2007) and Chong et al. (Chong et al., 2005) described that id2a is 
expressed in positions typical for premigratory and NCCs migrating along the 
anterior half of the somites in 24 hpf wild-type embryos. Both authors report 
expression in corpuscle of Stannius and brain by 48 hpf. Müller contrary to 
Chong et al. shows expression in the lateral line nerve whereas Chong et al. 
mention expression in the lateral line neuromasts. Müller also shows 
expression of id2a in iridophores until at least 72 hpf. Chong et al. were able 
to distinguish different brain domains such as: telencephalon, hypothalamus, 
dorsal retina, trigeminal ganglion and other sensory ganglia, cerebellum and 
hindbrain, later in development also in midbrain. Müller could not verify this 
as embryos were stained for longer and thus showed a strong head 
background; she speculated that the iridophore expression pattern seen at 
48 hpf and 72 hpf could be due to longer staining times, thus suggesting 
lower expression levels of id2a in iridophores when compared to the brain 
(Chong et al., 2005; Müller, 2007). Chong et al. also report expression in 
notochord, pronephric ducts. 
 
By looking at three different NC mutants: sox10m618, nacrew2 and ltkty82, 
Müller was able to show that at 24 hpf id2a was absent in migratory NCCs in 
homozygous sox10m618 and reduced in ltkty82 when compared with WT 
embryos. By 48 hpf id2a was expressed in a typical iridophore pattern in the 
DS and VS with an increase in nacrew2. In sox10m618 and ltkty82 mutants id2a 
expression was absent in DS and VS. By 72 hpf id2a was still expressed in 
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WT embryos along the DS and VS this was again absent in sox10m618 and 
ltkty82 mutants. Müller also suggests that id2a was expressed in other NCC 
precursors at 24 hpf (Muller, 2007). 
Müller further assesses the effect of id2a knock down using a 
translation blocking morpholino, and concludes that id2a downregulation 
leads to a significant reduction in iridophore numbers in the DS, VS and eye 
at 4 dpf. Müller also showed that at the earliest time point observed, 30 hpf, 
there is a strong reduction of ltk positive cells. Cbc632 was nearly completely 
absent by 48 hpf. The same reduction was seen with the iridophore marker 
ednrb1. This reduction effect was not observed in melanophores where 
numbers were equivalent in WT and morphants (Muller, 2007).  
Müller reports no further morpholino phenotypes with exception of heart 
oedema and shorter axis probably resulting from morpholino toxicity as this 
does not correlate with id2a expression pattern. She concluded that id2a in 
zebrafish is required for iridophore development. Also Müller suggested a 
direct dependence of id2a on ltk (Müller, 2007). 
 
I.5.2 ID SIGNALLING PATHWAYS, REGULATION AND CANCER 
In mammals ID proteins target preferentially the ubiquitously expressed 
‘E proteins’ of the Class A bHLH proteins (E12, E47, E2-2, HEB). Normally E 
proteins would form heteromeric complexes with the more tissue-specific 
Class B bHLH proteins. In mammals biochemical data suggests that even 
though IDs bind to any of the four E-proteins they might have preferential 
partners (Norton, 2000).  
ID proteins have also been reported to interact with other non-bHLH 
proteins such as Rb, ETS and MIDA1 in the context of cell cycle and growth 
control. These transcription factors are well known for their roles in regulating 
various cellular processes, particularly cell fate determination in diverse cell 
lineages (Norton, 2000). Additionally ID1 - ID3 interact in vitro with members 
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of the PAX family (PAX-2, PAX-5; PAX-8) and are antagonists of their 
function, by disrupting DNA binding and transcriptional activation of PAX-
responsive genes. In vivo, Id proteins modulate the transcriptional activation 
of the B-cell-specific mb-1 promoter, mediated by Pax-5 complexes, 
therefore regulating cellular differentiation (Norton, 2000; Roberts et al., 
2001). The adipocyte determination and differentiation factor-1 (ADD1), a 
member of the bHLH-leucine-zipper family of transcription factors also 
interacts with ID2 and ID3 (Norton, 2000). 
Several studies have been done into the possible interaction between 
retinoblastoma protein (Rb), Id2 and N-myc, particularly in neuroblastomas 
(Lasorella et al., 2002; Lasorella et al., 2000; Lasorella et al., 2006; Wang et 
al., 2003). Neuroblastoma is a form of cancer originated from a neoplastic 
transformation of the neural crest during embryogenesis, characterized by 
the hallmark expression of N-myc. The correct expression of Id2 is essential 
to regulate proliferation and differentiation of NC (Lasorella et al., 2000; 
Martinsen and Bronner-Fraser, 1998). 
Disruption of the Rb pathway (which includes cyclin D, cdk4/7 and p16) 
is a hallmark of cancer and is widely accepted that downregulation of Rb 
function must occur in all human tumours. Phosphorylated Rb (pRb) acts 
physiologically to maintain the cells in the G0/G1 phase of the cell cycle 
(Iavarone et al., 1994; Lasorella et al., 2000). pRb interacts with several 
cellular proteins including C-myc, the transcription factor E2F and myogenic 
factors like MyoD and myogenin. The interaction between MyoD and pRb 
mediates not only the induction of myogenic differentiation but also cell cycle 
arrest, which is induced by this bHLH factor (Iavarone et al., 1994). 
It has been reported that in neuroblastomas the Rb growth inhibitory 
pathway is bypassed by Id2 overexpression, in cells carrying extra copies of 
the N-myc oncogene. Levels of Id2 in these cells are above those of the 
hypophosphorylated Rb. In vitro c-Myc and N-myc were able to transactivate 
the Id2 promoter through the E-box. Thus transcription activation by an 
oncoprotein of the Myc pathway leads to Id2 overexpression, bypassing the 
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Rb block and driving progression of the cell cycle. This together with the fact 
that id2 is a key target of normal cells suggests that not only is Id2 a key 
factor in the timing of differentiation but also that it can be the effector of an 
oncogene in human cancer (Lasorella et al., 2000). Further studies by the 
same authors suggest that Id2 expression in neuroblastomas is strongly 
predictive of a poor outcome and suggest that Id2 overexpression may be 
better than N-myc amplification, as a prognostic indicator in neuroblastomas 
(Lasorella et al., 2002). Other studies have linked in human cell lines pRb 
and Id2, in these studies overexpression of Id2 was able to reverse the 
growth inhibition caused by pRb by binding to its unphosphorylated form 
(Iavarone et al., 1994). 
These conclusions by Lasorella et al. (Lasorella et al., 2002; Lasorella 
et al., 2000) are contradicted by Wang et al. (2003) that found no correlation 
between levels of Id2 and N-myc in primary neuroblastoma cell lines and 
suggest that transcription regulation of Id2 by N-myc is unlikely to be a 
seminal molecular event resulting in a highly neuroblastomas phenotype 
(Wang et al., 2003). Nevertheless several other authors have suggested the 
importance of Id apoptotic functions in the development of human 
malignancies (Florio et al., 1998; Fong et al., 2004; Sikder et al., 2003). 
Id2 over expression in vitro has been reported to augment apoptosis of 
32D.3 cells, an interleukin-3 (IL-3)-dependent myeloid progenitor cell line, 
and U2OS cells, an osteogenic sarcoma-derived cell line. This activity was 
not bHLH dependent but rather through the N-terminal region of Id2 and its 
interaction with a known modulator of cell death cascade, Bax (Florio et al., 
1998). 
Curiously a report by Mathas (2009) has shown that in ALCL with or 
without the NPM-ALK translocation (see I.7.1), Id2 and other genes near the 
translocation breakpoint are deregulated. Up-regulation of these genes 
promotes cell survival and repression of T-cell specific genes. This 
deregulation in proximity of the breakpoint, facilitates the translocation on 
induction of double strand breaks. The authors also suggest that deregulation 
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of the break-point proximal genes occurs before the translocation. Further 
they have shown that Id2 could not only bind to bHLH proteins E2A and HEB, 
but also lead to Id2-mediated decrease of several T-cell associated proteins 
and E2A activity. Because E2A acts as a tumour suppressor in the lymphoid 
compartment, Id2-mediated loss of E2A activity might be linked to tumour 
progression (Mathas et al., 2009). 
 
Very little is known about the upstream signalling that links extracellular 
signalling to Id expression. They are nevertheless regulated at the post-
translational level by cell-cycle-linked phosphorylation through CDK2-
dependent phosphorylation during late-G1/early-S phase and are regulated 
through the ubiquitin-proteasome degradation pathway. ID proteins have a 
fast turn over in the cell, with a reported half-life of 20-60 min. In the nervous 
system Id2 has been show to be a target of APC/CCdh1 complex for 
degradation. They are also regulated by subcellular localisation. They do not 
possess a nuclear localisation signal themselves, so it is thought that their 
bHLH protein partners sequester IDs to the nucleus, as bHLH possess an 
efficient nuclear localisation signal (Lasorella et al., 2006; Norton, 2000).  
 
Id proteins are not only involved in inhibiting differentiation but have 
been shown to promote differentiation by acting as a molecular switch. Id4 
has been show to act as such molecular switch in mesenchymal stem cells 
where it promotes adipocyte differentiation and represses osteoblast 
differentiation. Id4 releases Hes1 from Hes1-Hey2 complexes preventing 
Hes1 to stabilise the transcriptional activity of Runx2, responsible for 
osteoblast differentiation (Tokuzawa et al., 2010). In oligodendrocytes ID4 
expression decreases as cells proliferate, while overexpression inhibits 
differentiation, and has been implicated in the ‘molecular clock’ mechanism 
controlling the timing of oligodendrocyte differentiation (Norton, 2000). 
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Hacker et al. (Hacker et al., 2003) have described a signalling pathway 
involving TGF-b induced Id2 expression in dendritic cells. These authors 
have shown that Id2 represses B cell genes in dendritic cells, thus affecting 
lineage choice. Id2-/- mice showed increased numbers of B cells and 
reduction/absence of dendritic cells (Hacker et al., 2003). 
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I.6 RECEPTOR TYROSINE KINASES 
Receptor Tyrosine Kinases (RTKs) play not only pivotal roles during 
normal cellular processes such as promoting migration, proliferation and 
survival, but have a further critical role in the development and progression of 
many types of cancer. (Baselga, 2006; Lemmon and Schlessinger, 2010; 
Zwick et al., 2001). 
Receptor tyrosine kinases are a family of cell surface receptors with 
protein tyrosine kinase activity. They can be divided into 20 subfamilies that 
share a homologous domain encoding catalytic tyrosine kinase function 
(Zwick et al., 2001). Amongst the most well studied subfamilies of RTKs are 
EGFR, Insulin receptors, PDGFR, FGFR, VEGFR, Trk and LTK (Gilbert, 
2000; Zwick et al., 2001). In common all contain an extracellular ligand 
binding domain, a transmembrane helical domain and a cytoplasmic domain. 
The cytoplasmic domain contains the conserved protein tyrosine kinase core, 
plus additional C-terminal and juxtamembrane regulatory regions (Lemmon 
and Schlessinger, 2010; Schlessinger, 2000). 
The RTK pathway begins at the cell surface, where a specific ligand 
binds an RTK, upon ligand binding these receptors dimerize (these can be 
homo- or heterodimers depending on the family).or change conformation (in 
the case of the insulin receptor) leading to activation by cis- or trans-
autophosphorylation of the tyrosine residues in the cytoplasmic domain 
(Lemmon and Schlessinger, 2010; Zwick et al., 2001). Insulin receptor and 
IGF1 receptor form oligomers even in the absenceabsence of ligand. Other 
RTKs might require larger oligomers (Lemmon and Schlessinger, 2010). 
These activated receptors can then bind several adaptor proteins such as 
Src, Shp2, PLCγ, Ras, Grb2 or IRS (see Figure I.2) (Zwick et al., 2001). 
These adaptor proteins are then responsible for the activation of common 
downstream signalling pathways (Lemmon and Schlessinger, 2010). These 
include amongst others the MAP kinase pathway and the Jak/STAT pathway 
(Lemmon and Schlessinger, 2010; Schlessinger, 2000). 
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Figure I.2 - Generic receptor tyrosine kinase 
pathway (adapted from Zwick et al., 2002). 
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I.6.1 RTKS IN HUMAN DISEASE 
 Numerous human diseases result from genetic changes or 
abnormalities that alter the activity, abundance, cellular distribution, or 
regulation of RTKs (Lemmon and Schlessinger, 2010). Aberrant RTK 
function, i.e. abnormal signalling can be caused by diverse mechanisms, 
including deletion or mutation within the extracellular, catalytic or 
transmembrane domains and also translocations that create novel fusion 
proteins, all leading to ligand-independent kinase activation, or aberrant 
coexpression of the RTK and its associated ligand (Lemmon and 
Schlessinger, 2010; Salomon et al., 1995). These are then responsible for 
the RTK effect in disease progression in conditions such as: glioblastomas, 
neuroblastomas, melanomas and acute myeloid leukaemia. It is their central 
role in the signalling cascades that control several cancers that make RTKs 
great targets for pharmacological intervention (Zwick et al., 2001). According 
to a census of human oncogenes, translocations account for a big majority of 
those. These normally involve chromosomal translocations of one gene to 
the regulatory region of another gene, usually immunoglobulin or T-cell-
receptor genes. This is particularly common in leukaemias, lymphomas and 
mesenchymal tumours (Futreal et al., 2004). 
 
I.7 LTK AND ALK TYROSINE KINASES 
Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine Kinase 
(LTK) are RTKs that due to being closely related structurally and functionally 
are suggested to form a specific subfamily: ALK/LTK, closely related to the 
insulin receptor family (Iwahara et al., 1997; Lemmon and Schlessinger, 
2010; Morris et al., 1994; Morris et al., 1997; Ueno et al., 1995). They share 
significant homology throughout their full extent (Lopes et al., 2008; Pulford 
et al., 2004). Mammalian ALK and LTK are differentiated by the presence or 
absence of MAM domains, respectively. However phylogenetic analysis has 
shown that the existence of MAM domains in the ALK/LTK subfamily is the 
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ancestral condition, their loss being unique to mammalian LTK (Lopes et al., 
2008). 
 
I.7.1 ANAPLASTIC LYMPHOMA KINASE 
 Anaplastic Lymphoma Kinase (ALK) was first identified as a part of the 
oncogenic NPM-ALK fusion protein, resulting from the translocation 
t(2;5)(p23;q35), in Anaplastic Large Cell Lymphoma (ALCL)(Morris et al., 
1994). 
Normal ALK function is mainly unknown. In mice it is expressed in 
thalamus, hypothalamus, midbrain, olfactory bulb and cranial and dorsal root 
ganglia (Morris et al., 1997; Pulford et al., 2004). KO mice showed no defects 
(Pulford et al., 2004). In Drosophila DAlk shares high homology with the 
mammalian LTK/ALK subfamily, in this model it is also expressed in nervous 
system but in addition it is expressed in the developing visceral mesoderm 
(Loren et al., 2001). Drosophila mutants for DAlk fail in normal specification 
of visceral gut muscle development (Pulford et al., 2004). 
Most studies on ALK function and signalling pathways arise from 
studies in the oncogenic fusion forms of ALK (Pulford et al., 2004). Aberrant 
expression of full length ALK is implicated in neuroblastomas, glioblastomas 
(Pulford et al., 2004) and rhabdosarcomas (Piva et al., 2006). 
Overexpression of WT ALK has also been shown in several cancer cell lines 
(Piva et al., 2006). ALK mutations are responsible for some neuroblastomas 
in infants (George et al., 2008) although translocations account only for a 
small proportion of neuroblastomas (Osajima-Hakomori et al., 2005). Fusion 
forms of ALK have been implicated in a rare form of malignancy called 
inflammatory myofibroblastic tumor (Galkin et al., 2007). For a list of common 
ALK fusion forms see Table I.1. 
Most ALK fusion forms share one common characteristic, they all 
possess the entire intracytoplasmic region of the full-length human ALK, and 
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the subcellular localization is determined by the partner protein. All fusion 
proteins, with two exceptions, contain an oligomerization domain in their N-
terminal portion. The homomeric oligomerization of the fusion proteins leads 
to the constitutive activation of the tyrosine kinase domain (Pulford et al., 
2004). 
NPM-ALK translocation results in the fusion of the amino terminus of 
nucleophosmin (NPM) and the intracellular kinase domain of ALK, and this in 
turn results in constitutively active TK signalling (Morris et al., 1994). NPM 
participates in nucleo-cytoplasmic trafficking and it is the most common 
fusion partner of ALK (~80 % of translocations) (Chiarle et al., 2003; Giuriato 
et al., 2010; Koivunen et al., 2008). NPM-ALK can also be distinguished from 
other fusion forms by its subcellular localization, as it can be found in both 
the cytoplasm and the nucleus (Pulford et al., 2004). Second most common 
fusion form is TPM3-ALK, a fusion with the nonmuscular tropomyosin 3, 
accounting for 15 % of ALK positive lymphomas (Giuriato et al., 2010). 
Two different ALK-positive lymphoproliferative disorders have been 
described and are now recognized as distinct entities: systemic anaplastic 
large cell lymphoma T/null (ALCL) and a rarer variety of diffuse large B-cell 
lymphoma (Giuriato et al., 2010). Anaplastic large cell lymphomas (ALCL) 
are a subtype of non-Hodgkin’s family of lymphomas (Wan et al., 2006). 
ALCL presents itself as a systemic disease afflicting skin, bone, soft tissues 
and other organs. It can be subdivided in at least two subtypes characterized 
by the presence or absence of chromosomal rearrangements between ALK 
and various fusion partners such as NPM. NPM-ALK translocation accounts 
for approximately 50 - 60 % of the cases of ALCL (Galkin et al., 2007) and in 
total fusion forms of ALK account for 60 to 70 % (Wan et al., 2006). 
Another recently characterised fusion form of ALK is EML4-ALK. This 
fuses the ALK kinase domain with the echinoderm microtubule-associate 
protein like 4 (EML4) (Soda et al., 2007). This form is responsible for 6.7 % 
and 3 % of the non-small cell lung cancer (NSCLC), in Japanese patients 
and U.S. and Korean patients, respectively (Koivunen et al., 2008; Soda et 
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al., 2007). Four variants have been identified, the most common of which is 
version one. All variants contain identical portions of ALK, comprising the 
entire kinase domain (Koivunen et al., 2008). EM4-ALK fusion forms have a 
cytoplasmatic localization (Takeuchi et al., 2008). 
 
ALK pathway is still unclear. Several ligands have been suggested such 
as pleiotrophin and midkine in human, although this has not been confirmed 
(Powers et al., 2002; Stoica et al., 2001; Stoica et al., 2002). In Drosophila 
data is more conclusive indicating Jeb as DAlk ligand in visceral muscle 
development (Pulford et al., 2004), no mammalian homologues of Jeb have 
been indentified so far. Activated ALK chimeras, particularly NPM-ALK, bind 
multiple adaptor proteins such as Grb, Shc and IRS-1 linking then to several 
pathways such as PLC-γ, PI3K and Jak3 (Mourali et al., 2006; Piva et al., 
2006). This leads to the activation of numerous downstream molecules 
including cyclinD Erk1/2, AKT and STAT3 (Piva et al., 2006) it has also been 
described to act through the MAPK/ERK pathway (Pulford et al., 2004). 
Because of their involvement in human diseases fusion forms of ALK 
are excellent targets for de development of tyrosine kinase inhibitors, one 
such example is the development of NVP-TAE684 (Galkin et al., 2007). 
 
I.7.1.1 TAE684 A POTENT ALK INHIBITOR 
TAE684 (NVP-TAE684) was first identified by Galkin et al. (2007) as a 
potent NPM-ALK inhibitor. TAE684 is a 5-chloro-2,4-
diaminophenylpyrimidine. Galkin et al. (2007) have shown that this small 
molecule can efficiently block growth of ALCL-derived and ALK-dependent 
cell lines. Galkin et al. report IC50 values between 2 and 10 nM. TAE684 was 
able to block proliferation and survival of Ba/F3 NPM-ALK, SU-DHL-1 and 
Karpas-299 cells, the last two being derived from human ALCL lines. Galkin 
et al. tested TAE684 against a panel of RTK and found that TAE684 was 
highly selective against ALK.The authors were able to show in vivo that 
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TAE684 inhibits NPM-ALK inducing regression of established lymphomas 
(Galkin et al., 2007). TAE684 has also been show to inhibit EML4-ALK in one 
cancer cell line (Koivunen et al., 2008). 
Galkin et al. reported that NPM-ALK works through activation of STAT 
signaling. This was inhibited in a dose dependent manner by TAE684. In 
vitro, full inhibition of NPM-ALK was seen as early as 15 min and was 
sustained up to 48 h (Galkin et al., 2007). 
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Table I.1 – List of known ALK cromossomal translocations. Identification of the cromossomal translocation, description of partner fusion protein, 
and tumour type associated with. ALCL – Anaplastic Large Cell Lymphoma; IMT - Inflammatory Myofibroblastic Tumors; NSCLC – Non-Small Cell Lung 
Cancer. n/a – non-aplicable. Adapted from Palmer et al, 2008, Pullford et al., 2004, Li et al. 2008, Soda et al. 2007 and Takeuchi et al. 2008. 
Chromosomal 
translocation Partner protein Fusion protein Tumour type 
Frequency 
in ALCL 
t(2;5)(p23;q35) Nucleophosmin (NPM) NPM-ALK ALCL ~ 75 % 
Inv(2)(p23;p21) Equinoderm microtubule-associate protein like 4 (EML4) EML4-ALK NSCLC n/a 
t(1;2)(p25;p23) Tropomyosin 3 (TPM3) TPM3-ALK ALCL and IMT ~ 18 % 
t(2;3)(p23;q21) TRK-fused gene (TFG) TFG-ALK ALCL ~ 2 % 
inv(2)(p23;q35) 
5-Aminoimidazole-4- carboxamide ribonucleotide 
formyltransferase/IMP cyclohydrolase (ATIC); 
also known as PurH 
ATIC-ALK ALCL ~ 2 % 
t(2;17)(p23;q23) Clathrin heavy chain (CLTC) CLTC-ALK ALCL, IMT and B cell lymphoma ~ 1 % 
t(2;X)(p23;q11-12) Moesin (MSN), member of the ERM (Ezrin/ radixin/moesin) protein family MSN-ALK ALCL  
t(2;19)(p23;p13.1) Tropomyosin 4 (TPM4) TPM4-ALK ALCL and IMT < 1 % 
t(2;17)(p23;q25) Unknown gene, ALK lymphoma oligomerisation partner on chromosome 17 (ALO17) ALO17-ALK ALCL  
t(2;2)(p23;q13) or 
inv(2)(p23;q11- 13) RANBP2-ALK RANBP2-ALK IMT n/a 
t(2;22)(p23;q11.2) Non-muscle myosin heavy chain gene (MYH9) MYH9-ALK ALCL  
t(2;11;2)(p23;p15;- q31) Cysteinyl-tRNA synthetase enzyme (CARS) CARS-ALK IMT n/a 
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I.7.2 LTK AND SHADY 
Leukocyte Tyrosine Kinase (LTK) was first identified in mouse 
leukocytes (Ben-Neriah and Bauskin, 1988). Most knowledge on LTK relates 
to its involvement in human disease. Its expressed in hematopoietic cells 
from about half of leukaemia patients (Maru et al., 1990), and activating 
polymorphisms of LTK have been linked to systemic lupus erythematosis, a 
multigenic autoimmune disease (Li et al., 2004). In mammals LTK is 
expressed in cells of the hematopoietic lineage, particularly pre-B 
lymphocytes and B lymphocytes. It is also expressed in adult, but not 
embryonic, neurons of the cerebral cortex and hippocampus and various 
other tissues. Its endogenous function remains entirely unknown (Ben-Neriah 
and Bauskin, 1988; Bernards and de la Monte, 1990; Morris et al., 1997).  
Not only the function but also the signalling pathways of LTK are still 
largely unclear, although it has been shown that LTK utilizes two major 
signalling molecules, Shc and IRS-1. Both molecules equally stimulate the 
growth signals transmitted through the Ras pathway but only IRS-1 has been 
demonstrated to transmits anti-apoptotic signals, at least in Ba/F3 cells 
(Ueno et al., 1995; Ueno et al., 1996). LTK activates the PI3-kinase pathway 
through IRS-1 suppressing apoptosis in hematopoietic cells (Ueno et al., 
1997). 
Although no mammalian loss of function mutants are known, such 
mutations have been identified in zebrafish. Mutations in the zebrafish shady 
(shd) locus were identified in a large-scale mutagenesis screen (Kelsh et al., 
1996). Using positional cloning Lopes et al. (2008) identified shady as an 
orthologue of human LTK. This is currently the only vertebrate loss of 
function mutant for this RTK. Homozygotes for likely-null mutant alleles show 
no iridophores, but have otherwise normal NC development (Lopes et al., 
2008). shd/ltk mutants do not have defects in other NC derivatives, and have 
normal numbers of other pigment cell types, xanthophores and 
melanophores. Strong ltk mutant alleles are homozygous lethal; this lethality 
cannot be attributed to the iridophore phenotype. Injection of ltk translation 
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blocking morpholinos phenocopied the shd mutant iridophore phenotype in a 
dose dependent manner (Lopes et al., 2008). 
Ltk is expressed in a subset of premigratory NC with progressively 
posterior expression between 18 and 28 hpf. This early expression may 
include a subset of multipotent NCCs. From 26 hpf onwards ltk+ positive cells 
can be seen migrating in the medial pathway, consistent with an iridophore 
fate. By 30 hpf ltk pattern in the trunk strongly correlates with iridophore 
positions. Reduction in of ltk expression in ltk mutants can be observed from 
as early 20 hpf. In later stages such as 72 hpf ltk is still expressed in 
iridophores (Lopes et al., 2008). 
Even in ltk homozygotes it is possible to observe some “escaper” 
iridophores, these look normally differentiated strongly arguing against a role 
for Ltk in iridophore differentiation (Lopes et al., 2008). It is suggested that 
Ltk is required for the specification of the iridophore lineage from NCCs. shd 
is shown through transplantations experiments to function cell autonomously 
within the NC. ltk mutants lack all iridoblast lineage markers, such as ednrb1 
(Lopes et al., 2008). Zebrafish sox10 mutants share the same iridophore 
phenotype as ltk mutants: late iridophore markers are absent. It is 
hypothesised that in WT embryos ltk is expressed transiently in multipotent 
NCCs, before persisting in cells specified to the iridophore lineage (Lopes et 
al., 2008). 
Homozygous mutants for ltk show an increase in NC cell death 
suggesting that cells that failed to become iridoblasts are mostly likely lost by 
apoptosis. This is clearly a secondary effect since it occurs well after the 
initial fate specification phenotype. Maintenance of ltk expression in 
premigratory NCCs is dependent upon Ltk function since in ltk mutants, but 
not sox10 mutants, ltk expression was absent from iridophore precursors 
prior to their death. Using phosphohistone H3 as a marker for proliferating 
cells authors did not detect any effect on NC proliferation of shd mutants 
(Lopes et al., 2008). 
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Lopes et al. have injected a PAC containing the ltk gene into ltkty82 
mutants and demonstrated that this can rescue the iridophore phenotype 
(Lopes et al., 2008). Furthermore experiments in the Kelsh lab. using 
overexpression in vivo of the human NPM-ALK (see I.7.1), specifically 
targeted to NCCs by using the sox10 promoter (which is expressed in early 
NCCs (Kelsh, 2006)), resulted in many extra iridophores in WT zebrafish 
embryos (Figure I.6) (M. Nikaido and R. Kelsh, unpublished data). 
Overexpression also rescues iridophore production in ltk mutant embryos, 
implying that tyrosine kinase signalling may be limiting for production of 
iridophores. Interestingly, both ltk mutants and WT overexpressing embryos 
show what appear to be huge clusters of iridophores, strongly suggesting 
overproliferation of rescued cells (Figure I.6) (M. Nikaido and R. Kelsh, 
unpublished data).  
M. Nikaido and X. Yang from the Kelsh Lab. have also generated a 
construct with a constitutively active Ltk. In this construct the ALK portion of 
NPM-ALK oncogenic fusion was replaced with the homologous portion of the 
zebrafish Ltk gene. The NPM and Ltk fragments were PCR amplified and 
cloned into a pCS2-sox10(7.2) vector, generating a NPM-LTK fusion. The 
NPM-LTK fusion fragment was then subcloned into a -
4725sox10:IRES:eGFP backbone (also generated by Masataka Nikaido), 
generating the -4725sox10:NPM-LTK:IRES:eGFP construct. M. Nikaido has 
shown that this fusion form, like NPM-ALK, is capable of rescuing the ltk 
mutant phenotype and also leads to extra and ectopic iridophores is the trunk 
as well as precocious head iridophore differentiation in WT embryos (M. 
Nikaido, Y. Xueyan and R. Kelsh, unpublished data). 
 
I.7.2.1 LTK AND MIDKINE 
Ltk is an orphan receptor, i.e. the Ltk ligand remains to be identified. It 
has been suggested in humans that Midkine is the putative ligand of ALK, the 
closest related tyrosine kinase to Ltk (Stoica et al., 2001). In fish there are 
two copies of Midkine. Morpholino-mediated knockdown of the zebrafish 
39 
 
MidkineA protein phenocopies the ltk mutant phenotype. This indicates that 
MidkineA might be the Ltk ligand in fish (J. Mueller and C. WInkler lab 
unpublished results). Furthermore, our collaborators have shown that low 
dose morpholino injection for both Ltk and MidkineA give synergistic effects, 
strongly suggesting that MidkineA may be an endogenous Ltk ligand required 
for iridophore function (J. Mueller and C. Winkler lab unpublished results). 
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Figure I.3 - Structure of NPM, ALK and NPM-ALK fusion protein. Diagram of the full lenth ALK structure 
toguether with that of NPM its most recurrent fusion parter, and the respective fusion form. Arrowheads indicate biding 
sites for molecules in several signalling pathways adapted from Pulford et al. (2004). 
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Figure I.4 - Structure of TAE684. TAE684 has 
been shown to inhibit human ALK and ALK fusion forms 
(adapted from Galkin et al., 2007). 
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Figure I.5 – Ltk mutants have reduced or absent iridophores. A, B, D, E, G, H) Incident light images of 72 hpf zebrafish embryos, 
showing the eye (A, D, G) and posterior trunk (B, E, H). Iridophores can be seen as shiny spots. WT embryos (A, B) and two different shd alleles 
ltkty9 (D, E) a weaker allele and ltkty82 (G, H) a stronger allele. C, F, I) Adult fish showing WT and two viable mutant alleles, ltkj9e2, weaker, and 
ltkj9s1, stronger allele. Compared to WT embryos mutants for ltk show reduction (D) or absence of iridophores in eyes (G) and trunk (E, H). Adult 
fish for two ltk mutants show iridophore reduction in the body and the eyes (arrowheads) (adapted from Lopes et al., 2008). 
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Figure I.6 - Constitutive kinase activity in NCCs by overexpression of NPM-ALK. All 
images show 5 dpf embryos under incident light. A) WT uninjected sibling. B) WT embryo 
injected with sox10-NPM-ALK (or p80). C) ltkty82 mutant embryo. D) ltkty82 mutant embryo 
injected with sox10-NPM-ALK. WT embryos injected with a constitutive form of ALK (NPM-ALK 
or p80) under the control of sox10 promoter show increased number of iridophores (B) when 
compared with the control. In ltkty82 mutants where no iridophores are visible (C) injection of the 
same construct leads to production of iridophores (D) (M. Nikaido and R. Kelsh unpublished 
data).  
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I.8 DEVELOPING TYROSINE KINASES DRUGS 
In recent years and due to their huge involvement in human cancers, 
several approaches have been tried to inhibit aberrant RTK activity. 
Targeting extracellular ligand binding, tyrosine kinase domain or substrate 
binding region has been attempted using either monoclonal antibodies (mAb) 
or small molecule drugs (Zwick et al., 2001). The use of mAb has been the 
most successful strategy to selectively kill tumours cells, these are directed 
against the extracellular domain of RTKs (Zwick et al., 2001). One example 
of this is the development of a commercial antibody targeting HER2 gene, 
trastuzumabTM, in human breast and ovarian cancer (Gschwind et al., 2004). 
The use of small molecule drugs is nevertheless becoming an increasing 
therapeutic approach. One of the first and best known commercialised 
examples is the development of small molecule inhibitors of EGFR. This was 
based on observations that mutations in the ATP-binding region of this 
protein lead to abrogation of its tyrosine kinase activity (Gschwind et al., 
2004; Zwick et al., 2001). Another example of the efficacy of small-molecule 
RTK inhibitors as potent tumour suppressors is the case of imatinib 
mesylateTM (Gleevec) against a BCR-ABL fusion protein in chronic myeloid 
leukemia (Wan et al., 2006). This drug is not specific to BCR-ABL, it has 
been found to inhibit PDGFR and c-kit (Druker et al., 2001). Imatinib was one 
of the first examples of drugs discovered through in vitro screening for 
tyrosine kinase inhibitors (Druker et al., 2001), showing the usefulness of 
these screens for drug discovery and setting a precedent for future research. 
Despite its great initial success, some mutations in the BCR-ALB fusion 
protein have been show to be resistant to it (Sawyers). This prompted the 
pharmaceutical industry to develop mutation specific inhibitors (Sawyers). 
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I.9 ZEBRAFISH AS A MODEL FOR DISEASE AND DRUG TESTING 
In drug discovery in vitro testing of a drug is followed by in vivo testing 
in animal models and validation. Validation usually involves large numbers of 
animals. In vivo testing most often results in failure to repeat the in vitro 
results, due to problems with absorption, distribution, metabolism and 
excretion, and not the least side effects. By the time drug is invalidated, 
resources and animals have been sacrificed (Fleming, 2007; Kola and 
Landis, 2004).  
 On average it takes $800 m and 10 – 15 years to research develop and 
introduce a completely new drug (Fleming, 2007). Zebrafish provides a cost-
effective model to bridge the gap between in vitro and in vivo work, reducing 
the attrition rate (number of compounds that fail at different points in the 
process) (Fleming, 2007; Kola and Landis, 2004). The attrition rate is 
Figure I.7 - Different approaches to RTK inhibition (adapted from Zwick 
et al., 2002) 
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particularly high in areas such as oncology and CNS diseases and its 
reported that this is in part due to the need of more predictable animals 
models (Kola and Landis, 2004). Therefore zebrafish has the potential to 
obtain in vivo data at earlier stages of drug discovery, reducing the total 
number of animals used. This would also speed discovering novel 
therapeutics (Fleming, 2007; Kola and Landis, 2004). One example of this 
has been the use of zebrafish to test potential effects on cardiac QT interval, 
apparently one of the major side effects of drug discovery (Fleming, 2007). 
Zebrafish is currently being used as a model for several human 
diseases and also for drug testing (Peal et al., 2010; Zon and Peterson, 
2005). Why use zebrafish? According to the UK’s Animal (Scientific 
Procedures) Act (ASPA) 1986 there should be a drive to implement the 3Rs. 
The use of non-mammalian models has increased 33% from 2003 to 2005 
(Fleming, 2007). Zebrafish has several advantages to be used as a 
replacement for mammalian models. Its embryos are transparent and have a 
rapid development. Not the least the fact that the embryos are not licensed 
until they are 5 dpf by which time all organs with exception of the CNS are 
well developed. Nevertheless the mechanisms responsible for its 
development are highly similar to those of higher vertebrates (Peal et al., 
2010; Zon and Peterson, 2005). 
The fact that zebrafish is aquatic also means that delivery of drugs is 
easier and non-invasive compared to other animal models. Zebrafish has 
further advantage of being easy to create transgenic lines. It is possible to 
generate a reporter transgenic line for the organ of interest, to use for drug 
discovery screens or as disease/toxicity indicators (Fleming, 2007; Zon and 
Peterson, 2005). 
Zebrafish has increasingly been used as a tool for functional small-
molecule screens (Peal et al., 2010; Zon and Peterson, 2005). These 
screens generally involve bathing embryos in a library of chemical 
compounds and examining them for potential developmental defects such as 
in the cardiovascular and central nervous systems, pigmentation and the ear 
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(Peterson et al., 2000; Zon and Peterson, 2005). Zebrafish have been used 
to study cancer development but also using small-molecule screens would be 
advantageous to study anti-cancer drugs. Using ‘modifier screens’ on cancer 
susceptible strains it is possible to look for compounds that prevent or delay 
tumorigenesis, or compounds that target established tumours (Stern and 
Zon, 2003; Zon and Peterson, 2005). Screening for drugs in such a screen 
allows the assessment of several potential therapeutic targets but also to 
look for potential ‘off-target’ effects. Traditionally drug screening has been 
done using cell lines or in vitro protein binding assays, but these lack the 
complex physiology of a whole organism (Stern and Zon, 2003). 
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I.10 IN VITRO SYSTEMS 
I.10.1 MAMMALIAN AND AVIAN CULTURES OF THE NEURAL CREST 
The use of cell culture has proved a valuable technique in the field of 
NC study by helping identifying its derivatives, assessing the role of 
extracellular signals in NC development and determining possible lineage 
relationships between different types of NC derived cells. NCC culture has 
been widely used in both avian (Le Douarin, 2004) and mammalian model 
organisms (Morrison et al., 1999; Stemple and Anderson, 1992). In primary 
NCC culture occasional identification of single cells apparently able to 
generate five or more discrete cell-types has led to the proposal that, at least 
transiently, fully multipotent neural crest cells exist, able to generate all NC 
derivatives; this assumption remains unproven (Baroffio et al., 1991; Delfino-
Machin et al., 2007).  
NC stem cells have also been studied for their possible therapeutic 
perspective. Controlled reprogramming of NC stem cells in culture may have 
great potential in the treatment of disease (Delfino-Machin et al., 2007).  
In vitro studies in the avian embryo, particularly the use of clonal 
culture, have been a complementary approach to the study of neural crest 
stem cells. They have mainly examined the plasticity of the neural crest cells 
in vitro, how different derivatives give rise to a multitude of other derivatives 
when exposed to different environments (eg. Le Douarin et al., 1994; Stone 
et al., 1997). More recent work has also addressed the self-renewal property 
of some multipotent and some more restricted NCCs, although this property 
has been more evident in bipotent or unipotent precursors (Real et al., 2006). 
In vitro experiments have shown that neural crest cells are highly 
heterogeneous with respect to their developmental potentialities (eg. Baroffio 
et al., 1988; Catala et al., 2000; Stone et al., 1997). 
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Experiments mainly from the group of Le Douarin in NCC cultures have 
shown that in vitro migratory NCC are highly multipotent giving rise to all 
trunk derivatives such as pigment cells (Baroffio et al., 1991), neurons 
(Baroffio et al., 1991), glia (Baroffio et al., 1991), adrenergic cells (Baroffio et 
al., 1991), myofibroblasts (Trentin et al., 2004), and some cephalic NC-
specific derivatives such as cartilage (Baroffio et al., 1991). This plasticity is 
not restricted to migratory NC but is also shown by differentiated NC cells 
such as melanocytes (Real et al., 2006) or Schwann cells (see Delfino-
Machin et al., 2007 for a review in NCC stem cells; Dupin et al., 2003; Real et 
al., 2005). 
  
NC cells for culturing are obtained using a  variety of methods, such as 
FACS sorting using either p75 antibody (eg. Morrison et al., 1999; White et 
al., 2001; Wong et al., 2006) or Schwann cell myelin protein (SMP)(Dupin et 
al., 2003; Real et al., 2005) and also NT explants (see Le Douarin et al., 
2004 for a review). The NT explants technique is widely used in avian NC 
cultures; it consists of dissecting and plating NT prior to NC migration so that 
the latter migrate onto the plate. In these experiments the NT need to be 
cleaned of the surrounding tissues, this is done with the aid of proteases 
such as dispase (eg. Graham et al., 1993; Stone et al., 1997), trypsin (eg. 
Trentin et al., 2004; Yoshida et al., 2006) or pancreatin (Luo et al., 2003; 
Nikopoulos et al., 2007). Variations on the timing of NT dissection and on the 
time it is allowed in the plate before removing it are reflected in different 
composition of migrated NCC. 
 
In the NC field, cells are usually cultured at 37ºC with an atmosphere of 
5 % CO2 (e.g. Real, 2005; Trentin, 2004), the medium compositions are 
highly variable and include different base media such as L-15 (eg. Zhao et 
al., 2006), F12 (eg. Nikopoulos et al., 2007), DMEM (eg. Nataf and Le 
Douarin, 2000), MEM and several combinations of the above media (eg. 
Yoshida et al., 2006). They are generally supplemented with FBS although 
50 
 
the amount of serum used varies. The plating substrates used are also 
variable, but include laminin, fibronectin, poly-D-lysine, poly-L-lysine, poly-D-
lysine/fibronectin (eg. Graham et al., 1993; Morrison et al., 1999; Stemple 
and Anderson, 1992), collagen and feeder-layers. Finally addition of different 
supplements or extracellular signalling molecules are often used, including N-
2 neuronal supplement (Pomp et al., 2005; Zhao et al., 2006), all-trans-
retinoic acid (Motohashi et al., 2007; Rao and Anderson, 1997; Sieber-Blum 
and Chokshi, 1985), endothelin-3 (ET3) (Lahav et al., 1998; Lahav et al., 
1996; Nataf and Le Douarin, 2000), Jagged1 (Nikopoulos et al., 2007), 
glucose, insulin (Sieber-Blum and Chokshi, 1985) and others. 
Some of these molecules have been subject of more in depth studies; such 
is the case of endothelin-3 that has been shown to promote the survival and 
proliferation of melanocytic and glial precursors from an undifferentiated 
neural crest culture. This effect was not due to a shift in fate of other 
derivatives but to overproliferation of these precursors (Lahav et al., 1998; 
Trentin et al., 2004). Also exposure of committed Schwann cells to 
endothelin-3 reverts them to a glial-melanocytic bipotent precursor 
expressing markers of both phenotypes and giving rise to cells of both fates 
(Dupin et al., 2003).  
 
NC studies in other species of tetrapods include Xenopus (Akira and 
Ide, 1987; Hiroyuki, 1978; Ide, 1974; Ide and Hama, 1976) and axolotl 
(Thibaudeau and Holder, 1998). These studies have been mainly focused on 
pigment cell development. In Xenopus studies dissection of NTs was used as 
source of NC cells. Culture conditions vary slightly but they all use L-15 
conditioned medium, in plastic Petri dishes, in some cases coated with 
collagen and without serum supplementation. 
In axolotl the NC forms a ridge atop the developing NT and this ridge is 
then removed as a strip. Culture conditions include a mixture of L-15/water 
supplemented with antibiotics with or without serum supplementation. 
Authors describe that supplementation with 5 % FBS increases attachment of 
51 
 
NTs, cell migration, earlier and more frequent differentiation of melanophores 
(Thibaudeau and Holder, 1998). These authors also describe that addition of 
guanosine to the medium increases the number of xanthophores. This was 
also described by Frost et al. (1987), were it is also described that guanosine 
is involved in the biosynthesis of yellow pigments and increases the 
“yellowness” of axolotls fed with guanosine. 
 
In fish there is only one report about NCC culture. Sadaghiani and 
Vielkind (1990) describe the technique of NT explants in three different 
species of fish, Xiphophorus maculates (platyfish), X. helleri (swordtail) and 
Oryzias latipes (Japanese medaka), but not zebrafish. In this paper the 
authors describe the time point of NC cell migration at which they obtain a 
higher yield of NCCs. They test several medium compositions including 
M199, L-15 and DMEM with several concentrations of FBS and fish embryo 
extract (FEE) with 25 mM HEPES buffer. They assessed NT attachment and 
cell survival, and determined that the best medium composition was L-15 
supplemented with 20 % FBS. FEE did not improve the culture conditions in 
any aspect tested (Sadaghiani and Vielkind, 1990).  
 
I.10.2 OTHER IN VITRO FISH CULTURES 
The zebrafish is increasingly popular as a non-mammalian model for 
studies of vertebrate developmental biology, genetics, and toxicology. The 
availability of cell culture systems makes it possible to address many basic 
questions using in vitro approaches (Bradford et al., 1994). In vitro zebrafish 
cell culture was to our knowledge begun by Kuhn et al. (1979). In the 
Zebrafish Book a general method for zebrafish cell culture is described using 
L-15, 0.3 mg/mL glutamine, 50 U/mL penicillin, 0.05 mg/mL streptomycin, 0.8 
mM CaCl2, 10 % FEE, and 3 % FBS (Westerfield, 2000). 
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Bradford et al. describe a protocol to obtain fish cells culturing them in 
LDF medium (L-15, DMEM, F12) supplemented with insulin, heat-inactivated 
trout embryo extract, trout embryo extract and heat-inactivated FBS, selenite, 
LIF and bFGF (Bradford et al., 1994). 
 
Zebrafish cell lines have been used to study circadian clocks by at least 
two different groups. In both cases cell lines were produced (Carr and 
Whitmore, 2005; Pando et al., 2001).  The medium compositions varied: 
GP2-293 cell line is grown in DMEM medium supplemented with 10 % FBS 
(Carr and Whitmore, 2005) and Z3 cell line is grown in L-15 supplemented 
with 15 % FBS, 2 mM glutamine, gentamicin, and P/S (Pando et al., 2001). 
These works have helped to understand intrinsic cell cycles by determining 
gene expression patterns at different time points. They have shown that 
intrinsic night/day cycles regulate cell division. 
Other groups are currently trying to develop zebrafish cell culture of 
primordial germ cell lines (Hsin-Yi et al., 2007) or to study polarized cell 
division, (Girdler and Clarke, 2007). 
Other examples of fish cell cultures include teleost bone derived cell 
lines from solea by L. Cancela group, to study genes involved in extracellular 
matrix mineralization. In these lines, cells have been cultured in either L-15 or 
DMEM medium, supplemented with 10 %FBS (Pombinho et al., 2004). Also 
fish hepatocytes are cultured, in this case in M199 medium with 10 % FBS 
(Naicker et al., 2007). 
Fish cell culture conditions vary in the medium used, in that pH can 
range between 7.0 to 7.9 and also different salt concentrations. For a review 
in fish cell lines available consult Fryer et al. (1994). There are some online 
databases of fish cell lines although only a few of them relate to zebrafish. 
For a list of fish derived cell lines consult 
http://www2.brc.riken.jp/lab/cell/s1_list.cgi?lineno=Fishes and 
http://www.biotech.ist.unige.it/cldb/spestr.html).  
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I.11 AIMS 
I.11.1 GENERATION OF A TRANSGENIC LINE FOR NC PERMANENT LABELLING 
In the field of NC development several questions are still to be 
answered. Zebrafish is an excellent model to study this population of cells, 
and labelling of the NC is an excellent tool to follow and study their 
development. Currently zebrafish transgenic lines that label the NC with GFP 
under the regulation of the sox10 promoter are only transient, i.e. GFP is only 
expressed whilst sox10 is expressed. This provides a short time window of 
labelling, in particular in some NC derivatives where sox10 is downregulated 
early. A permanent labelling of this population would therefore be extremely 
useful. The Cre/loxP system as been used in other models to achieve this 
and has proved extremely useful. 
Upon generation of vectors containing sox10 promoter driving Cre 
recombinase these would be injected into a reporter line to test their function 
in transient embryos, followed by creation and analysis of stable transgenic 
lines. This sox10:cre line would be useful not only for permanent labelling of 
the crest in vivo but also in vitro, when crossed with a reporter line. In 
addition if crossed with a loxP responsive line with a resistance marker it 
would also allow us to positively select NCC in vitro. Further if crossed with a 
transgenic line containing, or if injected, a construct expressing constitutively 
active tyrosine kinases it would be an extremely useful tool for testing 
tyrosine kinases inhibitors. 
We propose to create and test different Cre lines with different length 
fragments of the sox10 promoter. As the sox10 gene is generally regarded as 
a NC early marker, and has been shown that fragments of its promoter are 
capable of drive GFP expression. These fragments include the 5’ region of 
the promoter and have been shown to express generally in a sox10 like 
pattern, with different expression levels and some with lowered expression in 
ear epithelium (Carney, 2003; Carney et al., 2006). Ideally several lines using 
54 
 
different fragments of the promoter should be created to address whether 
different regions could give us a stronger and more specific pattern. 
 
I.11.2 STUDY OF ID2A FUNCTION IN ZEBRAFISH NC 
Inhibitors of differentiation (ID) proteins have been shown to be 
important in several developmental processes such as differentiation, cell 
cycle arrest and apoptosis. They have been studied in several vertebrate 
models. But their function in zebrafish development is still sparse. The neural 
crest is an important model to study vertebrate development, and in particular 
pigment cells are used to study specification and differentiation. Id2a in 
zebrafish has previously been shown to be expressed in zebrafish NC, 
particularly iridophores. 
We propose to study the function of id2a in NC development. For that 
we shall determine the expression pattern of id2a in zebrafish embryos at 
several developmental stages and do a time course of its expression in crest. 
We also propose to study id2a expression in several NC mutants, and 
assess its function in NC development and differentiation. Further we want to 
fully characterise the effect of id2a knockout, including cell types affected and 
to help define its role. 
We also propose to determine how is id2a regulated in NC and which 
genes does it regulate namely how does it relate to Ltk and other iridophore 
markers. 
 
I.11.3 DEVELOPMENT OF A NEW IN VITRO SYSTEM FOR NCC CULTURE IN 
ZEBRAFISH 
NCC culture has been widely used in avian and mammalian embryos 
and there exists one work for three different species of fish but has yet not 
been developed for zebrafish. NCC culture has been extremely useful in the 
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study of NC, particularly in determining NCC plasticity and signalling 
pathways. Therefore we propose to generate an in vitro zebrafish NC culture 
system that allows for the study of the development of the NC. This would 
allow us for example to study in vitro NC mutants. For that we shall optimise 
primary culture of zebrafish NCC; establish culture conditions generating 
several NCC derivatives; optimise clonal culture of zebrafish NCC; and use 
this optimised culture conditions to grow zebrafish NT explants. 
Once culture conditions are optimised we intent to use the zebrafish 
NCC culture system to define precisely the role for Ltk in iridophore 
development in zebrafish using an in vitro approach. We will directly test 
whether Ltk signalling promotes specification of NCCs to the iridophore 
lineage, survival of iridoblasts and/or proliferation of iridophores. In addition, 
we will begin to test the hypothesis that MidkineA is a key ligand for Ltk 
function in iridophores. We will do this by comparing NCC cultures from WT 
and ltk mutant embryos, evaluate clone size and clone composition. We shall 
quantitate the effects of NPM-ALK expression in NCCs and evaluate the 
effect of treatment with Midkine on iridophore production from WT and shd 
mutant NCCs to assess the effects of Ltk. 
Together these will clarify the role of Ltk in this NC derived cell-type and 
will test if Midkine may be the first bona fide ligand for vertebrate Ltk. We 
expect to elucidate the role of LTK in NC development and thus to deepen 
our understanding of this process. This would be an excellent tool for further 
studies. 
 
I.11.4 DEVELOPMENT OF AN IN VIVO ASSAY FOR RTKS INHIBITORS 
Currently the pharmaceutical industry spends millions of US dollars 
developing and testing new drugs. The majority of these drugs are then 
discarded due to low efficacy or safety issues. This happens mostly when 
these drugs are transferred from in vitro testing to animal models, namely 
mammals (Fleming, 2007). This increases the overall cost of drug 
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development. We propose that zebrafish would be a more cost-effective 
system to supplement in vitro testing, as this model is cheaper to maintain 
and handle. As zebrafish is a vertebrate most developmental processes are 
the same and they share high homology at the protein level. Thus it is 
possible to test drug efficacy and safety in a whole organism prior to testing 
in mammals. This would allow reduction in animal costs, and general 
validation costs. 
Previous work in our group with injection of a constitutive active 
receptor tyrosine kinase, NPM-ALK, revealed that this could be powerful tool 
for drug screening and we will set about establishing proof of principle. We 
propose to develop a new in vivo method to test inhibitors for constitutively 
active tyrosine kinases. By developing transient transgenic assays where 
constructs encoding constitutively active tyrosine kinases are injected into the 
embryos; embryos are then assessed for possible phenotypes and for 
whether or not it is possible to revert their effects with tyrosine kinase 
inhibitors. 
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Chapter II - MATERIALS AND METHODS 
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II.1 SOLUTIONS, BUFFERS AND MEDIA 
ANTIBODY BLOCKING SOLUTION 
1 % DMSO 
0.5 % Saponin 
1 % BSA 
2 % Goat/Sheep serum 
in PBS 
CA2+-FREE RINGER’S SOLUTION 
116 mM NaCl 
2.9 mM KCl 
5 mM HEPES 
pH 7.2 in Milli-Q water 
COMMERCIAL BLOCKING REAGENT STOCK SOLUTION 
10 % (w/v) of Blocking Reagent (Roche, Manhein, Germany, Cat# 11096176001) in 
1xMAB can be prepared and kept in the freezer 
DANIEAU SOLUTION 
58 mM NaCl 
0.7 mM KCl 
0.4 mM MgSO4, 
0.6 mM Ca(NO3)2 
5 mM Hepes 
pH 7.6 in Milli-Q water 
HOLTFRETERS SOLUTION 
0.35 % (w/v) NaCl 
0,005 % (w/v) KCl 
0.01 % (w/v) CaCl2 
0.02 % (w/v) NaHCO3 
In water 
HYBRIDIZATION MIXTURE (HM) 
50 % (v/v) Formamide 
5X SSC 
50 ng/mL Heparin 
500 ng/mL tRNA 
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0.1 % (v/v) Tween20 
9.2 mM Citric Acid 
In DEPC treated Milli-Q water 
LURIA AGAR 
3.7 % (w/v) Luria agar base in Milli-Q Water 
LURIA BROTH 
2.5 % (w/v) Luria broth base in Milli-Q water 
MAB 5X 
500 mM Maleic Acid 
450 mM NaCl 
In Milli-Q water, adjust pH to 7.5 and autoclave 
MABT 
Dilute MAB 5X with Milli-Q water 
Add 0.1 % (v/v) Tween20 
NTMT BUFFER 
100 mM Tris-HCl pH 9.5  
50 mM MgCl2 
100 mM NaCl 
0.1 % (v/v) Tween20 
PBS 
2.7 mM KCl, 137 mM NaCl in sterile water 
PBSX 
PBS with 0.1 % (v/v) Triton X-100 
PBT 
0.1 % (v/v) Tween20 in PBS 
PFA 
4 % (w/v) paraformaldehyde in PBS 
Autoclaved PBS is firstly warmed to 60ºC and then PFA is added, it is necessary to 
adjust pH to improve PFA solubilisation, solution should never be warmed above 60ºC and 
should be frozen in aliquots as soon as cleared, to prevent degradation. 
PHENOL RED 
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0.5 % (w/v) phenol red 
In Milli-Q water 
PRONASE 
20 mg/mL stock solution of Pronase (Protease from Streptomyces griseus, Sigma-
Aldrich, England, Cat# P8811) in PBS, dilute to 2 mg/mL in EM for dechorionation 
PROPIDIUM IODIDE BUFFER 
50 ng/mL PI (stock at: 2 mg/mL in PBS) 
0.1 ng/mL of RNAse A 
0.1 % NP40 
50 ng/mL Trisodium citrate 
water to 10 mL 
SSC 20X 
3 M NaCl 
300 mM sodium citrate 
Adjust the pH to 7.0 with a few drops of 1 M HCl 
In Milli-Q water 
TE 1X 
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA (pH 8.0) 
10 mM NaCl 
TAE 1X 
40 mM Tris HCl 
20 mM sodium acetate 
2 mM EDTA 
In Milli-Q water and adjusted to pH 7.8 with glacial acetic acid 
ZEBRAFISH EMBRYO MEDIUM 
0.5 μM sodium chloride 
0.17 μM potassium chloride 
0.33 μM calcium chloride 
0.33 μM magnesium sulpate 
0.1 % methylene blue 
In distilled water 
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II.2 ZEBRAFISH METHODS 
II.2.1 FISH HUSBANDRY 
Zebrafish and zebrafish embryos were manipulated using standard fish 
handling techniques according to Home Office directives and as suggested in 
the “Zebrafish book” (Westerfield, 2000). Fish stocks were maintained in the 
University of Bath zebrafish facility. 
 
II.2.2 ZEBRAFISH STOCKS 
Several zebrafish stocks were used throughout the work. These include 
wild-type AB fish and several mutants: sox10m618 (Dutton et al., 2001b), 
sox10baz1(Carney et al., 2006), shdty82 (Lopes et al., 2008) and nacrew2 (Lister 
et al., 1999). Two distinct zebrafish reporter transgenic lines were also used:  
Tg(-4725sox10:GFP)ba4 (Carney et al., 2006) and Tg(EF1alpha:loxp-egfp-pA-
loxp-dsRed-pA)ba5 (Yoshikawa et al., 2008), the last one kindly provided by 
Dr. Laure Bally-Cuif.  
Mutant embryos were obtained through appropriate incrosses of 
heterozygous carriers. For fluorescent transgenic strains, heterozygous 
embryos were obtained by crossing WT fish with heterozygous transgenics 
and the resulting embryos were then screened for fluorescence. 
 
II.2.3 HANDLING, STAGING AND DECHORIONATING ZEBRAFISH EMBRYOS 
Embryos were raised in embryo medium and staged according to 
Kimmel et al. (1995). Embryos were staged by observing them under a 
dissecting scope a few hours after fertilization. Embryos were grown in 90 
mm Petri dishes (Sterilin, Cat# 101R20), unless stated otherwise, in a MIR-
155 incubator (Sanyo) at 28.5ºC. Sometimes it was necessary to slow down 
embryo development, in order to attain particular developmental stages; for 
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that embryos were incubated at 25ºC overnight during the first 24 hpf, re-
staging was then necessary. 
 
ANESTHETISING EMBRYOS 
Embryos older than 15 hpf were anaesthetized with tricaine (ethyl 3-
aminobenzoate methanesulfate salt) (Sigma-Aldrich, England, Cat# A5040) 
to approximately 0.2 % of the final volume prior to manipulation.  
 
PTU TREATMENT 
In some circumstances it was necessary to prevent melanin synthesis 
for better visualization of the embryos. Embryos were therefore incubated in 
EM with 0.003 % of PTU (1-phenyl-2-thiourea) (Sigma-Aldrich, Engand, Cat# 
P7629) from 24 hpf onwards until embryo development was arrested. 
 
DECHORIONATION 
Embryos were dechorionated using one of two methods, manual 
dechorionation or enzymatic dechorionation using 1X Pronase. Manual 
dechorionation involves holding embryos with Watchmakers’ No.5 forceps, 
one forceps gently holds it while the other gently pierces and pulls apart the 
chorion. 
For dechorionation with pronase, embryos were transferred into a glass 
beaker, EM removed and replaced with 1X Pronase in EM. Embryos were 
then incubated at 28.5ºC and swirled every few minutes, until a few embryos 
were seen outside the chorion. Pronase was then removed and embryos 
rinsed several times with fresh EM. 
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II.2.4 COUNTING IRIDOPHORES AND MELANOPHORES 
Iridophores were counted under standard dissecting scopes using 
incident light; due to their reflective properties these were easily identified. 
For statistical analysis only dorsal stripe iridophores were counted; when 
looking for potential iridophore phenotypes the whole fish was observed and 
counted. 
When counting iridophore spots and iridophore clusters the following 
were considered: iridophore spots were considered as any reflective signal 
that could be considered separate from the adjacent ones. We classified as 
clusters spots of iridophores that were not only brighter under incident light 
but also a size above the average, that could be explained by existence of 
more than one cell in such close proximity as to render them 
indistinguishable. 
In PTU treated embryos iridophores can also be distinguished in 
brightfield  by a grey coloration. 
 
Melanophores of the dorsal stripe were counted by incubating 
anesthetized 5 dpf embryos in 10 mg/mL epinephrine ((±) - Epinephrine (4-
[1-hydroxy-2-(methylamino)ethyl]-1,2-benzenediol)) (Sigma-Aldrich, England 
Cat#E4642) for 10 min. Epinephrine causes melanosomes to concentrate 
near the nucleus making it easier to distinguish individual cells (Parichy et al., 
2003). Embryos were then fixed and melanophores counted under a 
dissecting scope. 
 
II.2.5 MICROINJECTION 
The protocol for injection of either DNA or morpholinos was generally 
the same. Very thin needles were created by melting 31/2’’ Drummond glass 
capillaries (Drummond Scientific Co., Broomall, PA) in a Narishige, PC-10 
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needle puller (heater 1 at 63, all weights on). The tip of the needle was then 
broken to a wider diameter with a forcep; since very thin needles get easily 
blocked with liquid but not too wide as wider needles generate a higher 
mortality; this was assessed visually based on experience. The needle was 
then backfilled with mineral oil and inserted into a Drummond Nanoject II 
injector apparatus (Drummond Scientific Co., Broomall, PA). After partial 
withdrawal of the oil the needle was then filled with the solution to inject. 
Injected DNA or morpholinos were diluted to the appropriate 
concentration in 1X Danieau solution. Unless stated otherwise injection 
volume was 2.3 nL and injection speed was set to low. 
Injection plates were prepared beforehand using 2 % agarose in EM in 
90 mm Petri dishes; a glass slide was carefully placed on top of the melted 
agarose, allowing for the formation of a slope and a furrow. Upon 
solidification this furrow was designed to hold embryos in place while 
injecting them. 
Injections were always performed in freshly laid embryos, between 1 to 
4-cell stages. Embryos were collected and transferred into an injection plate. 
Embryos were injected under a dissecting scope, by piercing the chorion with 
the needle; the liquid was then inserted either into the 1-cell or in the middle 
of the yolk where the DNA or MO would then move into the cells via the 
cytoplasmic stream. 
 
II.3 MOLECULAR METHODS 
II.3.1 ISOLATION OF RNA 
For extraction and isolation of total RNA we have used TRI Reagent 
(Sigma-Aldrich, England, Cat# T9424) a commercially available reagent 
based on the single step total RNA isolation by Chomczynski and Sacchi 
(1987). Procedure was done following suppliers protocol. Dechorionated 
anesthetised embryos were transferred to a 1.5 mL microfugetube and 
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weighed, TRI Reagent was added at the proportion of 1 mL per 50 mg, 
embryos were then homogenised by passing them several times through a 
very small gauge syringe needle. Homogenate was centrifuged at 12,000 G 
for 10 min at 2 – 8ºC to remove insoluble material. Clear supernatant was 
then transferred to a fresh tube and allowed to stand for 5 min at RT. 0.2 mL 
of chloroform per mL of TRI Reagent were added and sample vortexed for 15 
s and allowed to stand for 2 – 15 min at RT. Sample was then centrifuged 
12,000 G for 15 min at 2 – 8ºC. The colourless upper phase containing RNA 
was then transferred to a fresh tube and 0.5 mL of isopropanol per mL of TRI 
Reagent were added. Sample was vortexed and allowed to stand for 5 – 10 
min at RT and then centrifuged at 12000 G for 10 min at 2 – 8ºC. 
Supernatant was removed and RNA pellet was washed with 1 mL of 75 % 
ethanol per 1 mL of TRI Reagent used. Sample was vortexed and 
centrifuged at 7,500 G for 5 min at 2 – 8ºC. Pellet was then air dried and 
resuspended in DEPC treated water by repeated pipetting at 55 – 60ºC for 
10 – 15 min. 
 Products were then analysed using gel electrophoresis (see II.3.4), to 
confirm purity and quality of RNA. 
 
II.3.2 REVERSE TRANSCRIPTION 
Isolated RNA (see II.3.1) was used for cDNA synthesis, this was 
performed using SuperScript III Reverse Transcriptase kit (Invitrogen, Cat# 
18080) as per suppliers instructions; random oligonucleotides were used as 
primers. Reaction was incubated in a programmable temperature controller 
(G-Storm 482) for ease and consistency. Products were then analysed using 
gel electrophoresis. 
 
II.3.3 TOTAL DNA EXTRACTION 
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To screen for id2a mutants, total DNA was extracted from 25 embryos. 
Embryos were transferred to a 1.5 mL microfugetube, liquid was removed 
and embryos washed three times in PBS, once in Milli-Q water and once in 
TE. 20 µL per embryo of 2 mg/mL Protease K in TE was then added, and 
incubated for 4 h at 55ºC followed by 10 min at 95ºC and finally cooled down. 
 
II.3.4 AGAROSE GEL ELECTROPHORESIS 
DNA and RNA products were normally visualized using gel 
electrophoresis. Agarose gels 0.8 – 2 % (w/v) (UltraPure Agarose, Invitrogen 
Cat# 15510-027) in 1X TAE buffer were made by heating in a microwave at 
full power with regular mixing till agarose was fully dissolved. Solution was 
allowed to cool down and ethidium bromide (10 mg/mL) was added to a final 
concentration of 0.4 mg/mL, mixture was then poured into an electrophoresis 
tray. Once solidified these were immersed into the electrophoresis thank 
(Wide Mini-sub Cell GT, BioRad) with 1X TAE buffer. Samples were loaded 
into the gel with 1X loading dye and run at voltages between 20 – 120V 
(PowerPac 300, BioRad), depending on the purpose of the experiment and 
type of nucleic acid. The agarose gels were then visualized and 
photographed under UV light (AlphalmagerTM 3400, Alpha Innotech). 
 
II.3.5 QUANTIFICATION OF NUCLEIC ACIDS 
For crude quantifications DNA concentration was determined by 
comparing their band sizes with the 1KB DNA ladder (Promega, UK, Cat# 
G5711) which was run along with the DNA sample. For RNA or when more 
precise quantifications of DNA were required samples were quantified by 
light spectrophotometry using a spectrophotometer (Biomate 3, Thermo 
Scientific) and its internal DNA quantification program. 
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II.3.6 DNA PURIFICATION 
For most experiments, either cloning, in situ probe synthesis or DNA 
injection, DNA needed to be purified, this was either done using QIAquick 
PCR Purification kit (QIAGEN, Cat# 28106) or phenol/chloroform/isoamyl 
alcohol (25:24:1) extraction (see bellow). PCR product purification kit was 
also used to purify DNA from enzymatic reactions or agarose gels. 
 
II.3.6.1 PHENOL/CHLOROFORM/ISOAMYL ALCOHOL EXTRACTION 
For phenol/chloroform/isoamyl alcohol extraction, Milli-Q water was 
added to the sample to 100 µL, followed by 100 µL of 
phenol/chloroform/isoamyl alcohol pH8 (Sigma-Aldrich, England, Cat# 
P2069); sample was vortexed for 15 s and centrifuged for 3 min at max 
speed. Supernatant was recovered and 2.5 volumes of EtOH and 1/10 
volume of NaOAc (3 M, pH 5.4) were added. Sample was then precipitated 
O/N at -20ºC or 30 min at -80ºC. Sample was centrifuged at max speed for 
30 min at 4ºC, supernatant was decanted and pellet rinsed with 500 µL of ice 
cold 70 % ethanol. Pellet was dried for 10 min at RT and re-suspended in 
sterile water. 
 
II.3.7 PCR REACTION 
For most applications Polymerase Chain Reaction (PCR) was done 
using KOD Hot Start DNA Polymerase (Novagen, Cat# 71086). This was 
chosen in preference to Taq as it is a high fidelity DNA polymerase, i.e. has a 
lower mutation frequency according to the manufacturer. KOD can also 
amplify larger fragments up to 20 kbp. Reaction conditions were as follows: 5 
µL of reaction buffer, 1 µL of 10 mM dNTPs, 2 µL of 25 mM MgSO4, 1 µL of 
each 10 µM primer, 1 µL enzyme and water to a final volume of 50 µL. 
Mixture was gently mixed and PCR reaction performed. PCR program was 
generally as follows, initial denaturation at 92ºC for 2 min, followed by 30 
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cycles of incubation for 15 s at 94ºC, 30 s at 60ºC (annealing temperature) 
and 30 s at 68ºC, cycles were followed by a further incubation of 5 min at 
72ºC for final extension of products. Note, annealing temperature was 
dependent on the primer and varied accordingly, for larger fragments 
extension temperature and duration was modified as per manufacturer 
instructions. 
For some of the cloning techniques we have used GoTaq Green Master 
Mix (Promega, UK, Cat# M7112), this is a premixed ready-to-use solution 
containing dNTPs, MgCl2 and reaction buffers at optimal concentrations, 
reactions condition and cycles were done as per manufacturer instruction. To 
the reaction mixture, 2.5 µL of both reverse and forward primer (stock at 10 
µM) and 1 µL of DNA template were added to a total volume of 25 µL in 
water.  
GoTaq was also used to test TILLING primers but in the following 
conditions: 250 nM of each primer, 0.5 µL of genomic DNA (see II.3.3) 1X 
GoTaq reaction mixture to a total volume of 10 µL in water. PCR program 
was as follows: initial denaturation at 95ºC for 2 min, followed by 35 cycles of 
45 s at 95ºC, 45 s at 60ºC and 1 min at 72ºC, followed by a final extension at 
72ºC for 5 min. These were made following indications by Mitch Levesque 
(personal communication). 
PCR products were then analysed by gel electrophoresis and fragments 
extracted from gel or PCR was cleaned (see II.3.6). All reactions were carried 
out in a programmable temperature controller (G-Storm 482). Primers used 
are listed below and were all synthesised by Invitrogen, they were ordered in 
dehydrated form diluted in Milli-Q water to 100 µM, and working aliquots 
were made at 10 µM in Milli-Q water. 
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Table II.1 – List of Primers used for sequencing and PCR 
Name Sequence (5’-3’) Use 
Actin 3’ gttcccatctcctgctcaaa Control for mRNA and DNA 
PCR 
Actin 5’ taccccattgagcacggtat Control for mRNA and DNA 
PCR 
ASP id2 tilling v2 ttgagtaggcggtgattcac TILLING primers 
ASP/id2 transcript  acggtaaagtgtcctgctgt Testing splice MO 
RW pT2KXIG ggaacaaaagctggagctcc Sequencing pTsox10:cre 
RW Sox10:Cre aaacataattaatttcatcaat Sequencing pTsox10:cre 
SalI 4.9sox10cre 
sense 
gcatgcatctcgagtggtcaggatcccctta
tca 
Amplification of -4.9sox10:cre 
SalI pT2 sense v3 gcatgcatcacgtcgacagatctgcgaag
atacggccacg 
Cloning pT2sox10:cre 
SalI sox10cre asense 
v3 
gcatgcatcacgtcgacgaatattagtgctt
acagacagcacttacat 
Cloning pT2sox10:cre 
sox10promoter_end gcacaattattttacaagaa Sequencing at the end of 
sox10 promoter 
SP id2a tilling cgagtcttttcaacgaaatcctgc TILLING primers 
SP/id2 transcript  ccagcgcgaacagggaatct Testing splice MO 
SpeI+Cre L27 gactagtcatcccatcgattcgaattc Amplification of Cre 
T3 ccctttagtgagggttaatt Amplification of Cre 
T7 gtaatacgactcactatagggc Sequencing of GEM-T 
XhoI pT2 asense v3 gcatgatccccctgctcgagggcccatctg
gcctgtgtttcagac 
Cloning pT2sox10:cre 
XhoI sox10cre sense 
v3 
gcatgcatactcgagatcctataaactgcg
cacaacactaagcac 
Cloning pT2sox10:cre 
  
II.3.8 CLONING TECHNIQUES 
RESTRICTION DIGEST 
Restriction digests were always incubated in a 37ºC water bath for three 
hours. All restriction enzymes used were purchased from Promega, UK. 
Typical restriction digest contained 0.1 % BSA, 1X restriction buffer, 1 µg 
DNA and 1 µL of enzyme (10 units) and Milli-Q water to a total volume of 20 
µL. Reactions were analysed in agarose gel electrophoresis and if reaction 
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was complete heat inactivation was carried out by incubation at 65ºC for 15 
min. Otherwise a further 1 µL of enzyme was added and digestion continued 
for another hour. 
 
DNA LIGATION  
DNA products were ligated using T4 DNA Ligase (Promega, UK, Cat# 
M1801). Ligations were performed in a 10 µL reaction containing 50 – 100 ng 
of plasmid DNA and a three molar excess of insert DNA, 10 units of T4 DNA 
Ligase and 1 µL of 10X ligase buffer. Reaction was incubated at RT for 15 
min or O/N at 4ºC.  
 
GENERATION OF BLUNT ENDS 
Generation of blunt ends from cohesive ends was done either by filling 
the remaining nucleotides (in 5’ overhangs) or by snipping the cohesive 
nucleotides. This can be done using two different enzymes T4 DNA 
polymerase (Promega, UK, Cat# M421A) or DNA Polymerase I Large 
(Klenow) fragment (Promega, UK, Cat# M220A), both contain 5’  3’ 
polymerase activity and 3’  5’ exonuclease activity, Klenow fragment lacks 
the 5’  3’ exonuclease activity that T4 DNA polymerase still retains. 
For T4 DNA polymerase reactions were as follows: 1 µL of enzyme, 100 
µM of dNTPs, 2 µL of 10X buffer and 2 µL of DNA to a total of 20 µL in Milli-
Q water. Reaction was incubated at 37ºC for 5 min and inactivated by 
heating at 75ºC for 10 min. 
Klenow fragment reaction was performed using 0.2 µL of Klenow 
fragment, 2 µL of DNA, 2 µL of 10X buffer, 0.4 µL dNTPs, 4 µL BSAS (100 
µg/mL) in a total volume of 20 µL in water. 
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REMOVAL OF 5’ PHOSPHATES 
For removal of 5’ phosphates from DNA for ligation reactions we used 
Shrimp Alkaline Phosphatase (SAP) (Promega, UK, Cat# M820). 1 µg of 
digested vector was incubated with 1 µL SAP (1 unit) with 1X SAP reaction 
buffer in a final volume of 30 µL and incubated at 37ºC for 15 min. Enzyme 
was then inactivated by heating at 65ºC for 15 min. Ligation of vector alone 
was used as a positive control. 
 
II.3.9 TRANSFORMATION AND GROWTH OF BACTERIAL CELLS 
The transformations of plasmid DNA into E. coli were performed by heat 
shock. Through the entire project DH-5αF’ (Clontech Laboratories Inc., CA) 
strain was used; these were prepared in the lab using chemically induced 
competency by M. Nikaido. 50 mL of competent E. coli at -80ºC were 
defrosted on ice for 20 min with occasional tapping of the 1.5 mL microfuge 
tube. 5 μL of ligation or 1 μL of a stock plasmid were added and cells kept on 
ice for 20 – 30 min with the occasional gentle mixing. Following that, tubes 
were incubated at 42ºC water bath for 42 s, immediately placed on ice and 
left for 2 min. After transformation, cells were incubated in LB for one hour 
before spreading on LB-agar plates containing antibiotic (see below). 
 
BACTERIAL CULTURES  
Glycerol stocks or transformed bacteria were propagated by streaking 
on LB-agar plates containing antibiotic for their specific resistance gene, 
either carbenicillin or kanamycin and incubated overnight at 37ºC. 
Prospective positive colonies on the plates were then picked and grown in 
LB-medium with antibiotic. Cells were then incubated O/N at 37ºC in a 
shaking incubator, the culture volume was chosen according to the specific 
extraction protocols. 
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II.3.10 PREPARATION OF PLASMID DNA SAMPLES 
High quality DNA for cloning, sequencing, embryo injection, etc was 
extracted for bacterial cells using Wizard Plus Mini plasmid extraction kit 
(Promega, UK, Cat# A1330) or QIA filter plasmid kits for Midi and Maxipresp 
(Quiagen Ltd, UK, Cat# 12243 and Cat# 12262). DNA extraction was done 
as per manufacturer instructions. Briefly, bacterial suspensions were lyses by 
alkali and loaded onto the provided columns. Following extensive washing of 
the column, plasmid DNA was eluted with Milli-Q water. 
 
II.3.11 DNA SEQUENCING AND SEQUENCE ANALYSIS 
The DNA sequencing was performed commercially by one of two 
external companies, Eurofins MWG Operon, London, UK or Geneservice, 
UK. Sequences were then analysed by the Basic Local Alignment Search 
Tool (BLAST) at NCBI and Vector NTI Advance 10 (Demo), Invitrogen. 
 
II.4 IN SITU HYBRIDIZATION  
II.4.1 IN SITU PROBES SYNTHESIS 
Prior to probe synthesis 10 µg of midi/maxi-prep plasmid DNA 
containing the cDNA or part of, of the desired gene was linearized by 
digesting 3’ end of the antisense sequence used as probe with a restriction 
enzyme. Reaction was cleaned either by using a DNA purification kit or by 
phenol/chloroform/isoamyl extraction. 
For in situ hybridization it was firstly necessary to create a RNA probe 
labelled with digoxigenin. All reagents used were from DIG RNA Labelling Kit 
(Roche, Mannheim, Germany, Cat# 11175025910) unless stated otherwise. 
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Probe was then synthesised in a sterile RNAse-free microfuge tube (on 
ice) with the following 1 µg purified template, 2 µL of dNTP labelling mixture, 
2 µL transcription buffer (10X), 1 µL RNase inhibitor, 10 mM of DTT and 
DEPC water to a final volume of 19 µL, this mixture was then mixed and 1 µL 
of RNA polymerase (SP6, T7 or T3 depending on the plasmid and direction 
of probe). This was then gently mixed and centrifuged briefly, followed by an 
incubation of 2 – 3 h at 37ºC in a water bath. DNA template was then 
digested by incubation for 15 min at 37ºC with 2 µl DNaseI, RNase-free. 
Enzyme was then denatured by heating at 70ºC for 5 min.  
Probe was then precipitated by adding Milli-Q water to 100 µL, 100 µL 
of NH4OAc 5 M and 500 µL of ice cold 100 % ethanol, mixture was vortexed 
and precipitated for 30 min at -70ºC or O/N at -20ºC, followed by 
centrifugation at maximum speed in a cold centrifuge. Supernatant was 
removed and pellet rinsed with 500 µL of ice cold 70 % ethanol. Pellet was 
dried briefly and resuspended in 100 µL of HM.  
Note all solution were RNase free, Milli-Q water used was firstly treated 
with DEPC to remove any possible RNase’s contamination. 
 
Table II.2 – List of plasmids used to transcribe in situ probes, with the respective 
restriction enzyme (RE) and RNA polymerase for antisense probe. 
Probe name Plasmid RE RNA polymerase 
Cb632 pBKSII+ PstI T3 
Dct pBSKII EcoRI T7 
Foxd3 pCS2 + MT BamHI T7 
Id2a pBKSII+ SalI SP6 
Id3 pGEM-T easy SacI T7 
Ltk pCR-Blunt II-TOPO BstEII SP6 
Sox10 pGEM-T easy SalI T7 
Xdh pKRX XhoI T3 
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II.4.2 WHOLE MOUNT IN SITU HYBRIDIZATION 
In situ hybridization was performed using the Kelsh lab protocol 
adapted from Henrique et al. (1995). All amounts of liquid are 1 mL unless 
stated otherwise. 
Embryos were fixed in 4 % PFA (DEPC treated) O/N at 4ºC or 2 h at 
RT. Embryos older than 24 hpf were dechorionated prior to fixation whereas 
younger was were dechorionated following fixation. After fixation embryos 
were washed with PBT and then dehydrated in methanol (MetOH) by 
washing twice 5 min in 100 % MetOH followed by another 10 min wash, at 
RT. Dehydrated embryos were then stored at -20ºC for at least 24 h or until 
needed. All washes were done under gentle agitation throughout the 
protocol. 
To begin the in situ embryos were first rehydrated in a downwards 
series of 75 % MetOH, 50 % MetOH, 25 % MetOH in PBS (DEPC treated), 5 
min each, followed by four 5 min washes in PBT. Embryos older than 16 hpf 
were then digested with PK (10 µg/mL) at 37ºC for a time according to the 
stage (see Table II.3); appropriate time was determined by a combination of 
lab members experience and by results of previous in situs, ideal times were 
assessed by analysing morphology of the embryos at the end of the 
procedure. To stop reaction embryos were quickly washed in PBT and re-
fixed with 4 % PFA for at least 20 min (can be extended until all embryos are 
ready) and washed four times 5 min in PBT. 
Embryos were then prehybridized for 15 min with HM at RT, followed by 
2 – 5 h incubation at 66ºC in HM (temperature can be altered to 
increase/decrease stringency). Embryos were then hybridized at the same 
temperature with 200 µl of HM containing 1/100th of one probe synthesis or 
another appropriate dilution.  
In the second day embryos were rinsed with 100 % HM, washed for 10 
min in each of the following 75 % HM/25 % 2X SSC, 50 % HM/50 % 2X SSC, 
25 % HM/75 % 2X SSC, 2X SSC all at the same hybridization temperature, 
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followed by two 30 min washes in 0.2X SSC at the same temperature. 
Embryos were subsequently washed at RT for 5 min in each of the following 
75 % 0.2X SSC/25 % PBT, 50 % 0.2X SSC/50 % PBT, 25 % 0.2X SSC/75 % 
PBT, followed by three 5 min washes in MABT. 
 
Table II.3 – Proteinase K digestion times used for in situ hybridization for different 
developmental stages. 
Developmental stage Time of PK digestion 
16 hpf 1 min 
18 hpf 1 min 
20 hpf 2 min 
22 hpf 5 min 
24 hpf 6 min 
28 hpf 12 min 
30 hpf 13 min 
36 hpf 19 min 
40 hpf 27 min 
42 hpf 30 min 
48 hpf 34 min 
72 hpf 50 min 
4 dpf 1 h 10 min 
 
Prior to incubation in antibody, embryos were blocked for several hours 
by incubation in 1 % of commercial blocking solution in MABT. Embryos were 
then incubated O/N at 4ºC with gentle agitation with 1/3000 or 1/5000 of anti-
DIG antibody in the same blocking solution. 
On the third day embryos were rinsed with MABT followed for at least 
six washes of at least 15 min each with MABT at RT. Subsequently embryos 
were washed three times 5 min in NTMT buffer. Embryos were then stained 
using BMPurple (Roche, Manhein, Germany, Cat# 11442074001) or 
NBT/BCIP stock solution (Roche, Manhein, Germany, Cat# 11681451001) in 
9-well glass dishes at RT protected from light. Progress of staining was 
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checked frequently, embryos were left to stain until signal was strong or until 
background started to appear. Reaction then stopped by rinsing with PBT, 
followed by a 5 min wash in PBT and an O/N fixation in 4 % PFA. Embryos 
were then stored in 50 % glycerol until needed. 
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II.4.3 IN SITU HYBRIDIZATION IN CULTURES 
The protocol for in situ in cultures was adapted from Henrique and Ish-
Horowitcz (1995) as per Real et al.. All volumes stated below are for cells 
grown in 4-well Petri dishes. 
Firstly cultures were fixed: culture medium was removed and cultures 
rinsed with 1 mL/well of PBS/EGTA pH 7.5, incubated for 2 h at RT or O/N at 
4ºC in 1 mL of formaldehyde 4 % in PBS/EGTA and washed twice for 5 min 
with PBT. Cells were then dehydrated in by incubation in 50 % MetOH/PBT 
for 5 min followed by two 5 min incubations in 100 % MetOH for at least 24 h 
(could be stored in methanol at -20ºC for a month). 
Following dehydration, cultures were rehydrated for 5 min in a series of 
75 %, 50 %, 25 % methanol/PBT (dishes were kept gently mixing), washed 
twice 5 min with PBT. Cultures were then rinsed once with PBT/HM (1:1) 
followed by one rinse in HM and prehybridized for 2 h at 70ºC in 1 mL of HM. 
Cultures were then hybridized O/N at 70ºC with 300 µL of HM plus 5 µL/mL 
of in situ probe. 
Probe was recovered and cultures rinsed twice with 70ºC preheated HM 
followed by two 40 min incubations with 70ºC preheated HM. Washed 30 min 
at 70ºC with (1:1) HM/MABT, rinsed twice with MABT and washed twice for 
30 min with MABT. 
Prior to incubation with antibody cultures were blocked for 2 h with 
MABT/2 % commercial blocking/20 % goat serum and then incubated 4 h to 
O/N at RT with anti-Dig (1/2000) in the same solution. Cultures were further 
washed at least three times 5 min with MABT and then at least three times 1 
h in the same solution always with gentle agitation. Staining followed by 
washing twice 10 min in NTMT and then staining solution until signal was 
observed. 
 
  
78 
 
II.5 IMMUNOHISTOCHEMISTRY 
II.5.1 WHOLE MOUNT 
Anesthetised and dechorionated embryos were fixed in 4 % PFA for 2 h 
at RT in shaker, washed three times 5 min in PBSX and washed three times 
1 h in Milli-Q water. Embryos were then pre-incubated for at least 2 – 3 h in 1 
% DMSO/5 % horse serum/PBSX, and then incubated O/N at -4ºC, with 
gentle agitation, in the same solution containing between 1/100 to 1/1000 of 
the appropriate antibody. For double immunostaining both antibodies were 
added at the same time making sure they were not from the same species.  
Following O/N incubation embryos were rinsed in PBSX and washed 
three times for one hour in PBSX. O/N incubation in appropriate secondary 
antibody followed, at 4ºC with gentle agitation. Embryos were protected from 
light from here on as secondary antibodies are light sensitive. Embryos were 
rinsed in PBSX and washed three times in PBSX. Embryos were stored in 50 
% glycerol and screened for epifluorescence in 9-well glass dishes. 
Table II.4 – List of antibodies used for detection of -4725sox10:cre expression 
Antibody Working 
dilution 
Use Reference 
Primary antibodies 
Polyclonal IgG Rabbit 
Anti-GFP Primary 
Antibody 
1 - 500 
Detect GFP in fixed 
embryos as a 
positive control 
Molecular Probes Inc., 
OR, USA, Cat# A11122 
Polyclonal Rabbit Anti-
DsRed Primary 
Antibody 
1 – 500 
Detect DsRed-
expression in fixed 
embryos 
Clontech Laboratories, 
Inc., Ca, USA, Cat# 
632496 
Secondary antibody 
Polyclonal IgG Alexa 
Fluor 546 goat anti-
rabbit 
1 – 1000 
Secondary antibody 
for GFP and RFP 
primary 
Molecular Probes Inc., 
OR, USA, Cat#A11035 
 
II.5.2 TISSUE CULTURE FLUORESCENT IMMUNOHISTOCHEMISTRY 
Fluorescent immunohistochemistry was performed on cultured cells for 
several neural crest or neural crest derivatives markers see Table II.5. 
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The protocol for fluorescent immunohistochemistry is the same as 
described by (Shen et al., 2000). Cultures were fixed in 4 % PFA for 10 to 15 
min at RT and washed twice in PBS (cells can then be stored for up to 1 
month at 4ºC). Cells were then permeabilized by incubating in 0.1 % TritonX-
100 in PBS for 15 min and 1 hour in 2 % commercial block reagent 
containing 0.1 % TritonX-100 at room temperature. Primary antibody diluted 
in the same blocking solution (concentration varied according to the antibody 
see below) was added and incubated O/N at 4ºC. Washed 3 times 50 min in 
PBS rocking and protected from light from this point on. Incubated for 3 h in 
secondary antibody diluted in 2 % block reagent (1 – 200) and washed 3 
times 50 min in PBS.  DAPI (Sigma-Aldrich, England, Cat# D8417) was 
added for nuclear staining (1 – 1000) and incubated for 10 to 15min. Cultures 
were then washed twice 5 min in PBS coverslips were then either removed 
from the wells and mounted in slides with Gel/Mount medium (Biomeda, Cat# 
M01) or stored in PBS at 4oC. 
 
Table II.5 - List of primary and secondary antibodies used in culture 
immunohistochemistry and the concentration at which they were diluted. 
Antibody Working 
dilution 
Cell type 
assessed 
Reference 
Primary antibodies 
αTubulin (mouse 
monoclonal IgG) 
1-300 Neuronal Sigma-Aldrich, 
England, Cat# T6793 
αGFAP 1-100 Glia  
αHu C/D IgG2b (mouse 
monoclonal) 
1-200 Neuronal Molecular Probes, 
Eugene, OR, USA, 
Cat# A21271 
αpH3 (rabbit polyclonal) 1-100 Cell proliferation Upstate, NY, USA, 
Cat# 06-570 
αSMA (rabbit anti mouse) 1-300 Smooth muscle 
actin 
 
αSox10 (rabbit 
polyclonal) 
1-200 Early neural crest Gift from Bruce Appel 
αTH (rabbit polyclonal) 1-100 Neuronal Pel-Freez, AR, USA, 
Cat# P40101 
αGFP (mouse 
monoclonal IgG) 
1-200 For GFP in 
sox10:gfp 
Molecular Probes, 
Eugene, OR, USA, 
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II.6 CRANIOFACIAL CARTILAGE PREPARATIONS 
Cartilage staining was performed according to the method in Kelsh and 
Eisen (2000). Morpholino injected embryos and controls were fixed at 5dpf 
O/N in 4 % PFA, embryos were then washed twice with acid-alcohol (1.85 % 
HCl, 70 % Ethanol) and incubated O/N in 0.1 % Alcian green in acid alcohol 
at 4ºC. Subsequently embryos were de-stained with extensive washes in 
acid-alcohol and rehydrated in a series of EtOH in PBS (50 %, 30 % 
EtOH/PBS and PBS), embryos were then bleached using peroxide (1 % 
KOH, 3 % H2O2 in PBS), cleared and stored in glycerol (0.25 % KOH, 50 % 
glycerol).  
 
II.7 QUANTIFICATION OF APOPTOSIS AND CELL CYCLE DISTRIBUTION 
Quantification of apoptosis and cell cycle was adapted from a freely 
available web protocol designed by R. Hsueh and T. Roach for primary B 
cells. 
Embryos were firstly disaggregated to obtain single cell suspension. 
Embryos were transferred to a 1.5 mL microfugetube rinsed once in 
Holtfreters solution, three times in Ca2+-free Ringer’s and subsequently 
pestled five times, tubes were kept on ice always, if possible, from here on. 
Tubes were centrifuged for 5 min, 400 G at 4ºC. Supernatant was removed 
transgenic line Cat# A11121 
Secondary antibodies 
AlexaFluor 488 (goat anti 
mouse polyclonal IgG) 
1-200 - Molecular Probes, 
Eugene, OR, USA, 
Cat# A31619 
AlexaFluor 488 (goat anti 
rabbit polyclonal IgG) 
1-200 - Molecular Probes, 
Eugene, OR, USA, 
Cat# A31627 
AlexaFluor 546 (goat anti 
mouse polyclonal IgG) 
1-200 - Molecular Probes, 
Eugene, OR, USA, 
Cat# A21123 
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and 1 mL of 0.5 % Trypsin-EDTA (Gibco, Cat# 25300) was added and 
incubated for 15 min, gently pipetting up and down every 5 min. Cells were 
then centrifuged 5 min, 400 G at 4ºC and resuspended in 500 µL of 10 % 
FBS/PBS. Suspension was then filtered using a 40 µm cell strainer in a 
falcon tube and washed with another 500 µL of 10 % FBS/PBS. Suspension 
was then transferred to a fresh microfuge tube and centrifuged 5 min, 400 G 
at 4ºC. Supernatant was removed and 250 µL of PI staining solution were 
added, and tubes incubated on ice for 15 min (tubes were covered in foil as 
PI is light sensitive). To stop staining 750 µL of 10 % FBS/PBS were then 
added. 
Samples were transferred to a FACS tube and were then analyzed by 
passage through a BD FACSCanto flow cytometer (BD Biosciences, USA). 
 
II.8 CHEMICAL TREATMENT OF ZEBRAFISH EMBRYOS  
Embryos were grown in 24-well plates, three embryos per well with 2 
mL EM and a total of 1 % or 2 % dimethylsulfoxide (DMSO; Sigma-Aldrich 
Chemical Company, St. Luis, MO) including compound. Control well 
contained either 1 % or 2% DMSO, depending on the experiment. 
Compounds were added at 6 hpf. Compounds used: Herbimycin A, 
Streptomyces sp.; PDGFR Tyrosine Kinase Inhibitor IV; VEGFR inhibitors I 
and II; EGFR inhibitor; Met Kinase Inhibitor; STAT3 Inhibitor Peptide; Jak3 
Inhibitor I and Jak3 Inhibitor II; VEGFR inhibitors I and II; all inhibitors were 
purchased from Calbiochem (see Table II.6). Compounds were dissolved in 
DMSO or water according to manufacturer’s specification. For all stock 
concentrations of the inhibitors, these were dissolved at the highest 
concentration possible according to their solubility (see Table II.6). 
 
TAE684 powder was kindly provided by Dr. Nathanael S Gray (Dana 
Farber Cancer Institute, Harvard Medical School, Boston, MA, USA). Upon 
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arrival powder was diluted in 100 % DMSO to a final concentration of 10 mM. 
Embryos were grown in 30 mm Petri dishes with 30 mL of embryo medium 
and 1 % DMSO, with or without (controls) 2 to 4 nM TAE684.  
 
Embryos were assessed at different time points for developmental 
defects. Time points included: 24, 48, 72 hpf, 4 and 5 dpf. Developmental 
defects assessed included: general morphology; ear; eye; circulation, 
whether or not red cells can be seen moving through the major vessels; heart 
oedema, accumulation of fluid in the interstitial space surrounding the heart 
(reflecting circulatory problems); caudal embryo morphology, including bent 
or misshapen caudal region of the embryo, might reflect possible problems in 
development of muscle or nervous system (Ton et al., 2006); melanophores 
and iridophores, we looked for normal melanophore pattern, iridophores were 
observed by applying incident light in anesthetized fish under a dissecting 
microscope, dorsal stripe iridophores were counted. Number of iridophores 
was plotted in GrapPad Prism 5 and t-test was used as a statistical test. 
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Table II.6 - Summary of commercially available inhibitors used. 
  Abbreviation Highest IC50 
in cell culture 
Mol. 
Weight 
Reference Solubility Stock 
concentration 
Working stock 
R
ec
ep
to
r i
nh
ib
ito
rs
 
Herbimycin A, 
Streptomyces sp. 
Herb IC50 = 70 nM 574.7 Calbiochem, 
Cat# 375670  
1 mg/mL in 
DMSO 
0.17 mM 100 µM 58.8% 
DMSO/EM 
PDGFR Receptor 
Tyrosine Kinase 
Inhibitor IV 
PDGFR IC50 = 45 nM 325.3 Calbiochem, 
Cat# 521233  
10 mg/mL in 
DMSO 
3.07 mM 100 µM 10% 
DMSO/EM 
VEGFR inhibitor I VEGFR I IC50 = 70 nM 310.4 Calbiochem, 
Cat# 676480 
10 mg/mL in 
DMSO 
10 mM 100 µM 10% 
DMSO/EM 
VEGFR inhibitor II VEGFR II IC50 = 70 nM 343.2 Calbiochem, 
Cat# 676485 
5 mg/mL in 
DMSO 
10 mM 100 µM 10% 
DMSO/EM 
EGFR inhibitor EGFR IC50 = 0.7 nM 369.2 Calbiochem, 
Cat# 168393 
200 mg/mL 
in DMSO 
2.7 mM 100 µM 10% 
DMSO/EM 
Si
gn
al
lin
g 
ca
sc
ad
e 
in
hi
bi
to
rs
 
Jak3 Inhibitor I Jak3 I IC50 = 78 µM 297.3 Calbiochem, 
Cat# 420101 
50 mg/mL in 
DMSO 
16,8 mM 100 µM 10% 
DMSO/EM 
Jak3 Inhibitor II Jak3 II IC50 = 5.6 µM 376.2 Calbiochem, 
Cat# 420104 
100 mg/mL 
in DMSO 
13.29 mM 100 µM 10% 
DMSO/EM 
STAT3 inhibitor 
peptide, 
Cell-permeable 
STAT3 IC50 = 500 
nM 
1958.4 Calbiochem, 
Cat# 573096 
1 mg/mL in 
water 
5,1 mM 102.5 µM 10% 
DMSO/EM 
Met Kinase Inhibitor Met IC50 = 20 nM 568.1 Calbiochem, 
Cat# 448101 
1 mg/mL in 
DMSO 
1.7 mM 100 µM 10% 
DMSO/EM 
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II.9 CELL CULTURE METHODS AND CONDITIONS 
Note that all the materials and solutions used for cell culture were 
sterilized either by washing with 70 % ethanol, autoclaving or filtering (for 
thermolabile solutions). 
Cultures were incubated either at 28.5ºC with CO2 (LEEC GA 15 CO2 
incubator), at 28.5ºC without CO2 (Sanyo incubator MIR-155) or at 37ºC with 
CO2 buffered atmosphere (Heraeus B 5060 EC-CO2). 
Throughout the experiments the efficiency and comparison of the 
protocols and different media was assayed for quality. In most cases the 
difference was quite obvious, alleviating the necessity of cell counting. 
Cultures were analysed for efficiency of cell attachment (i.e. did cells 
attached in the first 24 h), presence of GFP+ cells and how long these stayed 
alive. 
 
II.9.1 PREPARATION OF EMBRYOS 
Heterozygous Tg(-4725sox10:egfp) embryos were selected and 
anesthetised, carried to a horizontal flux chamber and from this point 
onwards all procedures were performed in sterile conditions and solutions. 
Embryos were washed in 70 % ethanol for 10 seconds, transferred to a 
sterile Petri dish, ethanol removed and embryos immediately rinsed three 
times in sterile EM. Embryos were then mechanically dechorionated. Due to 
several contamination problems at the early stages of the work, probably 
originating from the fish system, the initial protocol for preparation of embryos 
had to be modified and thus the ethanol washing step and the aseptic 
techniques were introduced. 
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II.9.2 MEDIA 
Initial medium and culture conditions were obtained with the help of 
Prof. Anthony Graham (Guys Hospital, London) according to chicken NC cell 
cultures. The composition has then been changed according to several 
references, as noted. The initial culture conditions were as follows: cells were 
cultured at 37ºC in a 5 % CO2 buffered incubator, F12+Glutamax medium 
(Invitrogen, Cat# 31765027) was supplemented with 10 % foetal bovine 
serum (FBS) (Sigma-Aldrich, England, Cat# F2442) and 15 mM HEPES 
buffer solution (Invitrogen, Cat# 15630-049) and 1 % of a commercial mixture 
of penicillin/streptomycin (P/S) (Sigma-Aldrich, England, Cat# P4333) both 
antibiotics. 
 
We have tested several medium compositions and combinations. Basic 
media tested range from: Dulbecco’s Modified Eagles’s Medium (D-MEM) 
(Invitrogen, Cat# 31885.023) (Dufour et al., 1988; Lahav et al., 1996; Singh 
et al., 2001), Leibovitz’s L-15 Medium (Invitrogen, Cat# 11415049) 
(Westerfield, 2000), Basal Medium Eagle (Invitrogen, Cat# 41010026). 
Several supplements were also added to the cultures such as: 1X N-2 
neuronal supplement (Invitrogen, Cat# 17502-048) (Pomp et al., 2005; Zhao 
et al., 2006), 100 nM of all-trans-retinoic acid (Sigma-Aldrich, England, Cat# 
R2625) (Motohashi et al., 2007; Rao and Anderson, 1997), kanamycin 
(Sigma-Aldrich, England, Cat# K1637), ampicillin (Sigma-Aldrich, England, 
Cat# A9518) (Singh et al., 2001), 1 μM guanosine (Sigma-Aldrich, England, 
Cat# G6264) (Frost et al., 1987; Thibaudeau and Holder, 1998). We have 
also tried the supplementation of the medium with zebrafish embryo extract 
(Singh et al., 2001; Westerfield, 2000), and several concentrations of the 
current components of the medium (see below). Fish embryo extract was 
prepared by rinsing 300, 24 hpf embryos in 0.5 % bleach for two minutes, 
followed by a wash in calcium-free Ringer solution for two minutes, solution 
was then removed, embryos dechorionated and homogenized with a pestle, 
vortexed, resuspended in F12 and stored at -20ºC. 
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Present culture conditions are as follows: cells were incubated at 
28.5ºC since this is the normal physiological temperature of zebrafish 
(Westerfield, 2000) with no CO2 buffering in F12+GlutamaxTM supplemented 
with 15 mM HEPES to maintain a pH of 7.2, 10 % FBS, 1 % P/S, 0.2 % 
gentamicin (10 mg/mL) (Gibco, Cat# 15710-049), 0.5 % Fungizone 
(Invitrogen, Cat# 15290), 100 mM of Endothelin 3 Human, Rat (Sigma-
Aldrich, England, Cat# E9137) (Lahav et al., 1998; Lahav et al., 1996) and 
1.7 mM of CaCl2 (to a final concentration of 2 mM) (Westerfield, 2000). 
 
II.9.3 ADDITION OF MIDKINE 
We have tried the supplementation of the medium with 2.2 µg/mL of 
Midkine, Human (Sigma-Aldrich, England, Cat# M3441). Midkine stock was 
diluted at 250 µg/mL in PBS at pH 7.2. In this experiment dissected NTs 
were incubated at 28.5ºC with no CO2 buffering in F12+Glutamax 
supplemented with 15 mM HEPES, 10 % FBS, 1 % P/S, 0.2 % gentamicin, 
0.5 % Fungizone, 100 mM endothelin 3. 
 
II.9.4 PLATING 
Several attachment substrates were tested during this work. Initially, we 
have tested the adhesion of cells onto the plastic surface of 4-well NUNC 
dishes (Fisher Scientific, Cat# TKT190130V) and also on glass coverslips 
(SLS, Cat# MIC3306).  Glass coverslips were first sterilized by incubating for 
at least three hours at 180oC.  
 
Adhesion molecules tested include bovine plasma fibronectin 
(Invitrogen, Cat# 33010-018)(Dufour et al., 1988), poly-D-lysine 
hydrobromide (Sigma-Aldrich, England, Cat# P7280)(Morrison et al., 1999), 
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laminin (Collaborative Biomedical Products, MA, USA; Cat# 40232) 
(Westerfield, 2000) and a feeder layer of mouse Swiss 3T3 fibroblasts 
(Baroffio et al., 1988). Detailed coating protocols are described below. 
 
COATING 
The bottom of the 4-well dishes with or without coverslip was covered 
with 150 μL of one of the coating substrates. Fibronectin (10 µg/mL in L-15) 
was added and incubated for one hour at 37ºC, fibronectin was then 
removed and dishes rinsed with Milli-Q water, water was then removed and 
dishes were air dried (A. Graham personal communication). For coating with 
poly-D-lysine (4 μg/mL in water) dishes were incubated for 30 min at RT, 
rinsed with Milli-Q water and air dried (Graham et al., 1993; Morrison et al., 
1999). Laminin (10 µg/mL in sterile PBS) was incubated at RT for 45 min, 
rinsed thoroughly with sterile PBS or distilled water, just prior to use. 
 
FEEDER-LAYERS  
We have used mouse Swiss 3T3 fibroblasts as a feeder-layer, since 
these can provide nutrients and growth signals to the cultured cells. Before 
plating dissected NT (see II.9.6) the feeder-layer of 3T3 cells was allowed to 
grow in D-MEM until it reached confluence. Once cells were confluent growth 
was arrested by treating cells with 2 mg/mL Mitomycin C from Streptomyces 
(Sigma-Aldrich, England, Cat# M4287) for 2 – 3 hours. Growth arrested 3T3 
cells were then washed with medium to remove any residues of Mitomycin C 
(Baroffio et al., 1988). Neural tubes were then plated with NC cells medium. 
 
II.9.5 CELL DISSOCIATION METHODS 
Dechorionated embryos were rinsed three times in 1X Holtfreter’s 
solution, transferred to a 1.5 mL microfuge tube and disaggregated with a 
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micropestle (Eppendorf, Hamburg, Germany) by firmly inserting the 
micropestle into the tube 5 – 6 times, being careful not to twist as not to grind 
the cells. The disaggregated cells were then centrifuged in a cooled benchtop 
centrifuge (Spectrafuge 24D, Jencons-PLS) at 800 rpm for 5 min and the 
supernatant discarded. From this point forward procedure was performed in a 
microbiologically safe cabinet. Pellet was resuspended in 1 mL of 0.5 % 
Trypsin-EDTA (Gibco, Cat# 25300) using a P1000 pipette tip. Cells were 
incubated for 15 min at RT and pipetted every 5 min to help breaking down 
large clumps of cells and enabling small clumps to be broken down into 
single cells. Cells were then centrifuged for 5 min at 800 rpm, supernatant 
discarded and cells resuspended in 1 mL of warm medium. Suspension was 
then filtered using a 40 µm cell strainer (SLS, Cat# 734-0002) into a 50 mL 
Falcon tube (BD Bioscience, NJ, USA) (previously rinsed with 10 %FBS/PBS 
since it prevents cells from sticking to plastic equipment), microfugetube was 
further rinsed with 500 µL of medium and filtered. Filter was then washed 
with another 500 µL of medium. The filtering process was performed to 
ensure that only single cells were then processed. 
 
II.9.6 DISSECTION OF NEURAL TUBES 
In this procedure we have used 16 hpf zebrafish embryos since by this 
time NC cells start to delaminate from the neural tube (NT), initially from the  
anterior trunk (Raible et al., 1992) . Embryos were processed as in II.9.1. The 
trunk region between the otic vesicle and the last somite was isolated. The 
neural tube was then incubated in a proteinase to facilitate the removal of the 
surrounding tissues; we have tried 1 mg/mL dispase (in L-15) (Gibco, Cat# 
17105)(Graham et al., 1993) and 0.5 % Trypsin-EDTA. The NT was then 
gently scraped away from somites and notochord by using fine flame 
sharpened tungsten dissecting needles (Goodfellow, Cambridge, Cat# 690-
670-53). In some cases we have tried the use of cloning cylinders, these 
allowed for the dissected NT to stay in the middle of the dish, facilitating 
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further experiments, such as fluorescent immunohistochemistry, due to the 
poor optical properties of the edge of the wells. 
 
II.9.7 CELL CULTURE FACS SORTING 
FACS sorting was performed in a FACSVantageTM SE cell sorter 
system (BD Bioscience, NJ, USA). For use in FACS sorting -
4725sox10:egfp+/- embryos were used. GFP positive embryos were selected 
and then processed as in II.9.5. The cell suspension was then transferred 
into FACS tubes (BD Bioscience, NJ, USA) previously coated with 5 % 
FBS/PBS to reduce cell adhesion and transported in ice to the FACS sorter. 
FACS machine was firstly run with sterile PBS at maximum velocity to 
remove any debris and possible contaminants in the system. A test run of 
50,000 events at 500 events/s was performed to calibrate the machine and 
set sorting gates. The FACS machine detector settings varied from session 
to session depending on the condition of the laser. The gates were set so 
that GFP+ cells were separated from GFP- cells (see Figure V.3). On average 
1,000,000 events were collected, this was dependent on the amount of 
sample available. Cells were collected into 1.5 ml microfuge tubes containing 
500 mL of cell culture medium. 
 
II.10 IMAGING 
Several imaging methods were used depending on the project or 
purpose. In general standard dissecting scopes (Leica MZ75) with either 
transmitted or incident bright light were used for analysis and manipulation of 
live embryos, analysis of in situ progression and counting of cells. 
Selection of GFP+ embryos was performed on an MZ12-FL dissecting 
microscope (Leica) with fluorescent attachment. Due to the lower sensitivity 
of this dissecting scope for DsRed fluorescence, screening and analysis of 
both transient and transgenic -4725sox10:cre fish was done under a more 
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powerful dissecting scope, a Leica MZ16F with a Leica Fluo III filter cassette, 
coupled UV light and a Leica DC 350 FX camera.  
Pictures of in situs, immunohistochemistry, cartilage staining and live 
fish, were done using an Eclipse E800 (Nikon) microscope using appropriate 
filters and Nikon Digital Sight DS-U1 camera, for better magnification. 
In all pictures embryos are oriented anterior to the left and dorsal to the 
top. 
CONFOCAL MICROSCOPY 
For time lapses, z-stacks and further analysis, embryos were imaged 
under a Zeiss Confocal microscope (LSM510 Meta). Live embryos for 
confocal microscopy were mounted into 2% agarose, in specially designed 
Petri dishes with a glass coverslip at the centre; embryos were then covered 
in EM with 200 mg/L of tricaine to prevent them from moving. 
 
CELL CULTURE 
Cells were imaged by wide-field fluorescent microscopy on an Eclipse 
E800 (Nikon) using a DS-U1 camera (Nikon) or confocal microscopy on a 
Zeiss Confocal microscope (LSM510 Meta). 
For cell culture immune staining, coverslips were mounted into 
Gel/Mount medium (Biomeda, Cat# M01) and observed under a Leica DM 
IRB microscope coupled with a SPOT RT Color camera (Diagnostic 
Instruments, Inc.). 
 
II.11 STATISTICAL ANALYSIS 
Statistical analysis in Chapter VI for the injections of constitutively active 
kinases and treatment with TAE684 was performed using freely available 
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webtool for Fishers Exact test (http://faculty.vassar.edu/lowry/fisher2x3.html), 
p values of 0.005 were considered.  
All other statistical analysis of the data was performed using Prism 5 
DemoTM (GraphPad, San Diego, CA). 
92 
 
 
 
 
Chapter III - GENERATING A SOX10:CRE 
TRANSGENIC LINE 
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III.1 AIMS 
Currently zebrafish transgenic lines that label the NC with GFP under 
the regulation of the sox10 promoter are only transient. This provides a short 
time window of labelling, in particular in some NC derivatives where sox10 is 
downregulated early. Therefore we propose to create a permanent labelling 
transgenic line using the Cre/loxP system. This system has been used in 
other models to achieve a permanent labelling of the crest and has proved 
extremely useful. For that we shall: 
• Generate a construct that expresses Cre in NC lineage by 
cloning Cre downstream the sox10 promoter; 
• Injected Cre responsive embryos with this construct and 
determine Cre expression in transient embryos; 
• Generate a stable transgenic line: 
o Inject and raise embryos for the production of transgenics; 
o Screen for potential founders; 
• Characterise Cre expression in stable lines. 
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III.2 RESULTS 
III.2.1 CLONING STRATEGIES 
CLONING -4725SOX10:CRE 
In order to create the permanent labelling of neural crest cells it was 
firstly necessary to construct a plasmid containing the sox10 promoter, as 
this is expressed in neural crest cells, followed by the gene for Cre 
recombinase. 
We started with a -4725sox10 (sox10 U/S) plasmid containing the 
sox10 promoter previously constructed in the Kelsh lab by T. Carney (2003). 
This plasmid contains the 5’ region of the sox10 gene, 4725 base pairs from 
the transcription initiation site of this gene. This promoter was shown by T. 
Carney (Carney, 2003; Carney et al., 2006) to drive GFP expression in a 
pattern consistent with that of sox10, and was therefore chosen. This plasmid 
was then digested with SpeI and NotI, run in an agarose gel to confirm the 
complete digestion and extracted. 
To clone the Cre gene downstream of the sox10 promoter, the Cre 
fragment was amplified by PCR from the pCSCre vector (Werdien et al., 
2001) (Figure III.1). Cre fragment, containing the coding sequence for Cre, 
was amplified by using the T3 primer at the 3’ end of the plasmid and at the 
5’ end, a primer was designed using 20 bp of the 5’ prime sequence of the 
Cre recombinase preceded by the SpeI recognition site and an extra base 
pair to aid the end digestion (see Table II.1). This fragment was amplified 
using KOD polymerase as this enzyme introduces fewer mutations. The PCR 
reaction was run in an agarose gel and the resulting fragment was then 
extracted and purified. Subsequently the fragment was digested with SpeI 
and NotI restriction enzymes and again purified. 
The two resulting fragments were then ligated O/N and transformed into 
competent E. coli, only 7 colonies were present, these were selected and 
miniprep was performed. Upon gel electrophoresis only 3 colonies were in 
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the right size range. These 3 colonies were then restriction analyzed and one 
showed a fragment with the correct size to correspond to Cre, this was then 
sequenced using a primer for the end of the sox10 promoter. This confirmed 
the cloning of the Cre. The resulting -4725sox10:cre plasmid was then fully 
sequenced by primer walking (see II.3.11). Sequence was analysed in Vector 
NTI to search for ORF (Open reading frame) confirming correct Cre protein 
sequence and contiguous reading frame (see Appendix I). 
 
CLONING CRE INTO DIFFERENT SOX10 PROMOTER FRAGMENTS 
In order to determine if different portions of the promoter would give us 
a better Cre expression, i.e. the closest possible to the endogenous sox10 
expression, we designed cloning strategies using the previously constructed 
reporter plasmids sox10:gfp with different 5’ sox10 promoter deletions 
previously prepared by J. Dutton (2008); and the pCSCre plasmid (Werdien 
et al., 2001). 
These different sox10:gfp constructs are respectively psox10-2425:GFP, 
psox10-1252:GFP, psox10-521:GFP and p+20:GFP (see Figure III.2), also 
referred to as S6, S7, S8 and S10, respectively. These four sox10:gfp 
constructs were the source of sox10 promoter fragments for the cloning of 
shorter sox10:cre constructs. The 5’ end of each construct is denoted by the 
amount of base pairs from the 5’ end to the transcription start site. 
Since all these constructs are in a pCS2+ backbone, the strategy used 
was therefore the same for all of them. The first step towards this engineering 
was to cut off the sequence of GFP in each one of the sox10:gfp plasmids 
and extract the backbone minus the GFP fragment. So the plasmids were 
digested with SpeI/NotI restriction enzymes, located at the ATG position of 
GFP and near the T3 promoter, respectively (Figure III.3). These two 
enzymes leave two incompatible cohesive ends which were then used to 
ligate the Cre fragment amplified by PCR (see above). 
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The Cre fragment was cloned from the pCSCre plasmid (Werdien et al., 
2001). For that the fragment was amplified by PCR reaction (see II.3.3). At 
the 5’ we used a primer containing the SpeI recognition sequence followed 
by a portion of the Cre 5’ sequence and at the 3’ end we used a primer for 
the T3 sequence, as this was already followed by the NotI recognition site in 
the original plasmid. Following the PCR, this fragment was excised from the 
gel and was then digested with both enzymes to obtain the desired cohesive 
ends (Figure III.3). This fragment was then ligated into the pCS2+:sox10 
vectors, transformed into competent E. coli and plated. Out of the four 
different promoters only two of them presented clones. However, sequencing 
of the resulting plasmids failed to show Cre sequence downstream of sox10 
promoter, indicating that the cloning failed.  
 
CONSTRUCTION OF PGEM-T:CRE 
Failure of the above ligation might have been caused by the incomplete 
digestion of Cre PCR product, since the digestion was at the end of the 
fragment. Therefore an alternative strategy with an intermediate step to clone 
the amplified Cre fragment was devised. This strategy involved inserting the 
Cre fragment into pGEM-T Easy vector. The pGEM-T is a commercial 
linearized vector with 5’ T overhangs that can be used for annealing with the 
3’ A overhangs naturally generated by Taq polymerase during PCR. 
After a standard PCR reaction using Taq, the products were quickly 
purified and ligated with the pGEM-T vector. The ligation mix was then 
transformed and lacZ screening used to identify positive transformants. After 
this process several colonies were selected and analysed by restriction 
digestion pattern. Only two colonies gave potentially positive clones, i.e. with 
an insert. These colonies were then sent for sequencing, and although the 
two were positive for Cre only one of the recombined plasmids had the 
desired orientation i.e. 5’ SpeI and 3’ NotI. Sequence was consistent with that 
of original Cre. 
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Figure III.1- Cloning -4725sox10:cre. Diagram showing the strategy used to clone 
cre under the -4725:sox10 promoter and map of the final -4725sox10:cre. 
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Figure III.2 – Diagram if the different length sox10 promoter constructs. 
Numbers shown at the 5’ end of the sox10 promoter regions indicate the amount of base 
pairs left in the region from the 5’ end to the transcription start site (indicated by the bent 
arrow). There are five plasmid stocks listed on the right for the cloning of sox10:cre 
constructs these different sox10:gfp constructs are respectively p-4725sox10:gfp, psox10-
2425:GFP, psox10-1252:GFP, psox10-521:GFP and p+20:GFP (Dutton et al., 2008). 
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Figure III.3 – Cloning Cre into sox10:egfp constructs. Pictures of agarose electrophoresis showing A) 
digestion of the different promoter length plasmids: S6, S7, S8 and S10 after digestion with SpeI/NotI, all showing 
apparent total digestion and excision of the gfp fragment; B) Purified S6, S7, S8, S10 promoter fragments and Cre 
recombinase PCR fragment, all after digestion with SpeI/NotI and phenol/chloroform extraction. In both images 
Promega 1kb ladder was used (M). 
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III.2.2 ANALYSING -4725SOX10:CRE TRANSIENT EXPRESSION 
Prior to generating a transgenic line it was necessary to confirm that the 
-4725sox10:cre construct (see III.2.1) was able to produce functional Cre 
recombinase in a pattern similar to that previously described by Carney et al. 
(2003) for GFP and to the endogenous sox10. In order to do this 
Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) zebrafish embryos were injected 
with 100 ng each of the -4725sox:cre containing plasmid. Tg(EF1alpha:loxp-
egfp-pA-loxp-dsred-pA) embryos constitutively express eGFP unless loxP 
flanked fragment is excised by Cre (see I.4.2). Injected embryos were thus 
observed under a fluorescent dissecting microscope to look for DsRed 
expression.  
 
If the -4725sox:cre was functioning we would expect that the eGFP 
excision would occur in cells normally expressing sox10, such as is the case 
of neural crest, and to have red fluorescence in a pattern similar to that of the 
endogenous sox10, i. e. the NC and its derivatives, as well as ear and 
oligodendrocytes. Expression in migrating crest would only be seen if DsRed 
folds and is detectable quickly after expression. As this is a transient analysis 
we would not expect to see all sox10 positive cells labelled but rather a few 
scattered clones of red cells, hopefully with examples in several neural crest-
derived populations. 
  
TRANSIENT ANALYSIS 
The function of -4725sox10:cre was then indirectly analysed by looking 
for red fluorescence under a dissecting scope, firstly in four day old embryos 
(Figure III.4 and Figure III.5). These transient analyses showed DsRed 
expression in some derivatives of neural crest such as neurons from the 
enteric nervous system, iridophores, xanthophores, craniofacial cartilage and 
dorsal root ganglia (DRG) but also in some ectopic sites such as muscle and 
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heart. Even though in the case of pigment cells some of the signal might be 
due to autofluorescence, as for example xanthophores have been shown to 
be autofluorescent due to their pigments (signal was later confirmed by 
immunostaining), and that muscle expression is ectopic, the remaining 
DsRed signal is consistent with known sox10+ derived cells. This provided 
evidence that at least partially, the -4725sox10:cre was working; confirmation 
of xanthophores and iridophores expression was necessary to exclude 
autofluorescence. Although ectopic expression in muscle is not consistent 
with sox10 expression, it consistent with that show in other reporter lines 
using this fragment of sox10 promoter. 
This expression was only observed at 4 dfp and not earlier. To 
determine if this was to lack of DsRed expression or just faint signal we 
performed DsRed immunostaining in earlier stages of development on 
injected embryos. At 24 hpf DsRed positive premigratory and migrating 
neural crest cells could be seen in head and trunk, as well as ectopic muscle. 
By 48 hpf expression in unidentified cells of the hindbrain could be seen, and 
craniofacial cartilage expression particularly in the jaw, by this stage 
migrating trunk neural crest cells were also visible. DsRed positive 
immunostaining was also visible in xanthophores in the head and trunk as 
well as ectopic muscle expression (Figure III.6). As a positive control we did 
immunostaining in 4 dpf embryos, as this was the time point we had seen 
DsRed signal in live embryos, this confirmed our live results. 
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Figure III.4 - Transient injection of sox10:cre gives DsRed positive NCC. Pictures 
showing expression of DsRed in transient -4725sox10:cre injected in 4 dpf injected embryos. 
Pictures taken under the dissecting scope in the red fluorescence channel. Photos A – D 
were taken with a monochromatic camera. A) Lateral view of an embryo with broad 
expression in muscle cells but also enteric neurons and iridophores (see C). B) Embryo 
showing at least three DsRed positive xanthophores. C) High magnification of A showing 
more clearly the enteric neurons, iridophores and ectopic muscle fibres. D and D’) 
fluorescent and phase contrast pictures (respectively) of the head of an embryo showing 
broad expression in the jaw and other craniofacial structures, cells in the eye and ear. E – F) 
head of two different embryos showing expression in branchial arches, cells of the ear 
epithelium, jaw, heart and muscle. G – H) 4 dpf embryos showing DsRed expression in jaw, 
ear, muscle and in the heart. ba – branchial arches, cns – central nervous system, en – 
enteric neurons, h – heart, i – iridophores, j – jaw; m – muscle.  
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Figure III.5 – Transient embryos express DsRed in DRG. Picture showing a portion 
of a Tg(EF1alpha:loxP:egfp:loxP:dsred) 4 dpf old embryo, dorsal to the neural tube. Embryo 
transiently injected with -4725sox10:cre. A) Overlay of red fluorescence and brightfield 
image. B) Red fluorescent picture showing more clearly the DRG. It is clear a DRG like 
structure with DsRed+ cells surrounding DsRed- cells, these positions are consistent with a 
satellite glia phenotype. drg – dorsal root ganglia, i – iridophore. 
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Figure III.6 – Immunostaining reveals DsRed expression at earlier stages. Immunostaining for DsRed in -4725sox10:cre 
injected embryos at three different developmental stages, 24 hpf (A - D), 48 hpf (E - F) and 4 dpf (G – I). Pictures taken under dissecting 
scope, A and G are green fluorescence all others red fluorescence channel. B – D) 24 hpf embryo where migrating NC cells can be seen 
in both trunk and head. E – F) 48 hpf embryo showing expression in hindbrain, branchial arches, jaw and xanthophores. H, I) 4 dpf embryo 
showing expression of DsRed in jaw, ear and iridophores. ba – branchial arches, cnc – cranial neural crest, hb –hindbrain, i – iridophores, j 
– jaw, tnc – trunk neural crest, x – xanthophores. 
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Together the live and the immunohistochemistry analysis of transient   -
4725sox10:cre showed that the construct was working, producing functional 
Cre recombinase in neural crest cells. We therefore set out to produce a 
stable transgenic line.  
 
III.2.3 CLONING TOL2:-4725SOX10:CRE:TOL2 
In order to create a -4725sox10:cre transgenic line we devised a 
cloning strategy to insert the -4725sox10:cre construct into a vector 
containing the Tol2 sites, as this would increase the rate of transgenesis (see 
I.4.4). This vector, pT2KXIGΔin, was the same one used to create the 
Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) line and was kindly provided by 
Dr. Laure Bally-Cuif. In order to do this it was necessary to first remove all 
coding sequences between the Tol2 sites. This proved difficult as there were 
no compatible cohesive ends restriction enzymes in both plasmids. Therefore 
we decided to cut both -4725sox10:cre and pT2KXIGΔin plasmids with 
compatible cohesive enzymes at one end and generate a blunt end at the 
other end. Since there were no enzymes capable of doing so these would 
have to be created by filling a cohesive end with the use of T4 DNA 
polymerase (see II.3.8). 
To generate the blunt ends -4725sox10:cre was cut with XbaI at the 3’ 
end and pT2KXIGΔin with BglII at the 5’ end, the resulting ends were then 
filled prior to the second digestion. Digestion with SalI at the 5’ end of the -
4725sox10:cre coding region, and XhoI at the 3’ end of the first Tol2 
sequence were chosen as these two enzymes generate compatible cohesive 
ends. Reactions were cleaned of enzymes in each step and fragments of the 
correct size were extracted from the gel in order to remove contaminants 
(see II.3.6). 
Several attempts with variations in the initial amounts of DNA, as well 
as enzymes involved, resulted in colonies that after restriction digestion 
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analysis yielded no positive clones. All clones contained the backbone 
without the sequence between the Tol2 sites, but no -4725sox10:cre 
fragment. This was not predicted as the pT2KXIGΔin backbone should not 
re-circularise as the ends were not compatible. 
A new non-directional strategy was designed for blunt end ligation. Both 
plasmids were double digested, -4725sox10:cre was digested with SalI and 
pT2KXIGΔin with XhoI/BglII. The linearized fragments were extracted, blunt 
ends were generated and to prevent unwanted re-circularisation of the 
pT2KXIGΔin 5’ terminal phosphate groups were removed with alkaline 
phosphatise (see II.3.8). This strategy yielded several colonies but restriction 
analysis of the resulting plasmid showed no positive colonies but religation of 
the backbone, showing that even though digestion and generation of the 
blunt ends was successful the SAP dephosphorylation was not. After several 
attempts to modify reaction conditions and increase of SAP time (see II.3.8) 
this gave no better results and the cloning was abandoned. 
 
III.2.4 GENERATING TRANSGENIC FISH 
Due to the difficulty of generating a tol2:-4725sox10:cre:tol2 plasmid, 
two different strategies were used to try and create successful transgenic 
zebrafish. The first strategy involved injection into wild-type AB fish of 100 pg 
(21.7 ng/µL x 4.6 nL) of the circular -4725sox10:cre plasmid (backbone 
included). As an alternative a -4725sox10:cre plasmid was digested 
generating a SalI/SalI fragment, this fragment included only the -
4725sox10:cre portion with no backbone (Figure III.1). This fragment was 
injected into AB fish at 2.3 nL of 46 ng/µL (105.8 pg). 
After removal of dead and deformed embryos these strategies 
generated on 05-08-2009 and 17-11-2009 two batches of fish, one with the 
full plasmid, the other with the linearized fragment, respectively. They were 
then raised to adulthood with stock numbers S1621 and S1624 and 
screened. 
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III.2.5 TESTING TG(-4725SOX10:CRE) F1 TRANSMISSION 
To create a stable transgenic line it was necessary to look for potential 
founders in injected fish, i.e. fish with germline transmission. Injected fish 
were kept individually in separate numbered tanks, crossed with 
Tg(EF1alpha:loxp-egfp-pA-loxp-dsred-pA) reporter line and the progeny 
screened for DsRed expression. Whenever these injected fish laid, embryos 
were collected and dead embryos removed at 6 and 24 hpf. A record of the 
number of times potential carriers laid and the numbers of both dead and live 
embryos was kept (see Appendix 2). At 4 dpf clutches of eggs were then 
screened for DsRed expression under a fluorescent dissecting microscope; 
number of GFP+ fish was also noted. At the time of submission of this thesis 
a 104 potential carriers had been screened with an average of 157 eGFP+ 
embryos looked at per fish, and an average mortality of 32 %. Four carriers 
were found, those numbered 5, 73, 74 and 101, with various frequencies of 
germ line transmission (see Table III.2). Individual fish that were considered 
unlikely to be founders were euthanized according to Home Office directives; 
normally when fish had a) laid several times and b) over 250 GFP+ embryos 
had been examined. 
 
 
Table III.1 – Summary of number of potential founders for -4725sox10:cre 
screened with average embryo mortality and number of positive founders. 
Number of potential 
founders 
Average of embryos 
screened per putative 
founder 
Mortality Number of Carriers 
104 157 32 % 4 
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Table III.2 - Number of DsRed and GFP positive embryos in indentified founders. 
Positive 
founders 
Number of 
positive embryos 
Number of GFP+ 
positive embryos 
Frequency of 
transmission 
Batch 05-08-2009 
5 3 1303 0.002 
Batch 17-11-2009 
73 80 151 0.530 
74 26 88 0.297 
101 22 108 0.204 
 
Upon discovery of the positive founders a few DsRed positive embryos 
were imaged at different developmental stages, the remaining embryos were 
raised in the Fish Facility as per Home Office rules, to create the F1 
generation. Embryos were imaged to determine DsRed pattern and how well 
this correlated with neural crest derived cells.  
Observation of Founder 5 offspring at 4 dpf showed DsRed+ cells in 
several NC lineages and sox10+ populations (Figure III.7). This embryo had, 
consistent with sox10 expression, DsRed+ cells in ear epithelium, the 
branchial arches, iridophores and dorsal root ganglia, all along the posterior 
lateral line nerve (possibly the Schwann cells), oligodendrocytes of the CNS 
and unidentified cells in the hindbrain.  
Careful observation of Founder 73 offspring revealed DsRed expression 
in several cell populations. Embryos were observed every 24 h, starting at 24 
hpf. At 48 hpf when DsRed expression was first visible, expression was seen 
in migrating NC cells of the head, iridophores of the trunk and eyes, 
xanthophores, neurons of the enteric nervous system, ear epithelium, 
trigeminal ganglia, gross pharyngeal ganglion, Schwann cells of the PLLn jaw 
and branchial arches (see Figure III.8). At 72 hpf lateral view of the trunk 
showed several positive Schwann cells in the DRGs as well as Schwann 
cells of the ventrally and dorsally projecting spinal nerves, iridophores and 
cells in the spaces between iridophores possibly melanophores. In the head 
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region we saw positive cells in the branchial arches, jaw and cells in the 
hindbrain (Figure III.9). 
By 4 dpf we saw evenly spaced DsRed+ just above the neural tube 
possibly DRGs, Schwann cells of the PLLN, xanthophores and iridophores 
(Figure III.10, A – C). In the head several DsRed positive derivatives were 
seen: eye iridophores, xanthophores, ear, trigeminal ganglia, pharyngeal 
ganglia, branchial arches and jaw (Figure III.10, D – G). Positive cells were 
also observed in the pectoral fin cartilage (Figure III.10, D).  
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We have generated a transgenic line that permanently labels the NC 
and derivatives using the Cre/loxP system. This transgenic line -
4725sox10:cre expresses Cre recombinase under the control of sox10 
promoter, sox10 being a known marker for NC cells. By crossing this line with 
a Cre responsive line we have been able to show labelling of several NC 
derivatives, these included: migrating NC cells of the head, craniofacial 
cartilage, cranial ganglia, iridophores, xanthophores, enteric neurons, 
Schwann cells of the PLLn, of the DRG and of the ventrally and dorsally 
projecting spinal nerves and sox10 positive populations such as  
oligodendrocytes of the CNS and the ear epithelium 
These expression domains of DsRed are consistent with that of NC 
derivatives and known sox10 expression, and with previous transgenic lines 
using the same promoter. This has therefore confirmed that our transgenic 
lines were expressing Cre in the correct positions thus confirming the 
potential of this line for a permanent labelling of the NC in zebrafish.  
 
For detailed discussion and future work please see VII.1 - Generation of 
sox10:cre transgenic lines. 
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Figure III.7 – Transgenic embryo shows sox10-like red fluorescence. Composite picture of a 4 dpf “Founder 5” 
offspring. A) Green fluorescence, showing ubiquitous eGFP expression. B) Red fluorescence for the embryo in A. C – D) 
details of embryo in B, showing DsRed positive cell populations such as ear epithelium (ear), branchial arches, iridophores, 
dorsal root ganglia, Schwann cells of posterior lateral line nerve, oligodendrocytes of the CNS and unidentified cells in the 
hindbrain. ba – branchial arches, drg – dorsal root ganglia, i – iridophores, hb – hindbrain, o – oligodendrocytes, plln - posterior 
lateral line nerve. 
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Figure III.8 – Transgenic embryos show red fluorescence in several head and 
trunk structures at 48 hpf. Confocal images of Founder 73 offspring at 48 hpf. A,D and I 
brightfield image; B, E and J green fluorescent channel; C, F, H and K red fluorescence 
channel; G overlay of green and red fluorescent channels. A – C) lateral view of tail 
showing the posterior lateral line nerve and xanthophores. D – F) lateral view of the anterior 
trunk showing iridophores as well as possible enteric nervous system neurons just above 
the yolk extension. G, H) projection of a Z stack of the head neural crest cells, iridophores 
of the eye, ear epithelium (arrow head), cells in a trigeminal ganglion position, 
glossopharyngeal ganglion and jaw. I – J) single slice showing cells of the ear epithelium 
(arrow head) and well as jaw precursors. ba – branchial arches, en – enteric nervous 
system neurons, i – iridophores, j – jaw, plln – posterior lateral line nerve, nc  – head neural 
crest cells, nt – neural tube, tg – trigeminal ganglion position, vag – vestibularacustic 
ganglia, and x – xanthophores. Scale bars, 100 µm. 
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Figure III.9 –NC DsRed expression in 3 dpf F1 embryos. Confocal images of a 3 dpf embryo from founder 73. A, E) Brigthfield images; B, G) green 
fluorescent channel; C, D, F, H) red fluorescent channel. A – C) Lateral view of the tail trunk showing several positive satellite cells in the dorsal root 
ganglia, iridophores and cells in the spaces between iridophores possibly melanophores or premigratory crest. D) Lateral view of the trunk showing 
Schwann cells of the ventrally projecting spinal nerves (arrow) and satellite cells of the DRG. E, F) lateral view of the head, with positive cells in the 
branchial arches, jaw and hindbrain. G, H) ventral section of the head where it is possible to see that a huge proportion of the mesenchymal cells of the jaw 
are DsRed positive. ba – branchial arches, drg – dorsal root ganglia, hb – hindbrain, i – iridophores, j – jaw, nc – premigratory neural crest. Scale bar, 100 
µm. 
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Figure III.10 – F1 shows sustained DsRed expression at 4 dpf. 
Confocal images of Founder 73, 4 dpf offspring. A is bright field; B, C, E and G 
red channel fluorescence, D and F overlay of green and red channel. C, F and 
G are projections of a Z stack. A, B) Lateral view of the tail where it is possible 
to see DRGs and iridophores. C) Lateral view of the trunk. It is possible to 
observe the dorsal root ganglia, Schwann cells of the ventrally projecting 
spinal nerves, enteric neurons, posterior lateral line nerve, xanthophores and 
iridophores. D - G) lateral view of a section of the head where it is possible to 
see not only in the pectoral fin cartilage but also xanthophores and eye 
iridophores, ear epithelium, trigeminal ganglia, vag – vestibularacustic ganglia, 
branchial arches and jaw. ba – branchial arches, drg – dorsal root ganglia, en 
– enteric neurons, gpg – glossopharyngeal ganglion, i – iridophores, j – jaw, 
plln – posterior lateral line nerve, sn – spinal nerves, tg – trigeminal ganglia, 
vag – vestibularacustic ganglia and x – xanthophore. Scale bars, 100 µm. 
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Chapter IV - CHARACTERIZING ID2A 
FUNCTION IN NEURAL CREST 
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IV.1 AIM 
Inhibitors of differentiation (ID) proteins have been shown to be 
important in several developmental processes such as differentiation, cell 
cycle arrest and apoptosis. Id2a in zebrafish has previously been shown to 
be expressed in zebrafish NC, particularly iridophores. Downregulation of 
using a translation blocking morpholino for id2a has also shown reduction of 
iridophores. 
Due to our particular interest in the NC and iridophores we proposed to: 
• Further characterise the expression domain of id2a in crest in WT 
embryos and two NC mutants; 
• Determine id2a function by morpholino KD; 
o including characterization of cell populations affected; 
• Determine how id2a relates to Ltk, another iridophore gene, in regards 
to their regulation. 
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IV.2 RESULTS  
IV.2.1 CHARACTERIZATION OF ID2A EXPRESSION PATTERN 
J. Müller (2007) had previously shown that id2a was expressed in 
premigratory crest by 24 hpf and later, 48 and 72 hpf, to be expressed in 
iridophores. This characterization was not extensive and more developmental 
stages were required for a more detailed characterization of id2a expression. 
 In order to determine id2a expression pattern in zebrafish embryos we 
performed in situ hybridization (see 0) at several developmental stages from 
16 hpf until 72 hpf. Outside of the NC, id2a is expressed in the cerebellum 
and telencephalon from 18 hpf until 72 hpf (Figure IV.1 and Figure IV.2). 
Expression was also observed in the rhombomeric lip at 22 hpf (Figure IV.1). 
By 40 hpf id2a is strongly expressed in the several domains of the CNS, 
where it is sustained until at least 72 hpf (Figure IV.2). By 18 hpf id2a 
expression is strong in dorsal retina where it was maintained until 22 hpf. 
Expression is also seen at the tail end of the notochord by 20 hpf where it is 
sustained until 24 hpf (Figure IV.1). At 22 hpf there is strong expression in 
the pronephric ducts and by 30 hpf it is expressed in the corpuscles of 
Stannius where it is sustained untill at least 72 hpf (Figure IV.1 and Figure 
IV.2). 
Within the NC and its derivatives id2 has a very dynamic pattern.  At 18 
hpf strong expression can be seen in cranial neural crest, at the surface of 
the embryo posterior to otic vesicle, this expression is maintained until 20 
hpf. By 22 hpf cranial neural crest expression can still be observed but less 
strongly, cells have now migrated to the position of the cranial ganglia, where 
signal is strong, expression in this region is maintained until 30 hpf. Some 
migrating cranial crest cells are also observed until 30 hpf (Figure IV.1).  
By 20 hpf expression in trunk neural crest is discernible in the dorsal 
side of the anterior trunk. This expression starts to expand posteriorly as the 
embryo develops, covering the whole dorsal side of the trunk and tail by 22 
hpf. By 22 hpf, streaks of migrating neural crest cells can be seen mainly in 
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anterior trunk, these streaks increase in intensity and the pattern extends 
more posteriorly by 24 hpf (Figure IV.1). By 30 hpf these streaks start to 
reduce in intensity and anterior streaks disappear. Eventually migrating cells 
disappear by 48 hpf (Figure IV.1 and Figure IV.2). 
At 36 hpf some individual spots can be seen in the dorsal stripe (dorsal 
side of the trunk) and the ventral stripe (ventral side of trunk above yolk 
extension), these spots appear first anteriorly eventually replacing the broad 
expression seen at early stages, and correlate with the known positions of 
iridophore markers and later iridophores. By 48 hpf expression of id2a in 
dorsal and ventral stripes is reduced to spots where it is maintained until 72 
hpf. 
From 48 hpf to 72 hpf very weak expression is seen along the posterior 
lateral line nerve. Strong expression in jaw and branchial arches is seen at 
72 hpf. 
 
IV.2.2 ID2A EXPRESSION PATTERN IN NEURAL CREST MUTANTS 
Since id2a is strongly expressed in NCCs we studied its expression 
pattern in two different sox10 mutants, sox10m618 and sox10baz1. Both 
mutants are defective for NC, lacking all but ectomesenchymal derivatives. 
But whereas sox10m618 lacks all remaining crest, sox10baz1 mutants lack most 
non-ectomesenchymal derivatives but have extra sensory neurons in the 
dorsal root ganglia. J. Müller (2007) had previously shown that id2a was 
reduced in these NC mutants, but the characterization was restricted to three 
developmental stages, 24, 48 and 72 hpf. We therefore set out to determine, 
how early we could observe a difference in id2a pattern in these mutants and 
make a more detailed characterization both in terms of stages as well as 
derivatives affected. Further considering that there is a phenotypical 
difference in these NC mutants, we wanted to know whether we would be 
mimicked by id2a expression pattern. 
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When compared with WT siblings, we found no difference in id2a 
expression in sox10m618 mutants before 30 hpf (Figure IV.3). By 30 hpf 
sox10m618 embryos have fewer id2a+ cells in the cranial NC region and 
branchial arches streams staining is also weaker. In trunk and tail, migrating 
streaks are almost absent and dorsal stripe expression is reduced. By 36 hpf 
all dorsal stripe and ventral stripe expression of id2a is gone and no streaks 
are visible (Figure IV.3). WT embryos have spotted expression in both dorsal 
and ventral stripes, no such expression was seen in the mutants at 48 hpf to 
72 hpf (Figure IV.3). 
Sox10baz1 mutants id2a expression differs from that of WT from as soon 
as 24 hpf where anterior trunk dorsal stripe expression is reduced (Figure 
IV.4). Cranial ganglia and cranial crest are mostly gone. This differs from that 
seen in sox10m618. 
Like sox10m618, sox10baz1 also have weaker expression in dorsal and 
ventral stripes by 30 hpf and 36 hpf, migrating NC streaks are also reduced 
or absent (Figure IV.3 and Figure IV.4). By 40 hpf dorsal and ventral stripe 
expression is gone, compared with WT where it is sustained in iridophores 
until 72 hpf (Figure IV.4). 
In summary both sox10 mutants lack late id2a expression and have 
reduced expression in pre-migratory and migratory NC cells at earlier stages. 
But id2a expression in sox10baz1 mutants can be distinguished from that of 
WT earlier than sox10m618, and also is reduced in cranial ganglia and cranial 
crest. These results show a difference between the id2a expression patterns 
in the two mutants, this could either be a direct result of different mutant 
sox10 activity or a consequence of the different phenotype of these mutants. 
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Figure IV.1 – Id2a is expressed in CNS and neural crest. A – G) in situ for id2a at several developmental stages, all embryos are oriented anterior to 
the left, posterior to the right. Id2a is expressed in cerebellum and telencephalon from 18 hpf to 40 hpf. Expression in the rhombomeric lip is seen at 22 hpf 
and in the hypothalamus at 36 hpf. Expression in cranial NC starts at 18 hpf and is visible until 30 hpf. Trunk neural crest expression (black arrows) starts at 
20 hpf and is maintained until 40 hpf, by 40 hpf individual spots of iridophores can be seen (green arrows). From 22 to 40 hpf NC migratory streams can also 
be observed (asterisks). Cranial ganglia expression is observed from 22 to 30 hpf (arrowheads). At 22 hpf expression in the pronephric ducts is observed and 
later on in the corpuscles of Stannius (30 hpf). E’ and E’’ magnification of areas in E. c – cerebellum; cnc – cranial neural crest; cs – corpuscles of Stannius; 
hyp – hypothalamus; n – notochord; ov – otic vesicle; pd – pronephric ducts; rl –rhombomeric lip t – telencephalon. Scale bars, 100 µm. 
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Figure IV.2 – Id2a is expressed in iridophores and PLLnerve ganglia. WT embryos expression of id2a at 48 hpf (A, B & F) and 72 hpf (C, D, E 
& G). Id2a is expressed in dorsal and ventral stripes in iridophore positions (arrows). Weak expression can be seen in lateral line nerve at both 48 hpf 
(F) and 72 hpf (G). At 72 hpf id2a is expressed in the jaw and branchial arches. There is a broad expression in the brain at both stages. ba – 
branchial arches; cs – corpuscles of Stannius; j – jaw; plln – posterior lateral line nerve. Scale bar, 250 µm. 
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Figure IV.3 – sox10m618 mutants lack id2a expression in crest derivatives. Comparison of WT (A, C, E, G) and sox10m618 (B, D, F, H) 
siblings for id2a expression at several developmental stages. At 30 hpf sox10m618 mutants have less migrating neural crest streaks (asterisks) 
and lower expression in cranial crest (hash). From 36 hpf onwards expression in dorsal (arrows) and ventral stripes (arrowheads) is completely 
absent. Scale bar, 250 µm. 
131 
 
 
132 
 
 
  
Figure IV.4 - sox10baz1 mutants lack id2a expression in crest derivatives. Comparison of 
WT (A, C, E, G, I, K) and sox10baz1 (B, D, F, H, J, L) siblings for id2a expression at several 
developmental stages. At 24 hpf (A, B) branchial arches streams (arrowhead) and cranial crest are 
almost gone in  sox10baz1 mutants when compared to WT siblings. From 24 hpf to 36 hpf sox10baz1 
mutants have reduced expression in dorsal stripe and reduced number of migratory streaks (asterisk) 
when compared with the WT siblings. At 40 hpf (H) migratory streaks are completely absent 
(asterisk). From 40 hpf onwards expression in dorsal (black arrows) and ventral (green arrows) stripes 
and iridophores is completely absent in mutants. Scale bar, 250 µm. 
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IV.2.3 KNOCKDOWN OF ID2A EXPRESSION USING MORPHOLINOS  
Having confirmed the expression of id2a in premigratory and migratory 
crest and subsequently in iridophores, we then assessed it’s function in these 
cell-types by knockdown of id2a gene expression using morpholino (MO) 
technology. J. Müller had previously shown that injection of a translation 
block morpholino reduces the number of iridophores in WT embryos, but 
when testing a control MO with five mismatches, embryos also showed some 
reduction in iridophores. Therefore we designed a new splice MO with the 
help of the manufacturer to the first exon/intron boundary of id2a gene (Table 
IV.1 and Figure IV.5). A correspondent control MO was made with five 
mismatches, but contrary to J. Müller control MO these were evenly spaced 
along the sequence, as suggested by the manufacturer. 
 
We started by testing the concentrations of MO to inject. We injected 
4.6 and 9.2 ng of MO per embryo (Figure IV.6). At both concentrations 
embryos looked anatomically normal and survived until late stages of 
development (5 dpf). Embryos had nevertheless reduction in or complete 
Figure IV.5 - Structure of id2a gene. Diagram of id2a gene structure. In yellow we 
can see the DNA sequence, including upstream and downstream portions. Orange arrows 
represent exons 1 to 3, with the intronic regions in between. Blue lines represent positions 
of the morpholinos (red letters), transcript primers (green letters) and tilling primers (blue 
letters). 
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absence of iridophores in dorsal, ventral and yolk sac stripes, they were also 
reduced in the eyes. Other phenotypes consisted of microphtalmia at 9.2 ng 
and heads appeared flatter (Figure IV.6). Splice mismatch MO at the same 
concentrations had no defects.  
  
We also tested a new translation blocking MO (Table IV.1). Injection of 
this MO gave the same reduction, as the splice MO, in iridophores in dorsal, 
ventral and yolk sac stripes as well as in the eyes. 
 
Table IV.1 – List of morpholinos used for id2a gene. 
Name of MO 5'  3' sequence Molecular weight 
Id2a splice MO ttgagtaggcggtgattcacctgta 8530 
Id2a splice mismatch MO ttcagtacgcgctgattgacctcta 8410 
Id2a translation blocking MO gttgacagcaggatttcgttgaaaa 8547 
 
CONFIRMING EFFICIENCY OF SPLICE MORPHOLINO 
As a control for our splice MO we designed primers spanning exons 
one and two of the id2a gene (since the MO targets the exon1/intron1 
boundary) (see Figure IV.5). We injected WT embryos with splice MO and 
mismatch MO, extracted mRNA, created cDNA and performed a PCR 
reaction for id2a, and for actin as a positive control. Extracted mRNA and 
PCR products were then run in an agarose gel. Uninjected siblings were also 
analysed for id2a, as well as actin. As expected, mismatch MO or uninjected 
siblings showed a band of approximately 500 bp corresponding to the normal 
spliced id2a mRNA; but splice MO embryos had an extra band between 750 
bp and 1 kb (Figure IV.7). We analysed the predicted length of the mispliced 
mRNA using our PCR primers. We would expect a 891 bp band, whereas the 
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normal spliced mRNA band would be 476 bp confirming that the band pattrn 
in the gel was that of spliced mRNA. WT id2a protein has 137 amino acids 
(aa) whereas the predicted id2a mispliced protein has 276, more than double 
the size. They share homology in the first 119 aa corresponding to exon 1 
(Figure IV.8). 
 
ID2A DOWNREGULATION LEADS TO REDUCTION IN IRIDOBLAST AND 
IRIDOPHORE NUMBER 
We counted number of iridophores and clusters in the dorsal stripe of 
splice MO injected embryos at 72 hpf. We considered iridophores, every 
individual iridophore ‘spot’, i.e. spaced enough to be perceived as separate. 
Clusters were spots of iridophores whose size was significantly larger than 
the average, and for that reason were considered to most likely have more 
than one iridophore. When compared to mismatch injected siblings there was 
a statistically significant reduction in the number of both iridophores (p < 
0.0001) and clusters of iridophores (p = 0.0013) (Figure IV.9). When counting 
the number of iridophores in embryos treated with the translation blocking 
MO there was a significant reduction in the number of iridophores (p < 
0.0001) (Figure IV.10). All stats done using unpaired t-test. 
We then asked whether or not the lack of iridophores was due to lack of 
the cells or failure in differentiating the reflective platelets. We did in situ for 
ltk, a known iridophore marker, at 30 hpf and 35 hpf. In both cases, there was 
a significant reduction in the number of ltk positive cells in the dorsal stripe 
when compared to either the mismatch or uninjected siblings (p < 0.0001, 
ANOVA followed by Bonferroni’s multiple comparison test) (Figure IV.11). 
We then tested another iridophore marker but this time one for 
differentiated iridophores, cb632 (Figure IV.12 and Figure IV.13). When 
compared to the mismatch injected siblings, splice MO injected embryos had 
reduced number of cb632 positive cells at 48 hpf (p < 0.0001, "Unpaired t 
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test"), correlating with the reduction in number of iridophores (p < 0.0001, 
"Unpaired t test") and clusters (p = 0.0009, "Unpaired t test"). 
We concluded that id2a downregulation leads to reduction in number of 
iridoblasts and iridophores. 
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Figure IV.6 – Morpholino KD of id2a reduces number of iridophores. KD of id2a using splice MO at two different concentrations 4.6 ng (A, 
A’) and 9.2 ng (C, C’); side to side, siblings injected with the same concentrations of splice mismatch MO (B, B’ and D, D’, respectively). Pictures in 
brightfield (A – D) and incident light (A’ – D’). Splice MO injected embryos have less iridophores in dorsal (white arrows), ventral (green arrows) and 
yolk stripes (arrowheads). Morphants also have reduced eye and less iridophores in the eye (e). Head is also smaller and flatter. Scale bar, 250 µm. 
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Figure IV.7 – Confirming splice MO efficiency using PCR. A) RNA extraction of 
slice MO injected embryos, WT siblings and splice mismatch MO and WT siblings. RNA 
looks in good quality in all cases, with the two bands characteristic of rRNA. B) PCR for 
actin and id2a on RNA extractions of (A). All actin lanes have a band the same size, 
corresponding to the expected 480 bp. In the id2a lanes, all samples have a band bellow 
500 bp corresponding to the expected 476 bp of the normal spliced mRNA. The splice MO 
lane has contrary to all others an extra band (arrow) between 750 bp and 1 kb 
corresponding to the 891 bp mispliced mRNA. 
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Figure IV.8 – Alignment of WT id2a protein with predicted mispliced protein. Id2a protein 
sequence aligned with the predicted protein sequence after misplicing with the id2a splice MO. The 
mispliced protein has more than double the size of the original protein but shares the first 119 aa 
(region in yellow) with the WT protein, corresponding to the first exon. The helix-loop-helix domain is 
still present from aa 42 to 84. 
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Figure IV.9 - id2a splice MO reduces number of iridophores and iridophore 
clusters. Counts of number of iridophores and iridophore clusters in 72 hpf old embryos 
injected with 9.2 ng of splice mismatch MO or splice MO. Splice MO injected siblings 
have a statistically significant reduction in the number of iridophores (p < 0.0001) and in 
the number of clusters (p = 0.0013). All stats using unpaired t-test. 
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Figure IV.10 – Translation blocking MO reduces number of iridophores. Counts at 72 
hpf of the number of iridophores in embryos injected with 2.3 ng of id2a translation blocking 
MO. MO injected embryos have a statistically significant reduction in the number of 
iridophores (p < 0.0001). Stats using unpaired t-test. 
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Figure IV.11 - Id2a splice MO reduces number of ltk positive cells. In 
situ for ltk at 30 and 35 hpf in embryos injected with 9.2 ng of id2a splice MO or 
mismatch MO, and uninjected siblings. Id2a splice injected embryos have a 
statisticaly significant reduction in the number of ltk positive cells at both stages 
(p < 0.0001, ANOVA followed by Bonferroni’s multiple comparison test).  
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Figure IV.12 – id2a splice MO reduces number of cb632 positive cells. In situ for cb632 in 48 hpf embryos, 
injected with 9.2 ng of id2a splice MO and id2a splice mismatch MO, and counts of iridophores and iridophore clusters 
in dorsal stripe of siblings at 4 dpf. There is a statistically significant reduction in the number of cb632 cells in id2a 
splice morphants (p < 0.0001) that correlates with a reduction in the number of iridophores (p < 0.0001) and clusters (p 
= 0.0009). All stats using unpaired t-test. 
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Figure IV.13 – Id2a morphants have reduced number of cb632 positive cells. In 
situ for cb632 in 48 hpf embryos injected with 9.2 ng of id2a splice mismatch MO (A) and 
splice MO (B, C). Id2a splice morphants have a reduced number of cb632 positive cells in 
the dorsal stripe (arrows) when compared to mismatch control. Scale bar, 250 µm. 
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ID2A KD ALSO REDUCES NUMBER OF OTHER PIGMENT CELLS 
Because id2a is expressed in a wide population of pre-migratory and 
migratory NCCs and that according to the progressive fate restriction model 
pigment cells share a common precursor (Kelsh, 2006; N. Nikaido and R. 
Kelsh, unpublished data), we tested whether downregulation of id2a could 
have an effect on the numbers of the other two pigment cell types, 
melanophores and xanthophores.  
After injection of splice MO (or mismatch MO as a control) we fixed 
embryos and performed in situ for the melanoblast/melanophore marker dct 
at 30 hpf (two repeat experiments). Some siblings were left to grow and 
dorsal stripe iridophores were counted at 72 hpf. In one occasion we counted 
dorsal stripe melanophores at 5 dpf. To count melanophores embryos were 
bathed in epinephrine so melanosomes contract to the nucleus, and fixed 
(see II.2.4). In both experiments there was a small reduction in the number of 
dct positive cells at 30 hpf (p = 0.0011, "Unpaired t test"). But when counting 
the number of melanophores of the dorsal stripe there was no statistically 
significant difference (p = 0.2648, "Unpaired t test") (Figure IV.14). In both 
cases the expected iridophore phenotype was observed. 
To determine if id2a KD had any effect on the xanthophore lineage we 
fixed 36 hpf embryos injected with id2a splice MO and performed in situ for 
xdh. Xdh is expressed in differentiated xanthophores at this stage; these are 
evenly spaced covering most of the surface of the embryo. We counted the 
number of xdh+ cells in one side of the embryos, including head and eyes. 
Statistic analysis showed a significant reduction in the number of xdh+ cells in 
splice MO injected embryos when compared with the controls (p = 0.0085, 
"Unpaired t test") (Figure IV.15 and Figure IV.16). Indicating a reduction on 
the number of xanthophores. 
The reduction of dct+ cells and xdh+ positive cells was not as dramatic 
as the reduction in the number of iridophores. And in the case of 
melanophores transient (late numbers of xanthophores were not counted), 
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presumably due to a different mechanism of regulation of melanophore cell 
number. 
 
PLLN IS UNAFFECTED IN ID2A KD 
Id2a is expressed in premigratory and migratory NCCs as well as in the 
PLLn we therefore performed in situ for sox10 in id2a morphants (Figure 
IV.17). Sox10 is regarded as a key gene in neural crest development and is 
expressed in premigratory and migratory NCCs as well as PLLn Schwann 
cells. We analysed the extension of the PLLn and found no differences 
between id2a morphants and controls. Levels of sox10 also seemed 
generally unaffected (Figure IV.17). 
 
DOWNREGULATION OF ID2A LEADS TO ABNORMAL CRANIAL CARTILAGE 
FORMATION 
Since id2a is expressed in cranial crest, jaw and branchial arches we 
tested whether id2a morphants had any head cartilage defects. Id2a splice 
MO injected embryos were fixed at 5 dpf and stained with Alcian blue (see 
II.6) to check for such defects. 
Comparing to mismatch morphants, splice morphants have a rather 
shorter head and several cranial cartilage defects. Ceratohyal cartilage is 
smaller and no longer extends anteriorly, occipitals is smaller to absent in 
some of the morphants. Ceratobranchials arches are reduced, disorganised 
and absent in some of the embryos and otic capsule is reduced. Ethmoid 
plate cartilage is shorter in its anterior-posterior axis. Meckel’s cartilage and 
palatoquadrate look less affected. Otoliths are normal and in normal position 
(Figure IV.18). 
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Figure IV.14 – Id2a splice MO reduces number of dct+ cells but not 
melanophores.  Siblings for WT embryos injected with 9.2 ng of id2a mismatch MO or 
splice MO were assessed for dct+ cells at 30 hpf, number of melanophores at 5 dpf and 
number of iridophores and clusters of iridophores at 72 hpf. At 30 hpf there was a statistically 
significant reduction in the number of dct+ cells (p = 0.011) but when counting the final 
number of melanophores in the dorsal stripe there was no statistically significant difference 
(p = 0.2648).  Iridophore numbers and clusters were reduced in 72 hpf siblings (p < 0.0001). 
All stats using unpaired t-test. 
150 
 
 
 
Figure IV.15 - Id2a splice MO reduces number of xdh+ 
cells.  Siblings for WT embryos injected with 9.2 ng of id2a 
mismatch MO or splice MO were assessed for xdh+ cells at 48 hpf. 
There was a statistically significant reduction in the number of xdh+ 
cells (p = 0.0085, unpaired t-test). 
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Figure IV.16– KD of id2a number of xdh+ cells. WT embryos were injected with 9.2 ng of id2a mismatch morpholino (A – C) or 9.2 ng of 
splice morpholino (D – F). Embryos were then fixed at 36 hpf and prossed for in situ for xdh. Xdh is a marker for xanthophores, these can be seen 
covering the entire body of the embryo. Analysis of stained embryos revealed quantitative reduction in the levels of xdh expression between id2a 
morphants and siblings injected with mismatch control. Scale bar, 200 µm 
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Figure IV.17 – Id2a KD has no effect on PLLn extension. WT embryos were injected with 9.2 ng of id2a mismatch morpholino (A – C) 
or 9.2 ng of splice morpholino (D – F). Embryos were then fixed at 48 hpf and processed for in situ for sox10. We analysed embryos for 
extension of PLLn. PLLn can be observed along the midline on the lateral side of the embryos. Analysis of sox10 expression in id2a 
morphants showed no difference in the extension of the PLLn when compared to mismatch injected siblings. Scale bar, 200 µm. 
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Figure IV.18 – Id2a morphants have several cranial cartilage defects. Three different id2a morphants (E – H, I – L 
and M – N) and control mismatch morphant (A – D) stained at 5 dpf with Alcian blue to stain cartilages. A, B, E, F, I, J are 
dorsal views of the embryos with two different focal points. C, D, G, H, K, L, M, N are lateral views of the same embryos at two 
different focal points. When compared with mismatch control (A – D) id2a splice morphants (E – N) have several morphological 
defects in cranial cartilage including a rather shorter head and several cranial cartilage defects. Ceratohyal cartilage is smaller 
and no longer extends anteriorly, occipitalis is smaller to absent in some of the morphants. Ceratobranchial arches are 
reduced, disorganised and absent in some of the embryos and otic capsule is reduced. Ethmoid plate cartilage is shorter in its 
A – P axis. Meckel’s cartilage and palatoquadrate look less affected. Otolith is normal and in normal position. cb – 
ceratobranchials; ch – ceratohyal; cl – cleithrum; eth – ethmoid plate, hm – hyomandibular; m – Meckel’s cartilage; o – otolith; 
occ – occipitalis; otc – otic capsule; pec – pectoral fin; pq – palatoquadrate; s – symplectic. Scale bar, 200 µm. 
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ID2A KD DOES NOT AFFECT PRE-MIGRATORY CREST 
Due to defect in several NC derivatives, such as pigment cells and 
craniofacial cartilage we questioned whether downregulation of id2a would 
affect the domain of the NC. Therefore we performed in situ for foxD3 at an 
early stage (22 hpf), foxD3 is an early NC marker (Lister et al., 2006). When 
compared to mismatch MO, there was no difference in foxD3 expression 
domain (Figure IV.19). 
 
CELL CYCLE AND NUMBER OF CREST CELLS ARE UNAFFECTED IN ID2A 
MORPHANTS 
To determine if injection of id2a MO had any effect on the number of 
NC cells, we performed FACS analysis on 30 hpf morphants. Transgenic -
4725sox10:gfp embryos were injected at one cell stage with 9.2 ng of id2a 
splice MO or mismatch MO. Fifty GFP+ embryos were then disaggregated 
(see II.9.5) and analysed in the FACS machine for GFP+ cells (Figure IV.20). 
When compared to either uninjected or mismatch injected embryos there was 
no statistically significant difference (p = 1, Two-way ANOVA) in the number 
of GPF+ cells (Figure IV.21), thus we can conclude there is no change in the 
number of NC cells at this time point, nevertheless this experiment needs to 
be repeated since it was only done once. As a control, siblings were counted 
for the number of iridophores; as expected there was a reduction in the 
number of those in id2a splice MO injected embryos.  
Since IDs have been implicated in cell cycle control we looked to see if 
there were changes in the cell cycle of id2a morphants (Figure IV.22 and 
Figure IV.23). For that we stained disaggregated 30 hpf injected embryos 
with propidium iodide (see II.7). Cells were then analysed in FACS machine; 
unfortunately it was not possible to distinguish GFP signal after propidium 
iodide staining, so analysis was made in the whole embryo. When compared 
to either uninjected embryos or mismatch injected embryos, id2a splice 
morphants had no differences in the percentage of cells at either G1, S or G2 
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phases of the cell cycle (p = 0.7436, Chi-square) (Figure IV.23). This 
experiment was repeated a second time with the same results. In both cases 
the expected iridophore phenotype was observed. 
 
IV.2.4 LTK AND ID2A REGULATION 
Because id2a is expressed in iridophores and downregulation of id2a 
leads to reduced iridophore numbers, we decided to study how ltk and id2a 
relate to each other. We inhibited Ltk by bathing embryos at different time 
points with 2 nM TAE684 in 1 % DMSO. TAE684 is a hALK inhibitor, but also 
inhibits zebrafish Ltk (see VI.2.6). Embryos were bathed from 18 hpf – 3 dpf, 
18 hpf – 26 hpf and 26 hpf – 3 dpf. Control embryos were bathed in 1 % 
DMSO alone. Number of iridophores and clusters was counted at 3 dpf and 
embryos fixed for id2a in situ. After treatment with TAE684 there was a 
statistically significant reduction in the number of iridophores and clusters in 
the time windows of 18 hpf – 3 dpf and 26 hpf – 3 dpf. This reduction was 
also mimicked by a reduction in the number of id2a spots in the same time 
windows. One-way ANOVA (p < 0.0001) followed by Dunnett's Multiple 
Comparison Test was performed (Figure IV.24). 
As a complementary experiment to test id2a regulation, we used the ltk 
mutants. Observing id2a expression in shdty82 mutants at 18, 24, 48, 72 hpf 
we noticed that at 18 hpf there is no difference in expression when compared 
to WT siblings. At 24 hpf expression embryos presented reduced migrating 
streaks (data not shown). At 48 and 72 hpf shdty82 mutants have no id2a 
expression in dorsal or ventral stripe iridophore positions (Figure IV.25). 
Our inhibitor experiments show that inhibition of ltk in different time 
windows leads to a proportional change in the number of id2a+ cells. Plus 
reduction of id2a in ltk mutants suggests that at least indirectly ltk signalling is 
required for id2a expression in iridophores, whether this is a consequence of 
direct signalling or of the lack of the cells remains unclear. 
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Figure IV.19 – Early foxd3 expression domain is not affected in id2a morphants. Embryos injected with id2a 
splice MO and mismatch control MO were fixed and prossessed for foxd3 in situ at 22 hpf. When comparing Mismatch 
MO (pictures on the left column) with Splice MO (right column) we found no differences in the expression domain of 
foxd3. 
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Figure IV.20 – Analysis of GFP expression in id2a morphants. -4725sox10:gfp 
embryos were injected with id2a splice MO or mismatch MO, disaggregated at 30 hpf 
and GFP+ signal was analysed in a FACS machine (right column). 
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Figure IV.21 – KD of id2a has no effect in number of NC cells at 30 hpf. -4725sox10:gfp embryos were injected with id2a splice MO or 
mismatch MO, disaggregated at 30 hpf and percentage of GFP+ was analysed in a FACS machine. Siblings were assessed at 72 hpf for number 
of iridophores. There were no statistically significant differences in the levels of GFP+ cells (p = 1, Two-way ANOVA), although the morphants 
showed the expected iridophore defects (p < 0.0001, unpaired t-test). 
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Figure IV.22 – Cell cycle analysis of id2a morphants. -4725sox10:gfp 
embryos were injected with id2a splice MO or mismatch MO, disaggregated at 30 hpf 
and analysed for cell cycle using propidium iodide staining (right panels). 
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Figure  
Figure IV.23 – KD of id2a has no effect on cell cycle. Analysis of cell cycle in two different experimental sets on 30 hpf 
morphants using propidium iodide staining. Embryos were disaggregated, stained for propidium iodide and run through a FACS 
machine, and percentage of cells in each cell cycle phase was determined. There were no statistically significant differences in cell 
cycle in any of the experiments (Two-way ANOVA). 
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IV.2.5 CLONING ID2A FOR OVEREXPRESSION 
Following the several crest defects of id2a KD, namely reduction of 
iridophores, we decided to test if overexpression of id2a gene in NC would 
lead to any developmental defects. For that we cloned id2a coding sequence 
downstream of the sox10 promoter. Firstly we performed a PCR for id2a with 
a predicted size of 480 bp. After separation by agarose gel electrophoresis, 
the PCR band was extracted and cloned into a pGEM-T easy vector. Upon 
successful ligation and confirmation of orientation plasmid was digested with 
NcoI, overhang was filled to create a blunt end digested again with SpeI. Id2a 
fragment was then extracted. To clone this fragment into -
4725sox10:IRES:egfp the plasmid was digested with XbaI, linearized plasmid 
ends were then filled to create blunt ends, plasmid was then re-digested with 
SpeI (Figure IV.26). Linearized plasmid and id2a fragment were then ligated 
and positive clones sent for sequencing. Several successful clones were 
found, generating a -4725sox10:id2a:IRES:egfp plasmid (Figure IV.26). 
-4725sox10:id2a:IRES:egfp was then injected into WT embryos, 50 pg 
per embryo. Dead embryos were removed at 6 and 24 hpf and mortality after 
24 hpf was determined. In one of the sets of injected embryos there was no 
increase in the mortality rate of injected embryos when compared to the 
control. In another case there was a slight increase in the mortality rate, from 
54 % to 81 % (see Table IV.2). This concentration was used for the 
remaining experiments, as surviving embryos looked morphologically normal. 
 
Table IV.2 – Summary of injections with -4725sox10:id2a:IRES:egfp. Table with 
the number of dead and live embryos, at 6 and 24 hpf in two sets of embryos injected with 
50 pg of -4725sox10:id2a:IRES:egfp and uninjected siblings. 
  
Dead at 
6 hpf 
Live at 6 
hpf Total 
Dead at 
24 hpf 
Total live at 
24 hpf 
Mortality at 
24 hpf 
Se
t 1
 
Control 12 16 28 2 14 50% 
Inj id2a 14 10 24 0 10 58% 
Se
t 2
 
Control 132 218 350 58 160 54% 
Inj id2a 244 67 311 7 60 81% 
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At 24 hpf embryos were observed under the dissecting scope and 
assessed for positive GFP+ cells. Some embryos had GFP+ cells, these cells 
were in the surface of the head, in the eye, dorsal trunk and dorsal NT. The 
morphology and position of these cells is consistent with a NC phenotype. 
Some muscle cells were also GPF+. Cells could also be seen in the dorsal 
NT with projections, these are putative interneurons of the CNS and their 
axons (Figure IV.27.A). The embryos were then left to grow and iridophore 
numbers and clusters counted at 3 dpf. There were no statistically significant 
differences in the number of iridophores. There seems to be an increase in 
the number of clusters, but this is not statistically significant (Figure IV.27 B). 
 
IV.2.6 SEARCHING FOR ID2A MUTANTS 
Following the defects caused by the KD of id2a we looked for id2a 
mutants within a zebrafish TILLING mutant library. This was done in 
collaboration with Mitch Levesque at the Max Planck Institute for 
Developmental Biology, Tübingen, Germany. 
TILLING or targeting-induced local lesions in genomes is a reverse 
genetic approach to obtain gene knockouts or knockdowns. In general male 
fish are mutagenised using ethylnitrosourea (ENU) and crossed with a WT 
female, thus generating the F1. Two different approaches can then be used, 
a live library or a frozen sperm library. In the case of the live library, F1 is 
kept in tanks, fin clips are removed and used to generate a genomic DNA 
library. In the case of the frozen sperm library sperm from the F1 males is 
stored and again a genomic DNA library is prepared. These libraries are then 
used for PCR amplification of the exons of the gene of interest and the 
resulting product sent for sequencing (Stern and Zon, 2003). 
We designed primers that targeted the id2a DNA, rather than the 
mRNA. Primers were designed to the beginning of exon 1 (5’) and beginning 
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of intron 1 (3’), since exon 1 contributes the most to id2a protein (Figure 
IV.5). By designing a primer at the intronic region we ensure that only DNA 
was amplified. DNA from 24 hpf WT AB embryos was crudely extracted (see 
II.3.3) and PCR was performed. When we tested the primers on this DNA we 
observed a single band with the expected size of 415 bp. As a control we 
used actin, we used the same primers as we used for mRNA of actin, but in 
this case the band was bigger in size (Figure IV.28). The fact that there was 
only one band and that this was bigger than the mRNA band suggests the 
PCR was quite clean and only genomic DNA was amplified. The PCR was 
performed with a low budget Taq Polymerase and with lower concentrations 
of primers. Crude extractions and low budget Taq were an important test 
since screening for mutants is done in a high throughput fashion. The PCR 
product was sent for sequencing, to confirm the PCR conditions provided 
good quality DNA for sequencing. Once we were pleased with the 
performance of the primers in such conditions, these were sent to Tübingen, 
where a library of 36 plates of TILLING mutants was screened by Mitch 
Levesque. 
We have also submitted a request for a mutant at the Welcome Trust 
Sanger Institute, Zebrafish Mutation Resource. At the date of completion of 
this thesis no mutant was found; neither at the Tübingen facility neither at the 
Sanger Institute. 
 
IV.2.7 ID3 EXPRESSION PATTERN IN CREST 
CLONING ID3 PROBE 
ID proteins in other species have been show to be at least partially 
redundant. We therefore questioned whether in zebrafish other IDs could be 
expressed in the same NC domains as id2a. Searching the ZFIN database 
for other IDs expression data in zebrafish we found that id3 was expressed in 
areas that could correlate with that of id2a. Thus we decided to determine the 
expression of id3 (NCBI Reference Sequence NM_152967), another id gene 
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from the same family as id2a, we purchased an Id3 IMAGE clone from 
Geneservice, UK (clone ID 6899625). This contains the sequence of id3 in a 
pDNR-LIB vector (Table IV.3). Due to the lack of information regarding this 
clone, we have extracted the id3 fragment using EcoRI and SacI restriction 
digest, the extracted fragment was then ligated into pGEM-T easy and 
sequenced. The resulting id3 cloneA (in pGEM-T easy) was then digested 
with NdeI, to remove 3’ unwanted sequence extracted and religated. Id3 
probe was then synthesised (see II.4.1) and expression pattern analysed. 
Table IV.3 – Id3 clone information from Geneservice. 
Clone 
ID 
Library 
name 
cDNA 
Library 
ID 
Vector 
name 
Insert 
digest 
GB GI Resistance gene 
689962
5 
GISZF0
01 
2089 pDNR-
LIB 
SfiI 
(directional) 
28999790 chloramphenicol 
 
ID3 EXPRESSION PATTERN 
Analysis of the id3 expression pattern revealed strong expression in the 
dorsal side of the trunk and tail by 24 hpf, a position evocative of that of the 
NC. By 24 hpf expression was also seen at the tip of the notochord, but 
nowhere else. By 28 hpf expression was weaker but still in the dorsal side of 
the trunk and tail. Expression pattern at 48 and 72 hpf was restricted to dots 
in the dorsal stripe, a pattern reminiscent of that of ltk or id2a, so possibly 
iridophores (Figure IV.29). Curiously, expression was not seen in any other 
iridophore positions such as ventral or yolk stripe. 
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Previous studies of id2a in zebrafish had shown that id2a was 
expressed in iridophores and involved in their development. Due to our 
particular interest in this population of cells we decided to characterize this 
function of id2a in NC in more detail. 
Here we confirm expression of id2a in several CNS domains, in pre-
migratory and migratory trunk NC and iridophores. But further to this we 
characterize the id2a pattern in more developmental stages and show 
expression in several other NC derivatives: migratory cranial NC, cranial 
ganglia, branchial arches, jaw and Schwann cells of the posterior lateral line. 
We also show distinct id2a expression pattern in two NC mutants compared 
to WT and pushed the time-point at which this can be seen to earlier 
developmental stages. 
Using MO knockdown of id2a we confirm id2a role in iridophore 
development by reduction of iridoblasts/iridophores confirmed by the use of 
iridoblast/iridophore markers. Further to this we show reduction of 
melanophores and xanthophores at early time points, this reduction was less 
severe than that of iridophores. We also show severe defects in craniofacial 
cartilage development after id2a knockdown. Inhibition of ltk using TAE684 at 
different time windows leads to a proportional change in the number of id2a+ 
cells.  
We suggest that id2a in trunk is expressed in a subset of NC cells, 
probably a chromatoblast, and later on in iridophores and we propose a 
model where id2a has three distinct functions in NC: i) is responsible for 
maintenance or proliferation of a cranial cartilage precursor; ii) is responsible 
for maintenance and/or proliferation of a chromatoblast precursor expressing 
pax3, sox10 and mitfa; iii) and later on is responsible for driving specification 
of iridophores possibly through regulation of ltk. 
 
For detailed discussion and future work please see VII.2 - Id2a and the 
NC. 
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Figure IV.24 – Inhibition of ltk with TAE684 is accompanied by reduction in id2a+ cells. WT embryos were bathed in TAE684 
at different time windows 18 hpf – 3 dpf, 18 hpf – 26 hpf and 26 hpf – 3 dpf, controls were bathed in DMSO alone. Number of iridophores 
and iridophore clusters was counted at 3 dpf, embryos were fixed and in situ for id2a performed at 3 dpf. There is a statistically significant 
reduction in the number of id2a positive spots in embryos treated for the whole duration of the experiment (18 hpf – 3 dpf, p < 0.0005) 
and embryos treated from 26 hpf – 3 dpf (p < 0.005). This reduction was accompanied by a reduction in both the number of iridophores 
and clusters (p < 0.0005). All stats using 1-way ANOVA followed by "Dunnett's Multiple Comparison Test". 
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Figure IV.25 - id2a positive cells are absent in ltkshd mutants. In situ for id2a in WT embryos (A, C) and ltkshd (B, D) siblings 
at 48 and 72 hpf. Lateral view of trunk and tail. Ltkshd mutants lack id2a positive cells in dorsal trunk and tail compared to WT siblings 
(arrows). Scale bar, 250 µm. 
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Figure IV.26 – Cloning -4725sox10:id2a:IRES:egfp. A) PCR for id2a gene showing a band in the right size range. This band 
was extracted and cloned into pGEM-T easy (first lane in B). B) Extraction of id2a fragment (yellow circle) from id2a pGEM-T easy (first 
lane) after digestion with NcoI, filling of ends and second digestion with SpeI. Second lane, linearization of -4725sox10:IRES:egfp by 
digestion with XbaI, end filling and re-digestion with SpeI. M – Promega 1 kb DNA ladder. 
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Figure IV.27 – Injection of -4725sox10:id2a:IRES:egfp gives GPF+ cells but no 
changes in the number of iridophore numbers or clusters. WT embryos were 
injected with 50 ng of -4725sox10:id2a:IRES:egfp. Injected embryos were assessed for 
GFP signal at 24 hpf and iridophore numbers and clusters were counted at 72 hpf. A) 
Green channel pictures of the head and anterior trunk of an injected embryo at 24 hpf. 
Several green cells (arrows) are seen in the surface of head and dorsal anterior trunk. 
These cells exhibit a stellate NC morphology. In the trunk one positive cell is observed in 
the dorsal NT with a projection, this could be an interneuron (i). On the dorsal trunk some 
cells with strong GPF signal can be seen (asterisks), due to their morphology and 
position they could be iridophores. A muscle fibre is also GFP+ (m). B) Counts on the 
number of iridophores and iridophore clusters on 72 hpf injected siblings and uninjected 
controls. No statistically significant differences were found in either number of iridophores 
or clusters. Nevertheless there seems to be a tendency in the increase of the number of 
clusters. 
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Figure IV.28 - Testing id2a TILLING primers. PCR on 24 hpf WT DNA for 
id2a using primers designed for TILLING. Actin primers were used as a control and 
gave a band around 750 bp in size. Id2a TILLING primers gave a single clear and 
intense band around the expected 415 bp. M – Promega 1 kb DNA ladder. 
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Figure IV.29 – Id3 is expressed in premigratory NC and in iridophores. In situ 
for id3 in WT embryos at 24, 48 and 72 hpf (A, B, C and D, respectively). Staining can be 
observed in very restricted areas of the embryo. By 24 hpf expression is restricted to 
dorsal trunk and tail and to the tip of the notochord. By 48 and 72 hpf this expression 
becomes restricted to iridophores in the dorsal stripe (i). Scale bar, 250 µm. 
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Chapter V - CULTURING ZEBRAFISH 
NEURAL CREST CELLS 
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V.1 AIMS 
NCC culture has been extremely useful in the study of NC, particularly 
in determining NCC plasticity and signalling pathways. We tried to develop 
an in vitro zebrafish NC culture system that allows for the study of the 
development of the NC. This would allow us for example to study NC 
mutants in vitro. For that we shall: 
• Optimise primary culture of zebrafish NCC; 
• Establish culture conditions generating several NCC derivatives; 
• Optimise clonal culture of zebrafish NCC; 
• Optimise culture conditions to grow zebrafish NT explants.; 
Once culture conditions are optimised we intended to use the zebrafish 
NCC culture system to define precisely the role for Ltk in iridophore 
development. We will test whether Ltk signalling promotes specification of 
NCCs to the iridophore lineage, survival of iridoblasts and/or proliferation of 
iridophores. We shall: 
• Determine number of iridophore clones and clone size and 
composition. 
Test the hypothesis that MidkineA is a key ligand for Ltk function: 
• Evaluation of clone size and composition in Mdk treated and 
non-treated WT cultures. 
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V.2 RESULTS 
V.2.1 DETERMINING CULTURE CONDITIONS 
The first step for developing a NC cell culture was to determine the 
appropriate medium conditions for attachment, growth and survival of NCC 
and their derivatives. Another issue to be addressed was the source of the 
NCCs. Initially we began with culturing conditions used for chick NCCs and 
experimented with multiple NCC sources. These conditions were not optimal 
for zebrafish cell growth; in particular there was low attachment efficiency 
and cells died prematurely. 
We have tried to optimise the culture conditions such as medium 
composition and plating substrate, and the protocols for obtaining NCCs such 
as disaggregation of whole embryos, dissection of NT and the FACS sorting 
protocol. A time line with a comprehensive description of the experiments can 
be seen in Appendix 3. This includes details about medium used, 
temperature, plating conditions and protocol used. 
 
From the beginning of the work there were serious bacterial 
contamination problems of the cultures, independent of the method for 
obtaining NCCs used. So to reduce this problem we have changed the 
protocol of preparation of embryos by introducing a sterilization step of 
rinsing embryos with ethanol (see II.9.1) and performing all the work under 
aseptic conditions. We have also introduced antibiotics in the medium 
composition (see II.9.2). All these changes combined have reduced the 
number of contaminated experiments, making them almost absent. 
 
The plating substrate of cultured cells is of high importance since this 
can affect the cell types present and how long cells attach, but can also 
influence cell metabolism. On the matter of the plating substrate NCCs 
seemed to prefer the plastic substrate, as there were higher numbers of cells 
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when compared with uncoated glass coverslips, using the same medium and 
dissociated cells. But since it made more difficult to posterior processing of 
the cultures, such as immunostaining, glass coverslips were preferred, 
although glass coverslips had to be always coated with some adhesion 
molecule. 
Adhesion molecules tested included: bovine plasma fibronectin, poly-D-
lysine and laminin. Fibronectin and poly-D-lysine produced higher numbers of 
attached cells but the fibronectin appeared to improve cell adhesion, 
probably because it is suggested that poly-D-lysine can be toxic to non 
neuronal cells. We tried a combination of fibronectin (FN) and poly-D-lysine 
but this did not seem to further improve the attachment. We therefore 
concluded FN was to be used in further experiments. We have also tried 
several methods of FN coating. Differences included time of incubation with 
fibronectin and number of times and solution with which the dish was rinsed 
before adding culture. We found no substantial difference so we maintained 
the original FN coating method, see II.9.4. 
 
Feeder-layers are one of the methods used in chicken for culturing of 
NCC (Trentin et al.). Feeder-layers provide the cells with growth factors and 
nutrients and also provide an attachment substrate. In this particular case we 
used Swiss 3T3 cells since these have been used in chick NC cultures 
(Lahav et al., 1998). The feeder layer of mouse Swiss 3T3 fibroblasts was 
tested with dissected NT. NT from 16 hpf -4725sox10:gfp embryos were 
dissected (see II.9.6) and plated. After 24 hours in culture it was possible to 
observe GFP+ crawling away from the NT, as with the other substrates, but 
we found that the existence of the feeder-layer did not increase the number 
of GFP+ cells obtained in comparison with the control. Furthermore, it 
impeded the identification of the zebrafish cells. 
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Several medium compositions were tested, some such has F12 
medium supplemented with 15 mM HEPES, 10 % FBS, 1 % P/S, 0.2 % 
gentamicin, 0.5 % Fungizone and 100 nM of ET3 were able to support NC 
cells for a few days. In some cases it was possible to observe some growth 
although in most cases cells started to detach as soon as after 3 days in 
culture such has with F12 medium with 5 % FBS, 1 % P/S, 1 % kanamycin, 
100 nM retinoic acid and 100 nM ET3. 
Several of the components tested such has D-MEM, L-15, Basal Eagle 
Medium, N-2 neuronal supplement, all-trans-retinoic acid, kanamycin, 
ampicillin and guanosine were not subsequently used since they either 
delivered worse results or did not improve the culture in any of the assessed 
parameters (adhesion, growth, maintenance or production of iridophores). 
FEE was also tested and did not increase the yield or survival of NCC, 
confirming the results of Sadaghiani and Vielkind (1990). 
As an example we compared F12 medium with F12/N2/bFGF. F12 
medium contains F12+Glutamax base medium with 15 mM HEPES, 10 % 
FBS, 1 % P/S, 0.2 % gentamicin, 0.5 % Fungizone, 100 nM of ET3 and 
1.7mM of CaCl2. F12/N2/bFGF contains the same composition but without 
Fungizone or gentamicin and was supplemented with 1% N2 supplement and 
50 ng/mL of bFGF (see Table V.1). When observed after two days in culture, 
cells grew equally and at same densities in both medium. There was no 
difference in number of GFP+ cells and both media had xanthophores and 
iridophores at two days. 
To date, the most successful combination of conditions have been 
incubation of cells at 28oC with no CO2 buffering in F12+Glutamax with 15 
mM HEPES, 10 % FBS, 1 % P/S, 0.2 % gentamicin, 0.5 % Fungizone, 100 
nM of ET3 and 1.7mM of CaCl2. The reason is that cultures in this medium 
showed an increased number of cells compared to other medium 
compositions, and reached confluence after 6 days of culture (Figure V.7) 
which other media never did. In this composition GFP+ cells were still 
identified and there was differentiation of iridophores (Figure V.8). We believe 
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the fulcrum component in this achievement was the addition of calcium since 
this changed the osmolarity of the medium. This was tried since in the 
Zebrafish Book the culture medium used is supplemented with CaCl2 to a 
final concentration of 2 mM (Westerfield, 2000). 
 
Table V.1 – Composition of two culture media tested. Example of the composition 
of two different media tested, comparison between F12/N2/bFGF composition and the 
normal F12 culturing medium used in most experiments. 
 F12 F12/N2/bFGF 
Base medium F12 + Glutamax 
FCS 15 % 15 % 
Hepes 15 mM 15 mM 
ET3 100 nM 100 nM 
CaCl2 1.7 mM 1.7 mM 
Pen/Strep 1 % 1 % 
Fungizone 0.5 % - 
Gentamicin 0.2 % - 
N2 suplement - 1 % 
bFGF - 100 µl 
 
Table V.2 – Composition of F12 medium used during experiments. 
F12 medium 
Base medium F12 + Glutamax 
Supplement Final concentration 
Foetal Calf Serum 15 % 
Hepes 15 mM 
ET3 100 nM 
CaCl2 1.7 mM 
Pen/Strep 1 % 
Fungizone 0.5 % 
Gentamicin 0.2 % 
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V.2.1.1 TESTING OSMOLARITY IN CULTURE 
Osmolarity of a medium can greatly affect the growth and survival of the 
cells; we therefore decided to test different osmolarities. Following a 
suggestion by Maya Sieber-Blum (personal communication) we tried 
reducing the osmolarity. We did so by diluting base growth medium (F12) to 
half with either Milli-Q water (F12/water) or EM (F12/EM). All supplements 
were added at the same concentrations. We started by measuring the 
osmolarity of the final medium using a freezing point osmometer. We used 
Milli-Q water as a blank. Our normal F12 medium had an osmolarity of 320 
mOsm whereas F12/water had 170 mOsm and F12/EM had 181 mOsm. 
When testing disaggregated 24 hpf embryos with the three media only F12 
showed good attachment and proliferation after two days in culture. 
F12/water and F12/EM showed some cells but these were greatly reduced in 
number when compared with F12 (Figure V.2). 
 
V.2.2 FACS SORTING 
The objective of the FACS sorting was to enrich the cell suspension in 
NC cells for posterior culture. Using the -4725sox10:eGFP, that expresses 
GFP under the control of the sox10 promoter, allowed us to positively select 
NCCs (Figure V.3). 
FACS sorting generally has a highly detrimental effect on the viability of 
cells compared with non-sorted cells, since they have in first place to be 
disaggregated and then pass through the FACS system; this was confirmed 
by plating sorted and non-sorted cell resulting from the same cell suspension. 
The initial FACS sorting protocol was developed by Amy Boyd for the 
collection of NC cells and RNA extraction, but was then modified in 
consultation with Dr. John Lawry (BD Biosciences) to increase cell viability. 
Thus we experimented with changing sorting velocity from the original 1200 
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cells/s to 500 cells/s. The method of cell collection was also changed: instead 
of collecting cells into a FACS sorting tube, cells were collected into a 
microfuge tube containing cell culture medium to reduce the shock to the 
cells. Viability was assessed by plating cells and observing if there were any 
attached cells. 
The FACS sorting is dependent on the viability of the disaggregated 
cells. Despite changes made to the dissociation method, such as reduction of 
centrifugation speed, digestion time and temperature, which allowed a better 
viability of the dissociated cells and the change of the sorting conditions (see 
II.9.7), the survival of the sorted cells was still impaired. 
We were able to successfully get surviving GFP+ cells on one occasion. 
Culture conditions were as follows: incubated at 28oC with no CO2 buffering 
in F12 base medium supplemented with 15 mM HEPES, 5 % FBS, 1 % P/S, 
0.2 % gentamicin, 0.2 % kanamycin, 0.5 % Fungizone, 10 pM endothelin-3, 
100 mM retinoic acid. However a further six attempts to reproduce this failed 
either because they were contaminated (two occasions) or because there 
were no attached cells. 
 
V.2.3 DISSECTING NEURAL TUBES 
The dissection of neural tubes is a technique used in chicken NCC 
culture that makes use of the migratory properties of NC cells. In these 
experiments NT tubes are dissected and plated, once plated the NC cells 
migrate away from the NT that can then be removed leaving the NC cells 
behind (Graham et al., 1993; Le Douarin, 2004). 
With changes in the protocol for dissecting NT and the gaining of 
experience in handling the NT we have increased the efficiency and 
cleanness of the process. Changes include the use of dispase as a protease. 
This proved to be gentler on the tissues and allowed a better scraping of the 
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NT than Trypsin. This produces a cleaner experiment meaning less 
contamination of other tissues, such as somites. 
The dissected NT adhered to the bottom of the culture and NCCs 
(GFP+), and other non-NCCs (GFP-), from the NT migrated into the substrate 
(Figure V.4). The nature of NCCs was further confirmed by immunostaining 
against the sox10 transcription factor where co-localization of the staining 
within the nuclei could be observed (Figure V.5). 
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Figure V.1 – Comparison of F12 and F12/N2/bFGF after two days in culture. Both 
media seem to have equal number of GFP+ cells and equal attachment. Scale bar, 50 µm. 
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Figure V.2 – Reduction of osmolarity is detrimental for cell attachment. 
Osmolarity test at 2d. All pictures are phase contrast. Disaggregated whole embryos 
were plated in three different media with different osmolarities. Scale bar, 50 µm. 
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GFP+ 
GFP- 
Figure V.3 - Example of a FACS sorting experiment. -
4725sox10:egfp+ embryos were disaggregated at 24 hpf and processed 
for FACS sorting. A total of 308391 events sorted at a 500events/s rate. 
The red gate shows the GFP+ population of cells that were sorted; the 
green gate is the control gate comprising of a set of GFP- cells. The red 
gate comprised around 3.5 to 5.5 % of the total number of events. 
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Figure V.4 – NC cells migrate from dissected NT. Confocal image 
of migrating cells (arrowhead) from a dissected NT (black arrow). Notice 
the existence of differentiated melanophores (white arrow). Scale bar, 50 
µm. 
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Figure V.5 - Immunohistochemistry for sox10 transcription factor. Cells obtained from 
a dissected NT. A) Confocal image of the migrated cells. B) Nuclear DAPI staining. C) AlexaFluor 
488 coupled secondary antibody staining against αsox10. D) Merge of the images A – C showing 
the existence of sox10 positive cells within the population, notice the nuclear co-localization of the 
sox10 transcription factor and the nuclear marker DAPI. Scale bar, 50 µm. 
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V.2.4 WHOLE EMBRYO CULTURES 
The disaggregation protocol allows us to dissociate zebrafish embryos 
in order to obtain single cells that can then be cultured or FACS sorted. So 
far we have modified the disaggregation protocol used previously in our lab 
for FACS sorting. This previous protocol provided a large number of dead 
cells, reducing the efficiency of the whole procedure. The efficiency of the 
disaggregation method was determined by disaggregating 24 hpf -
4725sox10:egfp zebrafish embryos, plating them and assessing cell survival 
and attachment. 
The disaggregation protocol previously used in our lab included 
centrifugation steps at 3000 rpm. Although useful for obtaining RNA, these 
conditions were not good for cell survival, as above 1000 rpm cell viability is 
highly reduced. Therefore the centrifugation speed was reduced to 800 rpm. 
The original protocol included a trypsinization step for 25 min at 33oC, 
although it provides a higher number of single cells, Trypsin has a 
detrimental effect on the cellular membrane, therefore the trypsinization was 
performed at RT for 15 min. 
Using the original protocol there were attached cells, but these were in 
reduced numbers and rarely GFP+. Subsequent changes to the protocol as 
now documented have progressively increased the number of attached cells 
and the number of GFP+ cells once plated. 
 
V.2.4.1 NEURAL CREST DERIVATIVES 
Using a combination of the disaggregation protocol and the dissection 
of NT we were able to obtain some neural crest derivatives, with our current 
medium conditions (Table V.2), which we have identified by use of specific 
markers. We have to date identified iridophores, melanophores, putative 
myofibroblasts, sympathetic neurons and glia. These derivatives were 
assessed by colour, morphology and optical properties using brightfield 
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microscopy and cell markers using immunofluorescence. 
Immunofluorescence was performed on cultured cells, for several NC or NC 
derivative markers, including: sox10, a transcription factor that is an early 
marker of NC cells and also a persistent marker of glial derivatives, Hu 
(neuronal protein), smooth muscle actin and GFP to confirm GFP expression 
after fixation. 
Melanophores were obtained both with NT dissections (Figure V.6) and 
with total disaggregated cells (Figure V.7). They seemed to be able to 
differentiate in almost all of the medium compositions tested. Our 
experimental data also shows that melanophores are not GFP+ at least at the 
point when pigmentation is visible. Melanophores start to be visible in culture 
after 24h. 
Using the current medium composition (Table V.2) with disaggregated 
cells we have obtained iridophores. These cells were identified by their 
combination of lightly pigmentation in transmitted light and iridescent 
appearance under incident light. They are detected by their iridescent 
property at least after 4 days in culture, by this time they appeared GFP+, 
with an even distribution of the signal throughout the cytoplasm. After 6 days 
in culture they showed a punctuated green signal, probably caused by 
autofluorescent of the guanosine crystals (Figure V.7 and Figure V.8). By the 
fact that they were iridescent and autofluorescent, and by their appearance in 
transmitted light both characteristics of iridophores, we concluded that they 
were in fact iridophores. 
Immunohistochemistry in dissected NT has allowed us to identify other 
types of cells such as neurons, as these cells were positive for the neuronal 
marker Hu (Figure V.9), and putative myofibroblasts (Figure V.10), although 
their NC origin remains to be confirmed. In this particular experiment NTs 
were incubated at 37ºC in a CO2 buffered incubator using F12 medium 
supplemented with 15 mM HEPES, 10 % FBS, 1 % P/S, 0.2 % gentamicin, 
0.5 % Fungizone and 100 nM endothelin-3 in fibronectin coated dishes. 
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With the disaggregation protocol and the current medium composition 
after 6 days in culture we notice the existence of GFP+ cells with 
neuronal/glial morphology possessing several dendrites (Figure V.11). Their 
morphology and the fact that they were GFP+, i.e. sox10+, lead us to believe 
that these were glia, as sox10 is expressed in glial cells. 
 
V.2.4.2 FLOATING CULTURES 
Another approach tried was a floating culture technique. This is used in 
neuronal cell culture to generate neurospheres, spherical aggregates (Rauch 
et al., 2006). In our case we saw that 24 h after plating some of the dissected 
NT detached and formed a sphere like structure. Inside this spheroid group 
of cells it was possible to observe several GFP+ cells that were maintained at 
least until 6 days in culture. It was also possible to distinguish differentiated 
melanophores in these spheroid NTs due to their dark pigmentation (arrow in 
Figure V.12.A). Notice that the pigmented region and the region rich in GFP+ 
cells were distinct. 
 
V.2.4.3 MIDKINE SUPPLEMENTATION 
Considering that Ltk is still an orphan receptor (Morris et al., 1997), but 
that morpholino experiments with Midkine and Ltk indicate that Midkine is the 
possible ligand for Ltk (J. Mueller and C. Winkler lab unpublished results), 
and in an early attempt to establish culture conditions conducive to iridophore 
differentiation, we assessed the effects of the addition of Midkine to a 
concentration of 2.2 µg/ml on iridophore numbers in dissected NT cultures. 
There was no increase in iridophore number; in fact there were no 
iridophores which was comparable to the control. Culture conditions were as 
follows: 14 hpf NT were dissected and plated in fibronectin coated glass 
coverslips at 28oC no CO2 buffering in F12+Glutamax medium supplemented 
with 15 mM HEPES, 10 % FBS, 1 % P/S, 0.2 % gentamicin, 0.5 % 
Fungizone, 100 nM endothelin 3. However since we have tested midkine 
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under culture conditions prior to establishing those generating iridophores, 
the lack of effect may be of little importance, since iridophore precursors 
might not be present. 
 
V.2.5 TOWARDS SINGLE EMBRYO CULTURE 
In an attempt to test whether we could use whole disaggregated 
embryos to study single embryos, as an alternative to NT explants we used 
the same protocol as in whole embryo cultures but instead of culturing -
4725sox10:gfp+ embryos, we used a single -4725sox10:gfp+ embryo with 49 
WT embryos. We tested this with two different media, F12 and F12/N2/bFGF. 
Cells were grown in fibronectin covered glass bottom Petri dishes, with 2 mL 
of cell suspension in each. In both media we could observe cells attached 
after 1 day, these cells contained a few GFP+ cells (Figure V.13). These 
preliminary observations confirmed that it is possible to grow a single embryo 
NC diluted in a WT background. 
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Neural Crest Cell culture has been of extreme importance in the study 
of the NC. Up to date no NC cell cultures have been reported in zebrafish. 
We first report here the development of such system. We set out to optimize 
culture conditions that allowed survival and growth of the zebrafish NC cells. 
For that we have tested different attachment substrates, different media 
compositions and different methods to obtain NC cells. 
 
We have achieved a set of culture conditions that we believe are 
suitable for zebrafish NC cells. These were as follows: cells were grown at 
28.5ºC without CO2 buffering in glass coverslips coated with fibronectin in 
F12 + Glutamax media supplemented with 15 mM HEPES, 10 % FBS, 1 % 
P/S, 0.2 % gentamicin, 0.5 % Fungizone, 100 nM of ET3 and 1.7                
mM of CaCl2. Out of the several modifications to the medium composition, 
we believe that addition of ET3 and CaCl2 were the most crucial ones. We 
have also tested several methods for obtaining the NC cells including 
dissection of neural tubes, and total disaggregation of embryos. Culturing of 
total disaggregated in these culture conditions has allowed us to identify 
several NC derivatives: melanophores, iridophores, putative myofibroblasts, 
sympathetic neurons and glia. We were also able to apply the NT method for 
the first time in zebrafish. 
 
For detailed discussion and future work please see VII.3 - Culturing 
zebrafish NCC. 
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Figure V.6 – Melanophores differentiate in culture. Bright field image of 
a dissected NT culture showing differentiated melanophores after 5 days in 
culture (black arrows). Scale bar, 50 µm. 
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Figure V.7 – Disaggregated whole embryo culture reaches confluence and differentiates melanophores and iridophores. Confocal 
images of disaggregated -4725sox10:gfp fish cells after 6 days in culture, showing a high level of confluence. A) Bright field image of the culture. B) 
Image in a green wavelength. Notice the number of green cells and the punctuate appearance of green signal; probably caused by autofluorescence of 
the guanine crystals of iridophores. C) Merged image of A and B, notice the co-localization of the green signal and the lightly dark cells (red arrows), 
iridophores. It is possible to see melanophores and iridophores juxtaposing (black arrows). Scale bar, 100 µm. 
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Figure V.8 – Confocal images of a disaggregated -4725sox10:gfp fish cell culture after 6 days. A) Bright field image. B) Image in a green 
wavelength. C) Overlay if A and B, notice that the lightly pigmented region shows autofluorescence in comparison to the dark region that does not 
show a green signal, this is probably a cluster of cells. Lightly pigmented cells are probably iridophores showing autofluorescent in comparison to the 
dark one that shows no fluorescence. Scale bar, 50 µm. 
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Figure V.9 – Neurons differentiate in cell culture. Immunohistochemistry for 
Hu protein in cells obtained from a dissected NT. A) Confocal image of the migrated 
cells. B) Nuclear DAPI staining. C) AlexaFluor 488 coupled secondary antibody 
immunostaining against Hu protein. D) Merge of the images A – C showing the 
existence of Hu positive cells within the population, indicating that they are neurons. 
Notice the nuclear co-localization of the Hu protein and the nuclear marker DAPI. 
Scale bar, 50 µm. 
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Figure V.10 – Putative myofribroblasts differentiate in vitro. Immunohistochemistry for smooth muscle actin (sma) 
using a αhuman SMA antibody. Cells obtained from a dissected NT. A) Bright field image of a Sma+ cell, a putative 
myofibroblast. B) Nuclear DAPI staining. C) AlexaFluor 488 coupled secondary antibody staining. D) merge of the images A 
– C. Scale bar, 50 µm. 
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Figure V.11 – Culture cells differentiate into putative glia. Confocal images of disaggregated -4725sox10:gfp fish cells after 6 days. A) 
Bright field image of the culture. B) Image in a green wavelength. Notice fluorescent cell (white arrow) with fluorescent cell protrusions, one of which 
seems to connect to a slightly pigmented cell (red arrows) that is also fluorescent. C) Merged image of A and B, notice the co-localization of the green 
signal and the lightly dark cells, probably iridophores, both adjacent to the cell marked with the red arrow and in the ones marked with an asterisk. 
Scale bar, 100 µm. 
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Figure V.12 – Dissected NT generates neurosphere-like structure. -4725sox10:gfp 16 hpf embryo dissected neural tube after 24 h in 
culture. Floating sphere contains GFP+ cells and dark cells (arrow), possibly melanophores. A) Bright field image. B) Fluorescent image of floating 
sphere in A. C) Close up of B. 
205 
 
 
Figure V.13 – Single GFP+ embryo cells can be distinguished in culture. A single -4725sox10:gfp+ embryo was 
disaggregated with 49 WT embryos and cultured in two different media: F12 and F12/N2/bFGF. Both media show 
equivalent numbers of GPF+ cells. This shows that it is possible to distinguish GFP+ cells from a single GFP+ embryo. 
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Chapter VI - A NOVEL IN VIVO ASSAY 
FOR RECEPTOR TYROSINE KINASE 
INHIBITORS 
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VI.1 AIMS 
The pharmaceutical industry currently spends millions on R&D of new 
drugs, most of these drugs are then discarded during in vivo validation. It has 
been suggested that new models are required for reduction of these attrition 
rates. Following our work with injections of a constitutive active tyrosine 
kinase in zebrafish, we decided to use this as a new tool for testing RTK 
drugs in vivo. For that we shall: 
• Determine optimum DMSO concentration to bathe embryos with; 
• Test if we can assess developmental defects caused by 
treatment with RTK inhibitors; 
• Determine concentration of an ALK inhibitor that causes no 
physiological defects; 
• Test if ALK inhibitor can inhibit constitutively active ALK fusion 
forms in vivo. 
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VI.2 RESULTS 
VI.2.1 DETERMINING OPTIMUM DMSO CONCENTRATIONS 
 We started by determining the ideal concentration of DMSO, i.e. a 
concentration that resulted in no visible developmental defects by 72 hpf. 
Embryos were grown in 24-square well plates with 3 mL of embryo medium 
and 3 embryos per well. We raised embryos in 1 %, 2 % and 5 % DMSO until 
72 hpf. Embryo development was assessed every 24 h, dead embryos 
counted and removed until 72 hpf. We looked for developmental defects, 
such as head and trunk morphology, ear, heart and pigment pattern as 
described in II.8. At concentrations of 1 and 2 % embryos showed no or low 
mortality, whereas treatment with 5 % DMSO resulted in 100 % death rate by 
24 hpf. By 72 hpf 2 % DMSO embryos often showed heart oedema (4/9) 
(Table VI.1). Embryos in 1% DMSO were normal up to 72 hpf. Upon rare 
occasions embryos treated in 1 % DMSO also presented heart oedema and 
up-curved tail (data not shown). In general DMSO controls embryos showed 
normal morphology and pigmentation with the exception of the occasional 
heart oedema and slightly up-curved tail. This lead us to conclude that 1 % 
DMSO was a safe concentration to use, 2 % DMSO was also used since the 
majority of embryos were normal and the abnormalities seen in the remaining 
embryos not as dramatic, with only curved body axis and the occasional 
heart oedema. 
 
VI.2.2 GENERIC RTK INHIBITORS 
To test our ability to do chemical screening experiments we used 
several commercially available inhibitors for tyrosine kinases or tyrosine 
kinase signalling pathways. These were: Herbimycin A, Streptomyces sp.; 
PDGFR Tyrosine Kinase Inhibitor IV; VEGFR inhibitors I and II; EGFR 
inhibitor; Met Kinase Inhibitor; STAT3 Inhibitor Peptide; Jak3 Inhibitor I and 
Jak3 Inhibitor II; VEGFR inhibitors I and II (Table VI.2). To our knowledge no 
other studies have used these inhibitors in zebrafish. 
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 EGFR inhibitor was tested at concentrations of 5, 10 and 27 µM (27 µM 
was used because that was the maximum concentration we could use it at, 
according to the solubility) (Table VI.3). Embryos were assessed for 
developmental defects according to protocol detailed in section II.8. 
Observation of treated embryos showed no defects by 24 hpf when 
compared to controls. By 72 hpf treated embryos showed a normal general 
morphology, observation of the circulatory system revealed heart oedemas 
and lack of circulating blood cells in nine out of 12 embryos at the lowest 
concentration of 5 µM. This was also true for embryos treated with 10 and 27 
µM doses where all embryos possessed heart oedemas and lack of 
circulating cells. Additionally (also at 72 hpf), embryos treated with 27 µM of 
EGFR inhibitor showed defects in the medial dorsal fin which failed to extend 
as anteriorly as it normally does. Two embryos also showed oedema in the 
medial fin in the tail region. By 5 dpf all of 10 and 27 µM treated embryos 
were dead as were 9 out of 12 of the 5 µM treated embryos (Table VI.3).  
 
VEGFR inhibitors I and II were tested at concentrations of 5, 10 and 50 
µM. Observation of treated embryos showed no morphological defects at 
either concentration, when compared to the controls, with exception of two 72 
hpf embryos treated with 50 µM VEGFR inhibitor II that possessed heart 
oedemas and two treated with 50 µM of VEGFR inhibitor I that degenerated 
(Table VI.3).  
We tested STAT3, JAK3 I and II, Met and Herb inhibitors at several 
concentrations (see below) but we could not find any effect either 
morphological or in the death rate, when compared to the control. We 
therefore raised the concentration of these inhibitors to the highest 
concentration possible (Table VI.4 and Figure VI.1). This was limited by the 
solubility of the compounds and the maximum DMSO concentration that gave 
no or low morphological defects (2 %). Both Jak3 inhibitor I and II when 
added independently revealed no defects at all the concentrations tested up 
to 336 µM and 260 µM, respectively (Figure VI.1). Four out of 14 embryos 
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treated with 260 µM of Jak3 inhibitor II showed a bent A–P axis, with an 
upcurved tail (Table VI.4 and Figure VI.2). When both inhibitors were added 
in combination, at 165 µM and 130 µM, respectively, 5 out of 5 embryos 
showed curved and shorter tail, microphtalmia, and impaired migration of 
melanophores by 72 hpf and defective jaw. Head also appeared smaller but 
ear looked normal. In repeat experiment 4 dpf embryos showed additionally 
reduction in iridophores (6 out of 6, data not shown). 
Embryos treated with STAT3 inhibitor peptide revealed no defects at all 
the concentrations tested, up to 205 µM (the maximum concentration 
possible according to inhibitor solubility) (Table VI.4 and Figure VI.1). 
Herbimycin A, a generic Protein kinase inhibitor, treated embryos 
showed no defects up to 11 µM; at the concentration of 3.4 µM four out of 15 
embryos showed upcurved tail (this tail phenotype did not differ from that 
occasionally found in the controls) (Table VI.4 and Figure VI.1). Embryos 
treated with Met Kinase Inhibitor were mostly normal at all the concentrations 
tested, up 28 µM. Two embryos treated with 34 µM presented several 
defects at 48 hpf, with heart oedema, swollen ear, reduced dorsal fins, 
melanophores failed to migrate from the dorsal stripe, had bad eye 
pigmentation, and were dead by 4 dpf (Table VI.4 and Figure VI.1). Mostly 
the inhibitor showed insolubility as observed by appearance of a yellow 
precipitate. 
Treatment of embryos with 1.6 and 3.3 µM of PDGFR inhibitor revealed 
complete mortality by 24 hpf (data not shown), therefore we tried lower 
concentrations. At the concentration of 750 nM three out of six died by 24 
hpf, the remaining three embryos when observed at 48 hpf showed heart 
oedema, abnormal melanophore morphology, defective skin, eyes and fins, 
and a bent tail (Table VI.4  and Figure VI.3). By 72 hpf they were all dead. 
Reduction of the concentration of PDGFR inhibitor to 500 nM showed less 
severe defects. Nevertheless treated embryos showed: reduced head, eyes 
and ear, bent axis and most prominently epidermis looking very deformed. 
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Pigment cells were also affected, particularly melanophores, these looked 
compact and with impaired migration. 
A summary of the inhibitors tested and maximum concentration used, 
as well as phenotype can be found in Table VI.2. 
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Table VI.1 – Summary of DMSO concentration testing. 
DMSO 
concentration 
Total number of 
embryos 
@ 24 hpf @ 72 hpf 
Live Dead Deformed Live Dead Deformed 
1% 12 12 0 0 12 0 0 
2% 12 11 1 0 9 3 4 heart oedemas 
5% 12 0 12 - 0 12 - 
  Χ2 p < 0.0001  Χ2 p < 0.0001  
 
  
213 
 
 
Table VI.2 – Summary of the effects of the inhibitors and higher concentrations tested. 
  Max concentration used Phenotype of treatment 
R
ec
ep
to
r i
nh
ib
ito
rs
 Herbimycin A 11 µM No effect. 
PDGFR Tyrosine Kinase 
Inhibitor IV 1.6 µM 
Reduced head, eyes and ear, bent axis. Deformed 
epidermis. Pigment cells were also affected, melanophores 
looked compact and with impaired migration. Doses higher 
than 750 nM were lethal. 
VEGFR2 inhibitor I 50 µM No effect. 
VEGFR2 inhibitor II 50 µM No effect. 
EGFR inhibitor 27 µM Heart oedemas and lack of circulating blood cells. 
Si
gn
al
lin
g 
ca
sc
ad
e 
in
hi
bi
to
rs
 Jak3 Inhibitor I 336 µM No effect. 
Jak3 Inhibitor II 260 µM No effect. 
Jak3 Inhibitors I and II 165 µM and 130 µM, respectively 
Short tail, small eyes, and impaired migration of 
melanophores and defective jaw. 
STAT3 inhibitor 136 µM No effect. 
Met Kinase Inhibitor 34 µM No effect. 
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Table VI.3 – Table summarizing VEGFR inhibitors I and II and EGFR inhibitor experiments, survival and phenotype. 
 
 Total 
number of 
embryos 
@ 24 hpf @ 72 hpf @ 5 dpf 
 Live Dead Deformed Live Dead Deformed Live Dead Deformed 
DMSO 1 % 12 12 0 0 12 0 0 12 0 0 
VEGFR inhibitor I 5 µM 12 11 1 0 11 1 0 6 6 0 
 10 µM 14 13 1 0 9 5 0 9 5 0 
 50 µM 9 9 0 0 9 0 2 degenerating 5 4 0 
VEGFR inhibitor II 5 µM 12 12 0 0 12 0 0 5 7 0 
 10 µM 12 11 1 0 11 1 0 10 2 0 
 50 µM 11 11 0 - 11 0 2 with heart oedemas 3 8 0 
EGFR inhibitor 
5 µM 12 12 0 0 12 0 all with heart oedemas 3 9 
all with 
heart 
oedemas 
 10 µM 12 12 0 0 12 0 
all with heart 
oedemas 0 12 0 
 27 µM 12 11 1 0 10 2 
all with heart 
oedemas 0 12 0 
215 
 
Table VI.4 - Table summarizing STAT, JAK 3, Met PDGFR and Herbimycin inhibitors experiments, survival and phenotype. 
Inhibitor 
Total 
number 
of 
embryos 
@ 24 hpf @ 72 hpf @ 4dpf 
Deformed embryos phenotype 
Live Dead Deformed Live Dead Deformed Live Dead Deformed 
Control 
2 % 
DMSO 
12 12 0 2 12 0 2 12 0 2 
Curved tail and heart oedema 
STAT3 
205 µM 12 12 0 0 9 3 0 9 3 0 
 JAK3 I 
336 µM 14 14 0 0 14 1 0 8 6  
 JAK3 II 
260 µM 15 15 0 0 14 1 4 10 5 2 
Shorter A - P axis and curved 
tail 
Jak3 I 
165 µM 
    + 
Jak 3 II  
130 µM 
6 6 0 6 5 1 5 5 1 5 curved tail, deformed eyes, 
impaired melanophore 
migration and small head 
Herb 
3.4 µM 15 15 0 0 15 0 3 15 0 4 Curved tail 
Met 
34 µM 15 15 0 0 15 0 2 12 3 0 
Heart oedema, swollen hear, 
reduced dorsal fin, defective 
melanophore migration 
PDGFR 
500 nM 6 6 0 0 3 3 0 0 6 0 General malformations, 
shorter axis, curved tail and 
impaired melanophore 
migration 
PDGFR 
750 nM 6 3 3 3 0 6 0 0 6 0 
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Figure VI.1 – Some RTK inhibitor treatments show no defects. WT embryos were 
treated with either 2% DMSO (A, A’) or different RTK inhibitors (B – G’) also in 2 % DMSO, 
from 6 hpf onwards, pictures taken at 4 dpf. A, B, C, D, E, F, G) Bright field pictures, 
showing normal morphology and normal pigmentation pattern. A’, B’, C’, D’, E’, F’ G’) 
Incident light pictures of same embryos, iridophores can be seen as shiny cells, in the eyes, 
head , yolk sac and dorsal and ventral stripes along the body. Scale bar, 500 µm. 
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Figure VI.2 – Combination of JAK3 inhibitors leads to synergistic effects.  Treatment of embryos with 2 % DMSO (control, 
A) or JAK inhibitors (B, C, D, E) from 6 hpf onwards. All pictures taken at 4 dpf. B, C) embryos treated with 260 µM of JAK3 inhibitor 
II. D, E) embryos treated with a combination of JAK3 inhibitors I and II, 165 µM and 130 µM, respectively. Embryos treated with both 
inhibitors are shorter, a with strongly curved A- P axis, smaller head and eyes. Scale bar, 500 µm. 
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Figure VI.3 – PDGFR inhibition defects are dose dependent. Bright-field pictures of 
2 dpf embryos treated with 2 % DMSO (A) and two doses of PDGFR inhibitor, 500 nM (B – E) 
and 750 nM (F – J). Treated embryos are shorter with curved axis, small heads, small or 
almost absent eyes, and misshapen melanophores. Higher dose embryos (F – J) have the 
same effects but they are more pronounced. Scale bar, 500 µm. 
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VI.2.3 ALK INHIBITORS 
Testing several commercial inhibitors allowed us to optimise optimum 
DMSO concentration, conditions for treatment and growing of embryos with 
inhibitors, and assessment of potential phenotypes. We then progressed to 
test a published ALK inhibitor, TAE684, kindly supplied by Nathaniel S. Gray 
(George et al., 2008; Koivunen et al., 2008). TAE684 was diluted in 100 % 
DMSO to a stock concentration of 10 mM. According to these authors, the 
IC50 in cell culture was 2 to 10 nM. 
 
We started by testing a series of concentrations to determine at which 
concentrations of inhibitor the embryos were able to develop normally. 
Embryos were bathed from 18 hpf until 72 hpf in 2, 4, 6, 10 and 50 nM of 
TAE684 (Figure VI.4 and data not shown). At concentrations of 10 and 50 nM 
all embryos were dead by 24 hpf (data not shown). Embryos treated with 6 
nM of TAE684 had a short axis and no iridophores but were otherwise 
normal, including melanophore pattern (Figure VI.4). At 2 nM embryos were 
normal with variable degrees of iridophore reduction (Figure VI.4). Embryos 
bathed in 4 nM of TAE684 were generally normal with exception of some with 
kinked or shorter A-P axis (Figure VI.4); at this concentration the reduction in 
the number of iridophores was stronger than that of 2 nM treated embryos, 
with iridophores mostly absent. We therefore decided to use 2 nM has a 
working concentration, as this concentration gave no other developmental 
defects with exception of reduction of iridophores, this phenotype was 
unexpected but quite interesting (see VI.2.6). In some cases 3 nM and 4 nM 
concentrations were used for treatment of embryos in short time windows. 
 
VI.2.4 TAE684-MEDIATED INHIBITION OF HUMAN NPM-ALK IN TRANSIENT 
TRANSGENIC ZEBRAFISH 
Previous work in the Kelsh Lab. has shown that injection of a 
constitutively active form of ALK, NPM-ALK (originated from a genomic 
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translocation where the tyrosine kinase domain of ALK is fused with the 
amino-terminus of Nucleophosmin) (see section I.7.2), is capable of rescuing 
iridophores in ltk mutants (see I.7.2). In WT embryos it also produces ectopic 
iridophores (i.e. iridophores outside the normal iridophore positions), 
generates large clusters of iridophores and precocious development of some 
head iridophores at 3 dpf.  
We proceeded to test whether the medically relevant human NPM-ALK, 
could be inhibited in vivo. Wild-type zebrafish embryos were injected with 20 
pg of -4725sox10:NPM-ALK:IRES:eGFP, encoding the NPM-ALK fusion form 
under the control of sox10 promoter; uninjected siblings were also kept as 
uninjected controls. Embryos were grown in 90 mm Petri dishes with 30 mL 
of embryo medium; both non-injected embryos and NPM-ALK injected 
embryos were divided into two dishes, the non-TAE684 treated where 
embryos were bathed in 1 % DMSO whereas treated embryos were bathed 
with 2 nM TAE684 also in 1 % DMSO (Table VI.5). At 6 hpf all dishes were 
screened for dead embryos and these were removed. Subsequently 
iridophore pattern was analyzed at 3 – 4 dpf and embryos classified into one 
of three classes: i) wild-type embryos; ii) embryos with extra iridophores, 
large clusters of iridophores or precocious iridophores in the head; and iii) 
embryos with fewer iridophores. Wild-type embryos have normally no ectopic 
iridophores, although the odd one does occur (F. Rodrigues and M. Nikaido, 
personal observation). 
Table VI.5 – Diagram with the 4 classes of embryos in NPM-ALK inhibition 
experiments. 
 
Embryos injected with: 
Non-injected 20 pg of -4725sox10:NPM-ALK:IRES:eGFP 
Embryos bathed 
in embryo 
medium with: 
1 % DMSO Non-injected non-TAE treated 
NPM-ALK injected 
non-TAE treated 
2 nM TAE684 
1 % DMSO 
Non-injected 
TAE treated 
NPM-ALK injected 
TAE treated 
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As expected, control embryos had normal iridophore pattern (Figure 
VI.5). In contrast, NPM-ALK injected non-TAE treated embryos we observed 
large clusters of iridophores along the dorsal stripe, ectopic iridophores along 
the trunk and, in some cases, precocious iridophores in the head, these three 
phenotypes accounted for 56 – 67 % of the embryos. These effects were not 
necessarily all seen in each embryo although embryos with more than one of 
these effects did occur. NPM-ALK injected embryos treated with 2 nM 
TAE684 usually had reduced or absent iridophores, and no or very few 
embryos had ectopic iridophores. This indicated NPM-ALK mediated 
production of extra and ectopic iridophores was being inhibited, as well as 
the endogenous development. When compared to non-injected non-TAE684 
treated embryos, NPM-ALK injected non-TAE684 treated embryos had a 
higher proportion of embryos with ectopic and/or clusters of iridophores (p < 
0.005, Fishers exact test) (Table VI.6 and Figure VI.6) 
 Non-injected TAE684 treated embryos had only embryos belonging to 
the less iridophores class when compared with non-injected non-TAE684 
treated embryos; this was statistically significant (p < 0.005, Fishers exact 
test) (Table VI.6 and Figure VI.6). In NPM-ALK injected TAE684 treated 
embryos, the ectopic and/or clusters class disappears (with the exception of 
one embryo) and most embryos fit into the fewer iridophores class (p < 
0.005, Fishers exact test). Comparison between non-injected TAE684 treated 
and NPM-ALK injected TAE684 treated embryos showed no statistically 
significant difference between the classes (Table VI.6 and Figure VI.6). 
Reduction of extra and ectopic iridophores by TAE684 confirmed this 
chemical as an inhibitor of NPM-ALK. Further reduction of the endogenous 
iridophores in non-injected embryos confirms TAE684 inhibition of the 
endogenous pathway for iridophore development.  
 
VI.2.5 TESTING TAE684 INHIBITION OF EML4-ALK 
Inhibition of the oncogenic NPM-ALK by TAE684 lead us to question 
whether other oncogenic fusion forms of ALK could also be inhibited using 
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this assay. We decided to test this method using EML4-ALK v1 another 
oncogenic form of ALK (see I.7.1). In vitro studies have previously shown 
inhibition of EML4-ALK by TAE684 (Koivunen et al., 2008). In order to 
develop the same assay as for NPM-ALK it was first necessary to clone 
EML4-ALK fusion protein in the same vector containing the sox10 promoter, 
as previously done for NPM-ALK. It was also necessary to test whether 
injection of this fusion form would produce the same iridophore phenotype 
seen in NPM-ALK overexpression. 
 
CLONING EML4-ALK INTO -4725SOX10:IRES:EGFP 
The EML4-ALK v1 in a pDNR dual plasmid was kindly given to us by 
Dr. Pasi A. Jänne and was used to extract the EML4-ALK fragment. We 
started by cloning EML4-ALK into the -4725sox10:IRES:eGFP vector (Figure 
VI.8). This vector contains the sox10 promoter that allows us to express 
EML4-ALK only in NC cells, plus an IRES regulatory element driving eGFP 
expression used for localization of the expression of the construct. The 
EML4-ALK was cloned just after the promoter by digesting the -
4725sox10:IRES:eGFP with XbaI1
                                            
1 The plasmid has two XbaI sites, but one of them is methylated in E. coli so was 
ignored, as it would not digest (M. Nikaido, personal communication). 
, and extracting a NheI/XbaI fragment of 
EML4-ALK. XbaI and NheI generate compatible cohesive ends. Both 
fragments were then ligated through non-directional cloning. This yielded 
several positive colonies that were then sequenced. Two positive colonies 
with the correct orientation were identified, and one was used from here on 
(see Appendix 4). Analysis of the sequence showed no mutations or frame 
shifts. 
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TESTING -4725SOX10:EML4-ALK:IRES:EGFP 
We injected -4725sox10:EML4-ALK:IRES:eGFP at different 
concentrations to assess ideal concentration, i.e. a concentration high 
enough to ensure that we would see a phenotype, if that was the case, but 
low enough as to not cause high mortality or developmental defects caused 
by toxicity. This was done in collaboration with Gail Doughton, a project 
student. 
Embryos were injected with 75, 100, 150 or 200 pg of plasmid. The 
backbone vector, without the EML4-ALK fusion was injected as an injection 
control, this would allow us to know what percentage of mortality was caused 
by the EML4-ALK protein (Table VI.7). Mortality caused by injection of EML4-
ALK was calculated by subtracting mortality of those embryos injected with 
the control. Mortality was 25, 31, 75 and 45 % for embryos treated with 75, 
100, 150 and 200 pg, respectively. Mortality seemed to be dependent on the 
amount of plasmid injected, with exception of the 200 pg injections that were 
lower than that of 150 pg, possibly due to different batches of embryos used 
(Table VI.7).  
In all concentrations we assessed embryos for GFP fluorescence at 24 
hpf. Some embryos showed GFP signal which demonstrated that the 
injections and plasmid were working (Figure VI.9). At 72 hpf embryos had a 
normal morphology and were assessed for iridophore phenotype looking for 
potential extra iridophores or large clusters, also dorsal stripe iridophores and 
iridophore clusters were counted. At none of the injected concentrations 
could we see ectopic and/or extra iridophores and we were unable to detect 
any difference in the numbers of dorsal stripe iridophores. Therefore we did 
not follow the injections with TAE684 treatment. 
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VI.2.6 HUMAN ALK INHIBITOR INHIBITS ZEBRAFISH CONSTITUTIVELY ACTIVE LTK 
KINASE 
Following inhibition of NPM-ALK with TAE684, the fact that endogenous 
iridophores were also reduced, and that Alk is most closely related to Ltk 
(which has been proven to be important in iridophore development), we 
hypothesised that reduction of endogenous iridophores was caused by 
inhibition of endogenous Ltk by TAE684. 
To test this we devised a similar approach as the used to test inhibition 
of NPM-ALK. Masataka Nikaido had previously shown that injection -
4725sox10:NPM-LTK:IRES:eGFP expressing NPM-LTK, a constitutive form 
of zebrafish Ltk, like NPM-ALK could recover iridophores in ltk mutants and 
generate extra and/or ectopic iridophores in both WT and ltk mutants. 
Injection of the constitutive NPM-LTK was done in collaboration with 
Masataka Nikaido, who injected embryos with 30 pg -4725sox10:NPM-
LTK:IRES:eGFP per embryos. Experimental embryos were then treated with 
TAE684 from 18 hpf and were assessed for phenotype at 3 – 3.5 dpf. 
Experiment was repeated twice. 
 We confirmed that injection of NPM-LTK leads to production of ectopic 
iridophores in the lateral side of the trunk and also produces large clusters of 
iridophores, particularly in the dorsal stripe (Figure VI.10). In contrast NPM-
LTK injected embryos treated with 3 nM of TAE684 showed an almost 
complete absence of iridophores when compared to the control embryos 
(Figure VI.10). Injection of NPM-LTK lead to an increase of the ectopic and/or 
clusters class, with 0% to 20 % of the control embryos compared to 29 % to 
33 % in -4725sox10:NPM-LTK:IRES:eGFP injected fish (p < 0.005). In 
injected siblings treated with TAE684 the proportion of embryos with ectopic 
and/or clusters of iridophores was significantly reduced (p < 0.005) (Table 
VI.8). The reduction of NPM-LTK induced ectopic and/or clusters, lead us to 
conclude that TAE684 is capable of inhibiting zebrafish Ltk tyrosine kinase 
domain. 
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Figure VI.4 - Testing TAE684 dosage in zebrafish embryos. WT zebrafish 
embryos were bathed in 2, 4 and 6 nM concentrations of TAE684 from 6 hpf until 3 dpf with 
1 % DMSO. Control embryos were bathed in DMSO alone. All pictures under incident light, 
which allows for the observation of iridophores are visible as shiny cells, due to their 
reflective platelets. Iridophores can be seen in both the eye and trunk. Increasing 
concentrations of TAE684 lead to a reduction in the numbers of iridophores in the eyes, 
yolk sac and trunk. Embryos treated with 6 nM of TAE684 also have shorter A-P body axis 
and heart oedema. Pictures taken by M. Nikaido. 
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Figure VI.5 – TAE684 inhibits NPM-ALK and reduces endogenous iridophores. WT embryos 
were injected with 20 pg of -4725:sox10:IRES:eGFP and treated with 2 nM of TAE684 ALK inhibitor. 
Incident light microscope pictures of control uninjected embryo (A), NPM-ALK injected sibling (B) and 
NPM-ALK injected TAE684 treated siblings (C). Injected embryos have ectopic (red arrowhead) and 
extra iridophores (red arrow) when compared to the uninjected control. Injected embryo treated with 
TAE684 has less iridophores than control in eyes (white arrow) and trunk (white arrowheads) and no 
ectopic iridophores or large clusters. Scale bar, 200 µm. 
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Table VI.6 – Summary of embryo distribution per class when testing NPM-ALK inhibition with TAE684. Embryos were injected with 20 pg of -
4725sox10:NPM-ALK:IRES:eGFP and treated with 2 nM of TAE684. Numbers represent number of embryos within each class. Classes are: normal, less 
iridophores and ectopic and/or extra iridophores. 
Ex
pe
rim
en
t 1
  
Total number of 
embryos by 72 hpf Normal Ectopic and/or clusters Fewer iridophores 
Non-injected control 12 12 0 0 
Non-injected + TAE684 13 0 0 13 
Injected control 15 4 10 1 
Injected + TAE684 17 0 0 17 
      
Ex
pe
rim
en
t 2
  
Total number of 
embryos by 72 hpf Normal Both ectopic + clusters Fewe iridophores 
Non-injected control 50 47 0 3 
Non-injected + TAE684 77 0 0 77 
Injected control 18 6 10 2 
Injected + TAE684 36 7 1 28 
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Figure VI.6 – TAE684 inhibits NPM-ALK. Embryos were injected 
with 20 pg of -4725sox10:NPM-ALK:IRES:eGFP and treated with 2 nM of 
TAE684. A and B) two independent experiments using the same conditions. 
Scale represent perecentage of embryos within each class. Classes are: 
normal, less iridophores and ectopic and/or extra iridophores. Graphics 
displaying relative proportion of the three different classes of embryos in 
each treatment set and control. 
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Figure VI.7 – Cloning -4725sox10:EML4-ALK:IRES:eGFP. A) digestion of EML4-ALK 
in pDNR-dual with NheI/XbaI and extraction of EML4-ALK band. B) Linearization of -
4725sox10:IRES:eGFP with XbaI and extraction of band. Lane M, Promega 1 kb DNA ladder. 
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Figure VI.8 - Strategy for cloning -4725sox10:EML4-ALK:IRES:eGFP. -
4725sox10:IRES:eGFP was digested with XbaI. NheI/XbaI fragment of EML4-ALK 
extracted from EAV1-pDNR-dual. XbaI and NheI generate compatible cohesive ends. 
Both fragments were then ligated through non-directional cloning. Lower panel shows map 
of the final sequenced construct. 
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Table VI.7 – Sumary of EML4-ALK injection experiments. Including genotype, total number of fish injected and mortality. 
Amount of 
plasmid injected Genotype 
Total number 
of injected fish 
Final mortality 
assessment 
Mortality of 
uninjected 
control 
Mortality of 
injected 
control 
Mortality of 
EML4-ALK 
injected 
Added 
mortality due 
to EML4-ALK 
75 pg Shady 1063 5 dpf 22.06% 20.06% 45.29% 25.23% 
100 pg Shady 657 5 dpf 21.72% 37.05% 68.74% 30.69% 
150 pg AB 356 3 dpf 15.19% 11.24% 85.95% 74.71% 
200 pg AB 457 3 dpf  3.84% 48.97% 45.13% 
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Figure VI.9 - Injection of -4725sox10:EML4-ALK:IRES:eGFP generates 
GFP+ cells. Pictures of 24 hpf embryos injected with -4725sox10:EML4-
ALK:IRES:eGFP in brightfield (A) and green fluorescent chanel (B). Embryo shows 
normal morphology (A) and has GFP+ cells in head (arrows in B). C) -
4725sox10:EML4-ALK:IRES:eGFP injected embryo under disecting scope green 
fluorescence channel showing GFP+ cells (arrows). Scale bar, 500 µm. 
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Figure VI.10 – TAE684 inhibits NPM-LTK. 3 dpf embryos where injected with NPM-LTK and treated with TAE684. A, A’, A’’) control 
uninjected, non-treated sibling. B, B’, B’’) NPM-LTK injected and non-treated sibling, embryo has ectopic iridophores in the trunk (arrowheads) and 
large clusters of iridophores in dorsal stripe (arrows) when compared to uninjected embryo. C, C’) NPM-LTK injected and TAE684 treated embryo 
with reduced number of iridophores and no ectopic or large clusters of iridophores. A, B, C) brightfield lateral view pictures. A’, B’, C’) incident light 
lateral view pictures. A’’, B’’) incident light dorsal view. Scale bar, 500 µm. 
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Table VI.8 – Summary of embryo distribution per class when testing NPM-LTK inhibition with TAE684. Embryos were injected with 20 pg of -
4725sox10:NPM-LTK:IRES:eGFP and treated with 2 nM of TAE684. At 72 hpf embryos were assessed for iridophore phenotype. Numbers represent number 
of embryos within each class. Classes are: normal, less iridophores and ectopic and/or extra iridophores. 
Ex
pe
rr
im
en
t 1
  Total number of embryos at 72 hpf Normal 
Ectopic and/or 
clusters Fewer iridophores 
Non-injected control 66 65 0 1 
Non-injected + TAE684 55 2 0 53 
Injected control 75 44 22 9 
Injected + TAE684 92 3 3 76 
      
Ex
pe
rr
im
en
t 2
  Total number of embryos at 72 hpf Normal 
Ectopic and/or 
clusters Fewer iridophores 
Non-injected control 65 54 11 0 
Non-injected + TAE684 63 0 2 61 
Injected control 48 30 16 2 
Injected + TAE684 46 0 0 46 
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Figure VI.11 – TAE684 inhibits NPM-LTK. Embryos were injected with 20 pg of 
-4725sox10:NPM-LTK:IRES:eGFP and treated with 2 nM of TAE684. A and B 
represent two independent replicas of same experiment. Iridophore pattern was 
assessed at 72 hp and classified into 3 classes. Classes are: normal, less iridophores 
and ectopic and/or extra iridophores. Graphics displaying relative proportion of the 
three different classes of embryos in each treatment set and control, of number in 
Table VI.8. 
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VI.2.7 DISSECTING LTK FUNCTION IN IRIDOPHORE DEVELOPMENT 
Our demonstration that TAE684 inhibited both iridophore development 
in wild-type fish, as well as the NPM-Ltk-dependent ectopic/supernumerary 
iridophores in injected fish suggested that this inhibitor was not ALK specific 
but was also inhibiting Ltk. Nevertheless no other developmental defects 
were observed at the low concentrations and embryos developed generally 
well, suggesting this inhibition was probably restricted to the two closely 
related RTKs (ALK and Ltk). 
We therefore decided to use this inhibition of Ltk by TAE684 to our 
advantage, and use it to study the function of Ltk in vivo. Ltk has been 
implicated in iridophore specification in zebrafish at early stages. Later it is 
expressed in differentiated iridophores, but its late function is still unknown 
since it is masked by an early failure of fate specification. By inhibiting Ltk at 
different time windows we hoped to determine the exact timing of 
specification as well as elucidate the later role. 
Using 2 nM of TAE684 as our working concentration we started 
assessing the effects of LTK inhibition in iridophore development, namely, if it 
was possible to distinguish between an early and a late effect of Ltk in 
iridophores. Firstly we assessed the effect of Ltk inhibition in 24 h time 
windows (Figure VI.12.A). We treated embryos from 24 – 72 hpf as a positive 
control, and two time windows: 24 – 48 hpf and 48 – 72 hpf. Numbers of 
iridophore spots and iridophore clusters were determined (see II.2.4). In all 
time windows the number of clusters was statistically significantly reduced. 
Number of iridophores was statistically reduced in both the early and the full-
length time windows. The effect on iridophore number was more pronounced 
in embryos bathed between 24 hpf – 48 hpf, whereas cluster number was 
more affected in the later time window, between 48 hpf and 72 hpf. Number 
of iridophores was not affected in the late time window (48 hpf – 72 hpf). This 
suggested two distinct phases of Ltk function. 
To test this further, we proceeded to treat embryos in smaller time 
windows. This would be important to determine possible time windows for an 
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early and late effect of Ltk in iridophore development. Negative control 
embryos were not treated with TAE684, whereas positive controls were 
bathed in TAE684 for the whole duration of the experiment. In this 
experiment embryos were bathed in 4 nM rather than the previously used 2 
nM, since the 4 nM TAE684 had a stronger effect in iridophore reduction and 
because the time small windows had no effects in general morphology. The 
compromise was that some embryos treated for the whole duration had a 
shorter axis. 
Counts of iridophores and iridophores clusters showed that all time 
windows had a statistically significant reduction in the number of iridophores 
and iridophore number when compared to non-treated embryos (Figure 
VI.12.B). The only exception was the late time window, 58 – 68 hpf, where 
only the number of clusters was reduced. The reduction in either number of 
clusters or number of iridophores was never as pronounced as that of 
embryos treated for the whole time span (18 – 68 hpf) which resulted in  
almost complete absence of iridophores. 
The number of clusters behaved differently from the iridophore spot 
numbers (Figure VI.12.B). In the 18 – 28 hpf treatment window the reduction 
in cluster number was not as significant as with the later time-windows. In 
contrast the latest time window (58 – 68 hpf) had a significant reduction in the 
number of clusters but not in the number of iridophores. Time windows of 28 
– 38 hpf and 38 – 52 hpf were the ones with the biggest reduction in the 
numbers of iridophores and iridophore clusters. This lead us to conclude that 
there are two distinct phases of Ltk function in iridophore development. 
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We proposed to create a new tool to test RTK inhibitors in vivo. RTK 
are responsible for a variety of human diseases and are involved in 
oncogenesis and cancer progression, thus important targets for drug 
discovery. In the development of new drugs most are discarded during the 
validation period, with great economical and animal costs. Zebrafish has the 
potential to reduce these costs. We have developed a new tool where 
embryos are injected with constitutively active tyrosine kinases and are then 
treated with inhibitors to revert its effects. 
We have started by treating embryos with a variety of RTK inhibitors to 
test our ability to perform inhibitor screens. This proved successful with some 
inhibitors giving phenotypes and confirming published data whereas others 
gave no phenotypes at the maximum concentrations tested. 
We then injected embryos with two different constitutive RTKs: NPM-
ALK and NPM-Ltk, both these fusion forms are able to generate ectopic 
and/or extra iridophores in vivo. Using TAE684, a published ALK inhibitor, we 
noticed that not only the ectopic and/or extra iridophores caused by the 
constitutive kinases were inhibited, but also the endogenous iridophores. 
This confirmed published data regarding inhibition of ALK but further showed 
that this inhibitor can also inhibit Ltk, a closely related RTK, as an off-target, 
confirmed by reduction of endogenous iridophores. We thus show that this 
method of testing RTK inhibitors in vivo is a good system. 
Following inhibition of endogenous Ltk we used TAE684 to study 
iridophore development. Here we show that when inhibiting Ltk at different 
time points it is indeed possible to distinguish different functions of Ltk in 
iridophore development. Treatments at early time points affected the number 
of iridophores more dramatically whereas late time treatment windows had a 
bigger effect in cluster number thus suggesting a role for Ltk early in 
specification and later in proliferation of iridophores. 
For detailed discussion and future work please see VII.4 - A new tool for 
RTK inhibitor studiesVII.2. 
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Figure VI.12 – Inhibition of Ltk has differential effects depending on time window of 
inhibition. WT embryos were treated at different time windows with 2 nM (A) or 4 nM (B), 
numbers of iridophores and clusters in the dorsal stripe were counted. In both cases negative 
control embryos were treated with 1 % DMSO alone and positive control embryos were treated 
for the full duration of the experiment. * p < 0.05, ** pz 0.005, *** p < 0.0005. One-way analysis 
of variance, followed by Dunnett's Multiple Comparison Test 
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Figure VI.13 – Time-window inhibition of LTK. C – F) 3 dpf WT embryos were treated with 4 nM of TAE684 at different time 
windows. A) Non-treated sibling. B) Embryo treated for the full duration of the experiment (18 – 68 hpf). Lateral view of the trunk, 
iridophores can be identified dots along the dorsal stripe. Scale bar, 500 µm. 
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Chapter VII - DISCUSSION 
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VII.1 GENERATION OF SOX10:CRE TRANSGENIC LINES 
We set out to create several Cre recombinase transgenic lines under 
the control of different fragments of the sox10 promoter. For that we 
designed several cloning approaches. We have successfully generated a -
4725sox10:cre construct containing a fragment of the sox10 promoter, 
unfortunately several attempts to clone Cre recombinase downstream of 
different length sox10 promoter fragments previously constructed in the 
Kelsh Lab (Dutton et al., 2008) were unsuccessful and abandoned due to 
time constrains. 
We tested the -4725sox10:cre construct using a Cre responsive line 
and this gave positive and encouraging results. Analysis of transient injected 
live embryos showed DsRed expression in several neural crest lineages but 
not all, and also other sox10 positive non-NC derivatives. This was also 
confirmed by immunohistochemistry against DsRed. Positive cells included 
craniofacial cartilage such as jaw and branchial arches, enteric neurons, 
Schwann cells of the dorsal root ganglia, at least two types of pigment cells: 
xanthophores and iridophores, and cells of the ear epithelium. This 
expression was nevertheless very patchy as expected for transient embryos. 
This was consistent with results from T. Carney (2003) for transient embryos 
using a GFP reporter line with the same sox10 promoter. Ectopic expression 
was also seen in muscle, also confirming previously reported data by T. 
Carney for transient embryos. 
Based on both the endogenous sox10 expression pattern and previous 
studies of these promoter fragments (Carney et al., 2006; Dutton et al., 2009; 
Elworthy et al., 2003) we expected to see DsRed in premigratory and 
migratory NCC. Transient transgenic live embryos showed no signal in 
premigratory or migrating crest. But when 24 hpf and 2 dpf injected embryos 
were immunostained for DsRed, positive cells were found in such positions. 
This difference in DsRed expression was probably due to the slow maturation 
of DsRed (Baird et al., 2000). This could be avoided by the use of a different 
reporter line such as that described by Boniface et al. (2009)  
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Iridophores and xanthophores are normally autofluorescent, therefore it 
was important to confirm that the positive signal was not due to 
autofluorescence but to DsRed expression. When immunostained for DsRed 
these cell types were still positive, confirming that at least partially the signal 
was due to DsRed expression. 
DsRed expression was also seen prominently in muscle cells, this 
expression was ectopic as these are neither neural crest derivatives nor 
sox10+. Regardless, this muscle ectopic expression has also been observed 
by T. Carney when generating GFP transgenic fish under the same promoter 
(Carney, 2003). That author reported that this was not observed later in the 
stable transgenic lines, and that this could be related to swamping or titration 
out of repressor complexes required for silencing, and that this would not 
happen when the transgene is integrated into the germline as these 
repressor complexes can function more efficiently (Carney, 2003; Kawakami, 
2004). This is consistent with our –4725sox10:cre stable lines. 
Some transient embryos showed DsRed positive cells in the heart, like 
muscle expression this was also not seen in any of the transgenic lines, but 
had previously been reported by T. Carney (Carney, 2003) for one of the 
sox10:GFP transgenic lines. 
Due to the positive results of transient fish analysis we decided to use 
this construct to create a transgenic line. We intended to use the Tol2 system 
has this has proved to be more efficient in generating transgenic lines 
(Kawakami, 2004) (see I.4.4). Several attempts to cloning -4725sox10:cre 
into a Tol2 vector failed. This was possibly due to the large size of both 
fragments has this is known to be problematic (Sambrook and Russell, 
2001). Due to time constraints this was abandoned. 
 
TRANSGENIC FISH EXPRESS CRE IN THE NC 
Transgenic fish were alternatively created by injection of the construct 
alone, with or without the vector backbone. Injected fish were grown and 
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once crossed with a Cre responsive line, 4 fish out of the 104 tested were 
positive carriers for the construct. One of these fish (founder number 5) was 
derived from a batch of fish injected with the whole circular vector. The 
remaining three founders were generated from fish injected with the same 
quantity of DNA but this time only the linearized -4725sox10:cre fragment. 
The total number of molecules of the digested fragment injected was higher 
and in linear form. This difference in the injected DNA might account for the 
fact that the second batch not only produced more founders, but also had a 
considerably higher germ line transmission rate. 
It has been reported that injection of plasmid DNA leads to a 5 to 20 % 
efficiency in producing germ line transgenics, the use of retroviruses and 
transposons such as the Tol2 system, are known to produce higher 
integration rates (approximately 50 %), and also less likely to cause 
chromosomal rearrangements (Amsterdam and Becker, 2005; Kawakami et 
al., 2000). Production of transgenic lines requires introduction of the material 
into the germ line. The timing of this integration is crucial, the earlier in 
germline formation the integration event occurs the higher the rate of 
germline transmission (Thermes et al., 2002). We therefore propose that the 
differences in germline transmission for each of the founders can be 
accounted by this. Alternatively it is also possible that more than one 
integration event has occurred. If so, this will be clear when crossing out the 
F2 generation, as these would be expected to segregate, and potentialy 
showing different expression patterns (Culp et al., 1991). 
Transgene expression is highly dependent on where in the genome 
they integrate. Transgenes can integrate in highly silenced regions of the 
genome or downstream of negative regulatory regions leading to either no or 
low expression (Allende, 2001). Alternatively transgenes can also integrate 
inside developmentally important genes leading to aberrant genes, 
developmental defects and subsequent death of the embryos. Insertion can 
also occur in genes important for gamete formation, lowering therefore the 
efficiency of germline transmission. Observation of our lines showed no 
evidence for abnormalities or silencing or ectopic expression due to nearby 
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enhancer trapping. Nevertheless only line 73 was observed in detail. 
Therefore in the future the remaining lines should be screened for these. Also 
PCR should done to confirm CRE presence and southern blot to confirm Cre 
integration.l 
 
In order to maximise our chances of establishing the sox10:cre 
transgenic lines, we restricted our imaging analysis to a few transgenic 
embryos. Observation of founder 73 progeny at 48 hpf, 72 hpf and 4 dpf 
showed expression in several cell populations: iridophores of the trunk and 
eyes, xanthophores, satellite cells in the DRGs as well as Schwann cells of 
the ventrally and dorsally projecting spinal nerves, and Schwann cells of the 
posterior lateral line nerve, oligodendrocytes of the central nervous system, 
enteric neurons. In the head it was possible to see several DsRed positive 
cell populations, namely glia of the trigeminal ganglia and pharyngeal 
ganglion, ear epithelium, cells in the branchial arches, jaw and other facial 
cartilage structures and unidentified cells in the hindbrain. This expression is 
consistent with that reported for reporter lines using the same promoter 
(Dutton et al., 2008) and a smaller version of the sox10 promoter (Carney et 
al., 2006). Cells were also observed in the pectoral fin cartilage also 
consistent with sox10 and GFP expression in the -4725sox10:GFP line 
(Carney et al., 2006). Unfortunately characterisation of all the transgenic lines 
created was not possible. For a comparison of the expression of -
4725sox:cre lines with published reporter lines see Table VII.1. 
 
The pattern of DsRed expression was consistent with that seen in 
sox10:GFP transgenic lines, but unfortunately we could not observe DsRed 
positive cell in trunk migrating NCCs nor expression in early migrating head 
crest cells (Carney, 2003; Carney et al., 2006) and DsRed appeared quite 
late in development in the positive cell populations. T. Carney et al. (2006) 
had previously shown that the sox10 promoter was able to drive GFP 
expression as early as 1-somite stage. This differene might be due to the fact 
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that, in contrast to GFP, DsRed is an obligate oligomer and has a slow 
maturation (Baird et al., 2000). In DsRed maturation kinetics studies Baird et 
al. have shown that DsRed passes through a green intermediate and takes 
approximately 27 h to reach half of its maximal fluorescence, reaching over 
90 % after more than 48 h (Baird et al., 2000). This lack of early expression 
hinders the potential of the reporter line to follow crest development as it 
makes it impossible to follow cells from very early stages. Nevertheless it 
would be interesting to know if it would be possible to use confocal spectral 
separation to separate the emission spectrums of the GFP and the non-
matured DsRed green signal, as to distinguish both from early stages of 
development. With this in mind it would also be useful to test the transgenic -
4725sox10:cre fish with a different reporter line with a fast folding fluorescent 
protein. As an example a different Cre responsive line has been described by 
Boniface et al. (2009). In this line rather than excising a fragment, Cre 
catalyses an inversion that changes GFP expression to mCherry expression. 
In contrast to DsRed, mCherry is a monomer and is fast folding, so this would 
allow us to track cells from early stages. 
An alternative explanation of the delayed DsRed detection might be that 
due to positional effects of where the -4725sox10:cre was inserted in these 
fish some neighbouring regulatory regions might be silencing its early 
expression, but both the fact that transient transgenic fish had no expression 
at early stages and the DsRed folding considerations make this less likely. 
The use of an alternative Cre responsive line as suggested above would 
distinguish these possibilities. 
Another issue observed while screening for potential founders, was that 
the eGFP driven by the EF1α promoter had variable intensities throughout 
the tissues, indicating a possible variation in the levels of DsRed produced in 
those cells. This might account, at least partially, for the weak DsRed signal 
observed at times. Once again a different reporter line, using a different 
ubiquitous promoter could solve this issue.  
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Table VII.1 – Comparison between sox10:gfp reporter lines expression and -
4725sox10cre expression. + : expression seen in this location; - : expression is not seen at 
this location; ? – presence or absence of GFP expression at this location has not been 
properly assessed. 
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Heart epithelia - + + - - 
Enteric nervous 
system + ? ? + ? 
Craniofacial 
cartilage + + + + + 
Schwann cells + + + + + 
Satellite glia + + ? + + 
Pigment cells + + + + + 
Other cranial 
ganglia ? ? ? + ? 
Pll ganglia + + + + + 
Oligodendrocytes + + + - + 
Interneurons + + ? ? ? 
Enteric ganglia - ? ? ? ? 
Muscle + - - - - 
Brain neurons + + + + + 
Olfactory bulb + + + ? ? 
Branchial arches + + + + + 
Cranial neural 
crest ? ? + + ? 
Migratory crest + + + ? ? 
Premigratory crest + + + ? ? 
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FUTURE WORK 
Sox10 is generally regarded as a marker for early and premigratory 
NCCs, being expressed as early 10 hpf (Dutton et al., 2001b; Kelsh, 2006)  
Even though several lines have previously been created that express 
fluorescent GFP under the sox10 promoter and give NC expression (Carney, 
2003), GFP expression is lost in most NC-derived cell-types soon after 
differentiation (Carney et al., 2006). Permanent lineage-labelling of zebrafish 
NC would be of great use to the field of NC development. This line would not 
only allow for identification of all NC derivatives but also allow lineage tracing 
of individual cells, and test the progressive fate restriction model (Le Douarin 
and Dupin, 2003; Lopes et al., 2008; Weston, 1991). Anesthetised transgenic 
embryos would be placed under the confocal microscope, Cre positive cells 
selected and followed for a time period to see which NC derivatives they can 
give rise to. This would be done repeatedly for numerous pre-migratory cells. 
Fates of daughter cells could then be determined according to their final 
position and morphology. 
This Cre line will also be useful in our zebrafish cell cultures to label 
NCC. One of the main problems we had in our cultures was the inability to 
recognise NC cells after they differentiated in culture, since these stopped 
expressing sox10 and thus the reporter gene (GFP). Using cell originated 
from our Cre line crossed with a reporter line this would allow us to follow 
NCCs and all their progeny allowing better identification of the derivatives. 
The Cre line could also be used in combination with a transgenic line with 
expression of a resistance gene upon loxP excision. This would allow only 
NCCs to express the resistance gene and therefore select against all others. 
As an example we could use a Cre responsive line containing the Puramycin 
resistant gene. 
The use of the sox10:cre system will also be of interest in our zebrafish 
drug screening model. Crossing the -4725sox10:cre line with a Cre 
responsive line that expresses an oncogenic construct would allow for 
expression of the oncogene in NCCs only, allowing us to screen a higher 
proportion of cells than that allowed by transient analysis since transient 
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transgenic fish are inevitably mosaic (Carney, 2003; Kawakami, 2004). It 
would also remove the need for injections. A similar approach has been used 
by Seok et al. (2010) to express oncogenic Kras in zebrafish. 
 
In future it would be interesting to fully characterise the 4 transgenic 
lines created to search for potential differences in expression. Further use of 
an alternative Cre responsive reporter line would be extremely usefull. 
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VII.2 ID2A AND THE NC 
Previous studies of id2a in zebrafish by J. Muller (2006) had shown it to 
be expressed in iridophores and to be important in their development. Due to 
our particular interest in this population of cells we decided to characterise 
this function of id2a in NC in more detail. 
 
ID2A IS EXPRESSED IN A WIDE RANGE OF NC CELLS 
To study the function of id2a in zebrafish we started by extending the 
analysis of its expression pattern in zebrafish. Müller (2007) had previously 
shown expression in premigratory and migratory crest by 24 hpf and in dorsal 
and ventral stripe iridophores at 48 and 72 hpf. We decided to extend on this 
by analysing a bigger range and number of stages (16 hpf – 72 hpf). We 
report expression of id2a in several CNS structures, including the cerebellum, 
telencephalon, rhombomeric lip and hypothalamus from as early as 18 hpf 
until 72 hpf (the last developmental stage studied). This expression is 
consistent with id2a expression described by Chong et al. (2005) in these 
CNS domains. We also confirmed the observations of Müller (2007) of id2a 
expression in trunk NC and iridophores. In addition, we have identified other 
domains that had been overlooked before, specifically we firstly show that in 
fish id2a is expressed in cranial neural crest (CNC). Interestingly, this 
expression is consistent with that of Id2 in chick where Id2 is expressed in 
the neural folds and cranial NC (Martinsen et al., 1998); unlike chick 
however, id2a in zebrafish is also expressed in trunk crest. Plus we describe 
expression of id2a in derivatives of the cranial crest such as the jaw and 
cranial ganglia. 
Id2a is also expressed in cells in positions of premigratory NC in both 
trunk and tail, from as early as 20 hpf; expression in premigratory positions is 
sustained until 40 hpf. This pushes the onset of id2a expression in trunk NC 
to 20 hpf compared to the 24 hpf reported by Müller (Müller, 2007). Id2a is 
also expressed in migratory NC cells from 22 hpf until 40 hpf in an anterior to 
posterior sequence. By 36 hpf id2a starts to be expressed in spots in both the 
 254 
dorsal and ventral stripes, this occurs firstly anterior, extending then 
posteriorly. By 48 hpf expression of id2a is reduced to spots. 
At early stages id2a expression pattern closely relates to that of other 
early NC markers such as sox10 (Dutton et al., 2001b) and crestin (Luo et 
al., 2001). Both these genes are known to be expressed in premigratory NC, 
both trunk and cranial. Nevertheless id2a it seems to be expressed in a 
smaller subset. 
In the trunk id2a expression appears to partially overlaps that of ltk, 
double in situ for these genes would confirm if they co-localise. Ltk is 
considered an iridoblast marker and is responsible for specification of 
iridophores. In early stages ltk is expressed in pre-migratory NCCs, cells 
migrating through the medial pathway and later on in development in 
iridophores (Lopes et al., 2008). Like ltk, id2a is expressed in positions of 
premigratory crest between 18 – 28 hpf (Lopes et al., 2008). Expression of 
id2a is broader than that of ltk though; and whereas ltk starts to have a 
restricted spotted expression from 26 hpf onwards (iridophores), clear spots 
of id2a only start to be visible by 36 hpf, suggesting that id2a is expressed in 
an extra subset of NC cells. Ltk is also expressed in migrating cells of the 
medial pathway, never the lateral. Id2a is seen in migrating cells from as 
early as 22 hpf and migrating streaks can still be seen in tail by 40 hpf, the 
intensity of these streaks is also higher than that of ltk. Suggesting that id2a 
is expressed in other migrating NC cells, not only iridoblasts/iridophores at 
this point. Contrary to ltk expression we report no expression of id2a in eye 
iridophores (Lopes et al., 2008). 
 
Considering broad expression of id2a in pre-migratory NCCs we 
questioned whether we could observe a difference in id2a expression in NC 
mutants. We report a difference in id2a expression in sox10m618 from as early 
as 30 hpf, where embryos have less expression in cranial NCC, and cranial 
ganglia expression is also weaker. Interestingly, in sox10baz1 mutants id2a 
expression is distinct from that of WT from as early as 24 hpf, where anterior 
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trunk premigratory cells are reduced and cranial ganglia as well as cranial 
crest are mostly gone. Expression in dorsal and ventral stripes and in 
migrating NC streaks is reduced in both mutants at 30 and 36 hpf. By 40 hpf 
dorsal stripe expression is gone in both, contrary to WT where it is sustained 
until 72 hpf. These findings not only indicate that id2a expression is 
dependent on the presence of the NC but also show a difference between 
sox10baz1 and sox10m618 mutants. These mutants have been shown to be 
identical in their NC defects with exception of extra sensory neurons in 
sox10baz1 mutants. 
Id2a is also expressed the cranial ganglia, and in the Schwann cells of 
the posterior lateral line nerve, like sox10 (Britsch et al., 2001). In sox10 
mutants glia associated with the PLL and other cranial nerves is reduced and 
was therefore suggested that sox10 mutations affect glial cell numbers in the 
cranial PNS (Kelsh and Eisen, 2000) (this was reported in other alleles of 
sox10 not sox10baz1 or sox10m618). In situ for sox10 in id2a morphants at 22 
hpf revealed no defects in the extension of the posterior lateral line. In the 
future number of cells should be addressed. It is nevertheless possible that 
the difference in id2a expression in cranial ganglia of sox10baz1 and sox10m618 
might reflect a difference in sox10 regulation of this population. 
 
ID2 KNOCKDOWN 
Following expression of id2a in NC and reduction of id2a in two NC 
mutants, plus reports from Müller (2007) on reduction of iridophores on id2a 
morphants we designed two new morpholinos one splice mismatch MO and 
one translation block MO to further assess id2a KD phenotype. Müller (2007) 
had shown that a translation blocking MO was capable of reducing number of 
iridophores, but mismatch MO for this translation blocking MO had proven 
problematic, showing reduction of iridophores too. 
Our splice mismatch MO was targeted at the first exon/intron boundary. 
Müller had previously shown using translation blocking MO reduction in 
dorsal and ventral iridophores. We observed the same using both our splice 
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block MO and our translation block MO. Müller had also shown that reduction 
in dorsal iridophores and ventral iridophores was equivalent (Müller, 2007). 
Therefore we only counted dorsal stripe iridophores in subsequent 
experiments. 
Using PCR on mRNA from injected embryos we confirmed the 
efficiency of id2a splice MO; splice morphants had an extra band when using 
id2a specific primers. This band had the correct size for a mispliced mRNA, 
the mismatch controls had only the normal sized band, the mispliced band 
needs to be confirmed by sequencing in the future.  
We injected id2a splice MO at two different concentrations (4.6 and 9.2 
ng) and found that at both concentrations mortality was low as were 
phenotypical defects. At both concentrations iridophores were reduced in 
both DS and VS, eyes and yolk sac. The injection of our translation block MO 
also showed reduction in iridophores. This data confirms that of Müller (2007) 
but our mismatch control gave no reduction in the number of iridophores, 
thus validating her knockdown data and provided convincing data of a role for 
id2a in iridophore development. 
Also Müller reported that embryos injected with MO had heart oedemas 
and a shorter axis, using our splice MO we did not get these phenotypes, this 
might be accounted by the considerably smaller amounts of MO required, 9.2 
ng compared to 46 ng used by Müller. Our morphants also had smaller eyes 
and a smaller head at 9.2 ng but not at 4.6 ng. 
 
ID2A AND THE CHROMATOBLAST 
To confirm if reduction of iridophores was due to defects in 
differentiation or to lack of iridophore precursors we also did an in situ in id2a 
MO for two iridophore markers, ltk a marker for iridophore precursors but also 
differentiated iridophores (Lopes et al., 2008), and cb632 a differentiation 
marker (Muller, 2007). At both 30 and 35 hpf we show reduction in the 
number of ltk positive cells, confirming Müller (2007) data at 30 hpf. Further 
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we show a reduction in cb632 positive cells by 48 hpf. This suggests that 
cells that are to become iridophores are lost before reflective platelets can be 
observed or do not differentiate. The reduction of ltk expression at early 
stages strongly argues that reduction of cb632 at 48 hpf is not due to poorly 
differentiation but lack of the cells, since ltk is expressed earlier than cb632, 
and is a iridoblast marker. We tested the converse, how was id2a expressed 
in ltk mutants. Observation of mutants at 18 hpf showed no difference in 
expression pattern when compared to WT embryos. By 24 hpf id2a 
expression was reduced in ltk mutants with fewer cells on the medial 
migration pathway expression in dorsal and ventral stripe iridophores and 
was absent in ltkty82 mutants at 48 hpf and 72 hpf confirming data from Müller 
(2007). In ltkty82 mutants a dramatic reduction of ltk positive cells in the trunk 
occurs around 20 hpf (Lopes et al., 2008). This suggests that id2a like ltk is 
also expressed in iridoblasts but the fact that reduction of id2a is not as 
dramatic as ltk, in ltkty82 mutants, strongly that id2a is expressed in an extra 
subset of cells. 
Following the chromatoblast hypothesis where all pigment cells share a 
common precursors we questioned whether this extra subset of cells could 
be the other pigment precursors. Müller (2007) had previously shown that at 
4 dpf there was no difference in the number of melanophores in id2a MO 
injected embryos when compared to water injected controls. We confirmed 
this by counting DS melanophores at 5 dpf and observed no difference in 
number, but in siblings stained for dct expression there was a reduction on 
the number of positive cells by 30 hpf, when compared to mismatch 
morphants. In ltkty82 mutants there is no change in the number of dct positive 
cells at 30 hpf. This strongly argues in favour of the idea that id2a is also 
expressed in a melanoblast precursor. 
Dct is a marker for differentiating melanophores (Kelsh et al., 2000) it 
would therefore be expected that reduced levels of dct positive cells reflected 
reduced numbers of melanophores. We hypothesise that directly or indirectly 
id2a is regulating the number of dct positive cells. Mitfa is a bHLH protein that 
has been shown to be crucial in melanoblast and melanophore development 
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(Elworthy et al., 2003) and is known to regulate dct expression 
(Steingrimsson et al., 2004) it would then be possible that id2a binds mitfa or 
its E-protein partner, thus preventing its function in 
melanoblasts/melanophores. Thus id2a could be responsible for maintaining 
proliferation or prevent premature differentiation of melanophores. The final 
number of melanophores is probably regulated by an independent 
mechanism thus the lack of difference in number of melanophores at 5 dpf. 
We also assessed id2a morphants for a xanthophore phenotype, the 
third pigment cell type in zebrafish. We observed a reduction in the number 
of xdh positive cells. It is interesting to note that even though the number of 
dct positive cells is reduced, the number of melanophores is not. It would in 
future be interesting to know if xanthophores, like melanophores, but contrary 
to iridophores, recover in number. 
Reduction of all pigment cells strongly argues towards a function of id2a 
in chromatoblasts lineage, supporting the chromatoblast model (Bagnara et 
al., 1979; Kelsh, 2006; Lopes et al., 2008). This model suggests that all 
pigment cells have a common multipotent precursor. This precursor as the 
capacity to originate all pigment cells and expresses several genes later 
restricted to only one of the lineages such as pax3, sox10, ltk, mitfa (M. 
Nikaido and R.N. Kensh, unpublished). We propose a model where id2a is 
important for maintenance of the chromatoblasts lineage probably by 
maintaining an undifferentiated state or promoting proliferation and upon 
reduction in numbers the iridophore lineage is the most affected. Also id2a is 
expressed later in iridophores which might explain why this population is 
more affected. Counts of reduced pigment cell types should nevertheless be 
repeated before fully confirming this model, particularly in xanthophores as 
these were only counted once. 
Together with the reduction in number of all pigment cells and the 
reduction of id2a+ in NC migration pathway in sox10 mutants, we suggest 
that the reduction in migratory streaks correlates with the loss of pigment 
precursors. 
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Several other bHLHs have been described in the NC, these include 
neurogenin1 and neurogenin2 (Ma et al., 1999), mitfa (Elworthy et al., 2003) 
and NeuroD (Andermann et al., 2002), it would thus be interesting to know if 
these could be the id2a partner in NC development. 
 
ID2A, ID3 AND IRIDOPHORES 
Following reduction of id2a in ltk mutants we decided to test how 
chemical inhibition of ltk signalling affected id2a expression. Inhibition of Ltk 
using TAE684 showed a correlation between the reduction of iridophores and 
iridophore clusters and id2a expression, suggesting id2a is expressed in all 
iridophores. Considering that id2a is expressed in a wider range of NCCs 
than ltk (see considerations above) and considering id2a expression pattern 
in ltk mutant we propose a different model to that of Müller (2007). Müller 
suggests dependence of id2a on ltk, we suggest that reduction of id2a in ltk 
mutants in not a direct consequence on regulation of id2a levels but rather 
that id2a reduction reflects only the loss of iridophores. So we suggest that 
id2a regulates ltk expression by driving the chromatoblast towards an 
iridophore fate. 
Following striking effects of id2a MO in pigment cells in particular 
iridophores and previous reports that id3 was expressed in NC (Dickmeis et 
al., 2002) we decided to look at id3 expression in iridophores. Our analysis of 
id3 expression pattern showed that id3 is only expressed in dorsal trunk by 
24 hpf and dorsal trunk and tail by 28 hpf, by 48 and 72 hpf expression was 
restricted to dots on the dorsal stripe, a pattern reminiscent of that of ltk or 
id2, suggesting that id3 is expressed in iridoblasts and latter on in 
iridophores. Curiously no expression was seen in either migrating NCCs or 
any of the other iridophore stripes. Expression of id3 in trunk crest is 
consistent with that reported by Dickmeis et al. (2002) in zebrafish, but 
contrary to Dickmeis we found no id3 expression in any other tissues. This 
was surprising, maybe our probe was not as sensitive as that used by 
Dickmeis et al. 
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In Xenopus over expression of Id3 leads to early production of 
melanophores from dorsal neural tube on the injected side and these then 
migrate bilaterally (Kee and Bronner-Fraser, 2005). It is then possible that in 
melanophores, zebrafish id2a has the same function of that Id3 in Xenopus. 
To assess this onset of melanogenesis in id2a morphants should be fully 
determined. In chick id2a was not reported to be expressed in trunk NC 
(Martinsen and Bronner-Fraser, 1998). We propose a model that in zebrafish 
id2 replaces id3 function, thus explaining why the broad expression in trunk 
when comparing to chick (Martinsen and Bronner-Fraser, 1998). 
 
ID2 AND OTHER CREST DERIVATIVES 
Following findings of defects in several NC derivatives in id2a 
morphants we questioned whether this was due to a disruption in the pool of 
NC precursors. We performed in situ at 22 hpf for foxD3, a premigratory crest 
marker (Lister et al., 2006), in id2a morphants. When compared with 
mismatch controls we found no difference in foxD3 expression, we therefore 
concluded that premigratory neural crest is not affected by id2a KD. 
Nevertheless other early neural crest markers such as crestin (Luo et al., 
2001), sox10 (Dutton et al., 2001b) and snail (Thisse et al., 1993) should be 
assessed and at extra stages, particularly earlier stages. 
 
Further to expression in trunk NC and iridophores id2a was also broadly 
expressed in cranial crest, branchial arches and in the jaw at later stages. 
We therefore performed staining for head cartilage in 5 dpf id2a morphants. 
When compared to mismatch morphants that had a normal morphology of 
the head structures, id2a morphants had a smaller head and several 
cartilage defects including entire depletion or reduction in size of the 
ceratohyal, occipitals ceratobranchials arches, otic capsule and ethymoid 
plate. Meckel’s cartilage and palatoquadrate are less reduced and otolith 
looks normal. This phenotype differs from that of sox10 mutants (Carney et 
al., 2006; Dutton et al., 2001b), like id2a, sox10 is also expressed in the facial 
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cartilage but sox10 mutants have no defects in this population (Britsch et al., 
2001; Dutton et al., 2001b; Kelsh and Eisen, 2000). 
Kee and Bronner-Fraser (2005) have shown that in Xenopus id3 KD 
leads to loss or reduction of head structures in the injected side of the 
embryo. These structures include Meckel’s cartilage, ceratohyal, basihyal 
and branchial arches this strongly correlates with our defects in id2a 
morphants. In Xenopus id3 is localized at the neural plate border during 
gastrulation and neurulation, overlapping the domain of neural crest 
induction. KD of id3 results in the absence of neural crest precursors and 
consequent loss of neural crest derivatives. This loss seems to be mediated 
by inhibition of the cell cycle followed by cell death of the NC progenitor pool, 
rather than fate switch. Overexpression of Id3 increased cell proliferation and 
resulted in expansion of the NC domain (Kee and Bronner-Fraser, 2005). 
Authors suggest that Id3 function in regulating cell cycle progression and 
survival of neural crest progenitors.  
We found no id3 expression in cranial crest, this contrary to early 
studies by Dickmeis et al. (2002), it is possible that our probe was not as 
sensitive. Considering our defects in cranial structures on id2a morphants, so 
we propose that in zebrafish id2a might have homologous functions (at least 
partially) to those of Id3 in Xenopus cranial crest (Kee and Bronner-Fraser, 
2005). We do not discard the possibility that if id3 is in fact expressed in 
cranial crest these might have redundant or partially redundant functions in 
zebrafish cranial neural crest, particularly as we found no changes in early 
NC domain of id2a morphants. We propose that loss/reduction of cartilages 
is a consequence of early disruption of the cranial neural crest pool, like that 
seen for Id3 in Xenopus. 
 
IDs have been implicated in cell cycle progression and apoptosis, in 
particular Id2. Studies of Id2 in chick and mammals have shown that Id2 is 
involved in inhibition of the Rb pathway thus bypassing the RB cell cycle 
block (Iavarone et al., 1994; Lasorella et al., 2002; Lasorella et al., 2000). 
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Other studies have shown that in mammals IDs regulate cell cycle 
progression in neural precursors and ablation of IDs leads to premature cell-
cycle withdrawal of neuroblasts and premature differentiation (Lyden et al., 
1999). Also combinatorial mutations of Id1 and Id3 or Id4 lead to a small 
brain phenotype in mice (Jung et al., 2010). These studies correlate with our 
small brain phenotype in id2a morphants. Further experiments to assess id2a 
KD effect on brain development should be performed, namely to determine if 
there was a premature differentiation. 
To determine if id2a could have the same effects in cell cycle 
progression in zebrafish we performed cell cycle analysis of 30 hpf id2a 
morphants, using Propidium Iodide staining. This showed no difference in the 
stages of cell cycle when compared to controls. This analysis was done in 
whole embryos so it is possible that whatever effect id2a might have in 
zebrafish NC was diluted by assessing the whole embryo. Considering id2a 
expression in NC starts from at least 16 hpf it might also be possible that 30 
hpf was not the appropriate time point to assess cell cycle. In the future cell 
cycle analysis should be performed at other time points using the same 
method, in particular early time points as these are more likely to be affected. 
 
We tried to assess cell cycle stages in NC alone by injecting -
4725sox10:egfp embryos with id2a splice MO. Unfortunately no GFP signal 
was detectable on FACS machine once embryos were processed for PI 
staining. We analysed the number of GFP positive cells at 30 hpf in id2a 
morphants and found no difference when compared with controls, suggesting 
that the total number of NC cells was not affected by this point. Once again 
other time points should be analysed.  
In order to overexpress id2a in NC we cloned id2a coding sequence 
downstream of sox10 promoter. This construct also expressed GFP under 
the same promoter. Injected fish showed GFP expression at 24 hpf, in NC 
locations. The location of this expression was consistent with that of other 
transient fish injected with same promoter (Carney, 2003). We assessed 
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injected embryos for number of iridophores and clusters, but we found no 
difference. This could either implicate that id2a levels are being controlled by 
some other mechanism or that construct cannot express id2a at the correct 
time point or for the required duration. At the time of submission of this thesis 
we have not assessed id2a overexpressing embryos to check for effects on 
brain, head cartilage or other pigment cell types. 
 
On our quest for an id2a TILLING mutant, we had no positive results up 
to the date of completion of this thesis. The discovery of a mutant would be of 
extreme usefulness to the study of id2a function in NC. In id2a KD due to the 
fact that the morpholino is diluted in the whole organism and that distribution 
of morpholino during cell division might not be homogeneous has the 
potential to dilute some of the effects id2a might have. Schilling et al. (1996) 
describe a series of zebrafish mutants with craniofacial cartilage defects. 
Several of these mutants also present smaller eyes and pigment defects. 
Unfortunately none of these mutants seems to have defects in only cartilage, 
eyes and iridophores (since this is the most affected pigment cell in id2a 
morphants), suggesting none of them to be an id2a mutant. Nevertheless it is 
possible that because these are mutants rather than morpholinos that their 
developmental defects are more preeminent, and could therefore be potential 
id2a mutants. 
 
Concluding we propose a model where id2a has three distinct functions 
in NC: i) is responsible for maintenance or proliferation of a cranial cartilage 
precursor; ii) is responsible for maintenance and/or proliferation of a 
chromatoblast precursor expressing pax3, sox10 and mitfa; iii) and later on is 
responsible for driving specification of iridophores possibly through regulation 
of ltk. 
 
FUTURE WORK 
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Following our hypothesis that id2a in zebrafish replaces the function of 
id3 (see considerations above), and that id3 overexpression in Xenopus (Kee 
and Bronner-Fraser, 2005) has been shown to lead to early differentiation of 
melanophores, we should in future determine the onset of melanogenesis in 
id2a morphants. 
In the future it would be interesting to determine id2a expression in 
early stages of ltk inhibited embryos to determine whether id2a reduction in 
ltk inhibited embryos is due to lack of iridophores or a consequence of 
downstream signalling. Inhibition of ltk in short time windows in early stages 
followed by in situ hybridization for id2a would tell us if id2a is downstream of 
ltk, as cell would still be present, so lack of id2a would imply direct regulation. 
Alternatively, following increasing numbers of iridophores upon ltk 
overexpression, it would help to determine if constitutive ltk signalling 
increases numbers of id2a positive cells, by injecting -4725sox10:NPM-
LTK:IRES:egfp. This would allow us to see if id2a expression is a 
consequence of Ltk signalling, or if it is upstream of ltk. If id2a is responsible 
for regulating ltk expression we assume that overexpression of Ltk would 
have no effect on id2a levels, the converse is true, if ltk is responsible at least 
in part for id2a regulation we could expect increase in id2a expression. Still 
regarding the regulation of Ltk and Id2a in iridophores it would be interesting 
to know if injection of -4725sox10:id2a:IRES:egfp into ltk inhibited embryos or 
ltkty82 mutants could rescue the iridophore phenotype, this would allow us to 
see if id2a could drive iridophore development independent of ltk. 
Alternatively, injection of id2a mRNA like that done by Uribe et al. (2010) 
When compared with mismatch controls we found no difference in 
foxD3 expression, we therefore concluded that premigratory neural crest is 
not affected by id2a. Nevertheless other early neural crest markers such as 
crestin (Luo et al., 2001), sox10 (Dutton et al., 2001b) and snail (Thisse et al., 
1993) should be assessed and at extra stages, particularly earlier stages. 
In the future cell cycle analysis should be performed at other time points 
using the same method, in particular early time points as these are more 
likely to be affected. As an alternative, since we could not analyse cell cycle 
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in NCC using FACS sorting, maybe staining embryos for PH3-antibody for 
cell proliferation in -4725sox10:egfp embryos or -4725sox10:cre embryos. 
Since studies in sox10 mutants have show that NCCs die but only in a small 
time window between 35 and 45 hpf, after failing to become specified 
(Carney et al., 2006), it would therefore be interesting do test id2a morphants 
for number of NCCs at these time points and also to check for elevated cell 
death using TUNEL at the same stages. 
To confirm if id2a is only important in cranial cartilage and 
chromatoblast, it would be needed to assess if other non-ectomesenchymal 
derivatives are affected such as: number of Schwann cells of the DRGs, 
enteric neurons, sensory neurons and glia. This could be done by assessing 
the morpholino phenotype is several transgenic reporter lines. Using the -
4725sox10:gfp line it would be possible to distinguish glia phenotypes by 48 
hpf, as these cells retain GFP expression. Alternatively, the Tg(-
8.4ngn1:nRFP) line would allow us to screen for potential sensory neurons 
phenotypes. Use of our cre line would also help dissect these functions as 
this would label all NC derivatives, thus making search for phenotype easier. 
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VII.3 CULTURING ZEBRAFISH NCC 
We proposed to develop Neural Crest primary cell culture in zebrafish 
iridophores. This would be used as an in vitro approach to study Ltk function 
in zebrafish. We have tried to establish optimal conditions for the culture of 
zebrafish NCCs. The best culture conditions should allow us to obtain the 
widest range of NC derivatives, specifically iridophores, and allow the 
maintenance and proliferation of these. We have explored the following 
aspects: i) culture media and supplements, ii) source of NCCs and iii) fates 
obtained. Although the conditions are not yet fully optimized they have 
allowed growth and differentiation of zebrafish NC cells, including 
iridophores. 
 
CULTURE CONDITIONS, MEDIA AND SUPPLEMENTS 
Before being able to start our study of NC in vitro it was necessary to 
optimise the medium composition and cell attachments substrate. Culture 
medium composition is of high importance since it is going to provide 
nutritional support for the cells and is also a source of growth and 
differentiation signals, it is therefore crucial to have a medium that provides 
the correct signals and support for each species and population of cells. We 
therefore tested several medium compositions, including different basal 
media such as F12, L15 and DMEM, and several supplements such as N2 
neuronal supplement, bFGF and ET3. After testing several combinations of 
media we concluded that F12+Glutamax with 15 mM HEPES, 10 % FBS, 1 
% P/S, 0.2 % gentamicin, 0.5 % Fungizone, 100nM of ET3 and 1.7 mM of 
CaCl2, was the composition that allowed attachment and survival of a greater 
number of NCCs, plus allowed differentiation of several NC derivatives such 
as glial cells, melanophores and iridophores. 
Of the changes in medium composition addition of ET3 and change of 
osmolarity by addition of CaCl2 were the ones that showed the greatest 
improvement. It has been shown that treatment of NCCs with ET3 increases 
NCC proliferation (Lahav, 1998). In our case the introduction of ET3 has 
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indeed increased the number of NCCs (GFP+ cells), and was therefore used 
in subsequent tests. 
Osmolarity is an important factor for survival of cells. This can be 
influenced by several factors such as free ions, sugars and other molecules. 
In the Zebrafish Book (Westerfield, 2000) it is recommended that the addition 
of CaCl2 to 2 mM when culturing zebrafish cells. Therefore we tested adding 
CaCl2 to our cultures. This provided us with a major breakthrough with our 
system. After addition of CaCl2 to the F12 medium cells started growing 
better and for longer and we also obtained differentiating iridophores. So we 
believe that the addition of CaCl2 to the medium with the consequent change 
in the osmolarity was the pivotal factor in improvement of the culture and for 
production of iridophores. Nonetheless this could also be due to other effects 
the Ca2+ ion might have in cell signalling. 
Posterior to this M. Sieber-Blom suggested reducing osmolarity by a 
tenth (personal communication). We therefore tested the osmolarity of the 
medium and reduced the osmolarity to half to see whether this improved the 
growth and attachment. Our F12 medium had an osmolarity of 320 mOsm 
whereas reduced media osmolarity ranged from 170 to 181 mOsm. 
Reduction in osmolarity had a detrimental effect on the attachment and 
growth of cells. This effect could have been due to other factors such as the 
reduction in the concentration of nutrients existent in F12 medium as for 
reduction of the osmolarity this had to be diluted. 
One of the major problems encountered was the recurrent 
contamination of the cultures. The introduction of an ethanol washing step, 
the handling of the embryos in sterile conditions and supplementation of the 
medium with antibiotics have considerably reduced the contaminations, 
although some still occur. Therefore in future we shall try to improve the 
asepsis technique and/or change antibiotics. One possible approach to solve 
this is introducing a step of washing with 0.5 % bleach for 2 min, as used by 
Pando et al. (2001). We believe that most contaminations were carried by the 
eggs and were originated from the fish tanks rather than the handling, since 
sterilization of the embryos was the most important step to reduce these. 
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Sadaghiani and Vielking (1990) described a method for NCC culture in 
three fish species other than zebrafish. Although these authors describe 
some NC derivatives including melanophores they were not always able to 
generate pigment cells and they do not report the differentiation of 
iridophores, as is our case. We can therefore suppose that our culture 
conditions might be more suitable at least to pigment development. 
There are not many reports of zebrafish cell cultures and most of them 
relate to culturing zebrafish embryonic stem cells (Fan et al., 2004a; Fan et 
al., 2004b; Ma et al., 2001; Xing et al., 2008). Ma et al. (2001) reported a in 
vitro system for culturing zebrafish germ cells. This was done in the presence 
of a rainbow trout cell line, but authors note that this is just a short-term 
culture. Nevertheless they used very different conditions: 50 % L15, 35 % 
DME and 5 % F12 media, supplemented with 50 ng/ml bovine bFGF, 50 
ng/ml of murine epidermal growth factor, 10 µg/ml of bovine insulin, 10 nM 
sodium selenite, 50 µg protein/ml of trout embryo extract, 0.4 % trout serum 
and 5 % FBS (Ma et al., 2001). Fan et al. (2004a) also used the same 
combination of L15/DME/F12 medium and a similar combination of 
supplements: 50 ng/ml human epidermal growth factor, 50 ng/mL human 
bFGF, 10 µg/mL bovine insulin, 50 µg/mL trout embryo extract, 1% trout 
serum, and 5% FBS. In the future it would therefore be interesting to test 
some of the supplements as well as the combination of L15/DME/F12. 
 
NCCS SOURCE AND SINGLE CULTURES 
Apart from determining optimum conditions for survival and growth of 
zebrafish NC cells it was also important to determine how to obtain these 
cells. 
The choice of NCCs source is of high importance, since the cells have 
to be viable and the culture enriched in NCCs (GFP+) rather than other 
populations. We proposed to refine two distinct methods for NC isolation: 
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culture of isolated NT and NCC isolation with FACS. Both methods have their 
advantages and disadvantages. The NT isolation provides an easy system 
for obtaining viable NC cells (Le Douarin, 2004). We have successfully been 
able to apply this technique of dissecting NT to zebrafish. In our case we 
could see NCCs migrating away from the NT. NCC identity was confirmed by 
the fact that they were GFP+ when using -4725sox10:gfp transgenic line, 
GFP- cells were considered non-NC. This resulted in a mix population of cells 
and also a low number of cells. Further, considering that we were using -
4725sox10:gfp embryos and in this line GFP expression is only transient 
(Dutton et al., 2008), we were unable to further distinguish them from the 
surrounding cells. In any case we believe we were able to refine the NT 
dissection technique for zebrafish as this had never been done before, and 
we shown that we can grow NC cells out of the dissected NTs. 
The FACS sorting looked like a better approach for obtaining a pure 
population of cells and in higher numbers but it is also very harsh on the cells 
reducing their viability. In other NC studies p75 surface marker was used in 
FACS sorting to isolate NC cells (Morrison et al., 1999; Stemple and 
Anderson, 1992). This allows the collection of a NC enriched cell suspension. 
In our case we took advantage of the -4725sox10:gfp line and selected for 
GFP+ NC cells. Previously in our group T. Chipperfield (2009) had used this 
line to isolate NC cells for RNA extraction. The FACS sorting is dependent on 
the cell dissociation protocol. Initially we used a dissociation protocol used by 
T. Chipperfield (2009) for isolation of cells for RNA extraction. Modifying 
some conditions such as reducing centrifugation speed, time and 
temperature of trypsinization (see II.9.5) resulted in an increased number of 
live GFP+ cells, and so were used then onwards. The actual FACS sorting 
protocol was also changed with a reduction in the sorting speed. Although we 
have changed both protocols and obtained GFP+ cells in one occasion, we 
were unable to reproduce this to date, mostly due to problems with the FACS 
sorting machine. 
Although FACS sorting has not worked so far, other approaches are 
possible. An alternative to FACS sorting consists of using cell specific 
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surface antibodies that are then traped by the use of magnetic beads into a 
column. This allows the positive separation of cells bearing the cell 
population-specific surface antibody that can then be harvested and cultured. 
This method is less harsh on the cells and therefore yields a higher number 
of live cells. The downfall is that it is necessary to have an antibody for a 
membrane bound protein and at the same time specific for our population. 
Although p75 has these properties and has shown to be specific for NC stem 
cells in mouse and chicken (Hari et al., 2002; Morrison et al., 1999; Stemple 
and Anderson, 1992) this is not the case in zebrafish (data not shown). 
Unfortunately in zebrafish NCC there are no known surface markers, but 
once those become available they would be extremely useful for our culture 
experiments. 
It is important to notice that the culture conditions used at the time of 
development of FACS sorting and NT dissections were not ideal for NC 
development as these were done previous to addition of CaCl2, so now that 
the culture medium seems to be more suitable for NC development it would 
be interesting to repeat both tests. 
 
Ideally we wished to develop single cell NC culture, to allow clonal 
analysis of single cells this would be important to test the progressive fate 
restriction model (Kelsh, 2006) like previously done in chick NCC cultures 
(Real et al., 2006). Plus for analysis of mutant phenotype in vivo its important 
to be able to grow NCCs derived from a single embryo. With initial attempts 
of growing a single GFP+ embryo amidst WT embryos and growing them in 
culture together we were able to observe GFP+ cells after one day. This 
contrasts with our inability to grow a single embryo alone in culture, this fact 
is possibly because the existence of more cells in the culture dish not only 
increased the cell density but also provided nutrients and growth factors 
required for cell growth and survival. Unfortunately it is impossible to 
determine if this single embryo can give rise to any derivatives without 
sustained GFP expression. 
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Culturing a single GFP+ embryo amidst several other embryos would 
allow us to distinguish and study the cells that are derived from that one 
embryo alone. The ability to study the NC from a single embryo in vitro would 
be particularly useful. It would allow us amongst other things to determine 
whether the phenotype observed in a mutant was cell autonomous or non-
cell autonomous, by growing on GFP+ mutant embryo amidst WT embryos. 
In our experiment we tested a dilution of 1/50 (one gfp+ embryo and 49 WT 
embryos), in future it would be interesting to test smaller dilutions, i.e. one 
gfp+ embryo with less WT embryos. 
Instead of using -4725sox10:gfp embryos we could in the future use -
4725sox10:cre embryos (as described in this thesis), this would be a 
permanent labelling and would not only allow us determine which derivatives 
are formed by each embryo but also to follow individual cells. As an 
alternative to obtain a purified NC cell culture we could use a Cre responsive 
cell line containing an antibiotic resistance gene. This would allow us to 
positively select NCCs by killing the non-NCC. 
 
In the study of neural cells researchers also use an alternative method 
for cell culture called neurospheres (Rauch et al., 2006). We have shown that 
at least very crude way our culture conditions allow the growth of suspended 
cell cultures. In these NC cells could be distinguished and were increasing in 
number. Therefore maybe we could use a suspended cell culture to grow NC 
cells instead of an attached culture. 
 
NCC FATES 
One of the objectives of optimisation of zebrafish NCC culture was to 
determine conditions that allowed differentiation of a wide range of NC 
derivatives and promoted proliferation and survival of these. We have 
established a protocol for primary NC cell cultures from zebrafish embryos 
that allows survival of NC cells for 6 days and have to date obtained putative 
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myofibroblasts, neurons, melanophores, Schwann cell-like cell-types and 
iridophores. 
One possible problem is proving that differentiated cells are in fact NC 
derived, for that the optimisation of either FACS sorting or sorting using 
magnetic beads would be of great advantage. This could be achieved with 
the use of either double immunostaining, or a combination of immunostaining 
and in situ hybridization, if NC markers and markers for different derivatives 
co-localize in the same cell, this would prove sufficient to confirm their NC 
origin. Once again use of a permanent labelling of the NCCs or use of a 
selection marker would solve this problem (see VII.1). 
 
FURTHER WORK 
It is important to notice that the culture conditions tested in most of the 
cases were not ideal for NC development. It was only later in the 
development of this system we were able to get a medium composition (after 
addition of CaCl2) that allowed us to have an increased number of zebrafish 
cells, compared to the other medium tested. These were proliferating having 
reached confluence at 6 days. These conditions seemed to be more suitable 
for NC development. Therefore experiments such as FACS sorting and NT 
should also be repeated using the new medium composition. Also 
experiments to repeat include supplementation with N-2 neuronal 
supplement and all-trans retinoic acid. In addition a combination of different 
protective agents such as BSA and/or serum should be tested in FACS 
sorting. 
Considering change in osmolarity of the medium was crucial for the 
development of our cultures, further optimization of the osmolarity of the 
medium might be required for better culture conditions. In particular it could 
be useful to increase osmolarity even more, rather than reducing, as for 
example fresh water salmon blood osmolarities range from 300 mOsm in the 
adult and 360 - 370 mOsm in chum (Finn and Kapoor, 2008). Since zebrafish 
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is a fresh water fish maybe these values are more closely related to the 
physiological values of zebrafish cells. 
 
One important objective that we have achieved was the differentiation 
of iridophores. On the matter of iridophore number we shall repeat the 
supplementation of the medium with guanosine and determine if there is an 
increase in iridophore number as described by Frost et al. in axolotls (1987). 
Although we have tried supplementation of the medium with guanosine, this 
was when the medium conditions were still unfavourable, and there was no 
production of iridophores either way. It has also been described in Xenopus 
NCC cultures that in the presence of guanosine some melanophores formed 
reflecting platelets characteristic of iridophores (Hiroyuki, 1978), this could be 
a case of transdifferentiation of pigment cells. It would thus be interesting to 
see if the same occurs in our cultures, this is, if reflecting platelets and dark 
pigments co-localize in the same cell. 
Using the new culture conditions we shall also confirm the derivatives 
already attained and start assessing other NC fates, makers to address these 
questions shall include dct and mitf (melanophores), pax7 (xanthoblasts), ltk 
(iridophores), neurogenin (sensory neurons) and TH (sympathetic neurons). 
We would also try to determine at which time point each NC derivative 
observed starts to differentiate in culture. 
 
In future we should proceed to the main goal of this project, which is to 
determine if Midkine could be a bona fide ligand for Ltk. Midkine has been 
strongly implicated a possible Ltk ligand (J. Mueller and C. WInkler lab 
unpublished results). This should be tested by evaluating quantitatively the 
effects of supplementing the culture medium with varying concentrations of 
Midkine. This should be done using the optimised culture conditions and a 
single sox10:cre line embryo, for permanent labelling and identification of 
individual clones. It would be expected an increase in the number of clones 
with iridophores or a higher number of iridophores per clone depending 
 274 
whether ltk it is involved in specification or proliferation, respectively, or both. 
Tests on NCC cultures from shady/ltk mutants will also allow us to test 
whether Midkine acts via the Ltk receptor or via an alternative pathway.  
It has described that NCCs, as they age, lose their sensitivity to 
instructive differentiation signals, and that addition of soluble Jagged1 to 
culture medium reduces lateral inhibition and maintains cells in a more 
proliferative state (Nikopoulos et al., 2007). It would therefore be rather 
interesting to add Jagged1 to our cultures as it might both increase the 
number of cells in culture and the responsiveness to Midkine. 
 
In whole disaggregated embryos it would be interesting to know if the 
development of cells in vitro follows the same order and time-course as those 
in vivo, for that a detailed time course of the cultures should be performed, as 
well as using PCR for gene expression of markers such as: sox10, 
neurogenin1, ltk, mitf, dct, id2a, xdh and neuroD. 
 
One of the potentialities of NC cell culture would be to use it to 
determine the different phenotypes of several neural crest mutants. As an in 
vitro system would allow, in the future, testing not only differentiation but also 
proliferation and apoptosis. This could be done by determining the proportion 
of the different phenotypes by counting total number of NCCs (using the 
sox10:cre line) and the total of number of cells of each phenotype. 
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VII.4 A NEW TOOL FOR RTK INHIBITOR STUDIES 
We proposed to create a new tool to test RTK inhibitors in vivo. RTK 
are responsible for a variety of human diseases and are involved in 
oncogenesis and cancer progression (Lemmon and Schlessinger, 2010), 
they are therefore important targets for drug discovery (Lemmon and 
Schlessinger, 2010; Zwick et al., 2001). Currently the pharmaceutical 
industry spends thousands of US dollars in the development of new drugs, 
most of which are discarded during the validation period, with great 
economical and animal costs (Fleming, 2007; Peal et al., 2010). Zebrafish 
has the potential to reduce these costs. We have developed a new tool 
where embryos are injected with constitutively active tyrosine kinases and 
are then treated with inhibitors to revert its effects. 
 
TESTING RTK PATHWAY INHIBITORS. 
Firstly we tested bathing embryos in several commercially available 
RTK or RTK signalling inhibitors, to test if we could perform a chemical 
screening. These included: Herbimycin A, Streptomyces sp.; PDGFR 
Tyrosine Kinase Inhibitor IV; VEGFR inhibitors I and II; EGFR inhibitor; Met 
Kinase Inhibitor; STAT3 Inhibitor Peptide; Jak3 Inhibitor I and Jak3 Inhibitor 
II; VEGFR inhibitors I and II. 
When bathing embryos with EGFR inhibitor all embryos presented heart 
oedemas and lack of circulating blood. EGFR knockout mice have been 
reported to have defects in several organs such as skin, and gastrointestinal 
tract. It is reported that EGFR might be required amongst other things for 
epithelial development (Gschwind et al., 2004). Unfortunately we could not 
confirm the results of EGFR KO mice. This might be due to species 
difference. Nevertheless our results confirm previous experiments by Goishi 
et al. (2003) in zebrafish where authors reported that treatment of zebrafish 
embryos with an EGFR inhibitor resulted in cardiovascular defects, including 
impared blood flow via the outflow tract into the aorta and impeded circulation 
in the axial and intersegmental vessels and dilatation of heart chambers and 
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pericardial sacs. Authors also confirmed this data by morpholino experiments 
(Goishi et al., 2003). 
VEGFR have been implicated in development of embryonic vasculature 
and in regulating tumour angiogenesis. Knockout mice for both receptors 
show defects in organization of embryonic vasculature and development of 
haematopoietic and endothelial cells (Bayliss et al., 2006; Gschwind et al., 
2004). Previous experiments with VEGFR inhibitors in zebrafish have shown 
that these are able to prevent angiogenesis in fish (Chan et al., 2002). We 
could not confirm this data, this could be due to the use of different inhibitors, 
or to the fact that author assessed angiogenesis in more detail with the aid of 
a fluorescent transgenic line, whereas our assessment was done purely by 
observing existence of circulating blood cells. 
When testing inhibitors for the JAK/STAT pathway we found that 
embryos treated with STAT3 inhibitor and JAK3 inhibitors I and II were 
generally normal. When both JAK3 inhibitors were added at the same time 
with half of the concentrations, most embryos presented several 
developmental defects such as small head and eyes, absent or small jaw and 
a curved and shorter axis, as well as reduced numbers of melanophores. 
Interestingly the phenotype of both inhibitors together shows how useful 
zebrafish could be for drug screening, namely to test efficacy. JAK3 is a 
promiscuous effector of the RTK pathway (Han et al., 2006; Shi et al., 2006), 
therefore it would be expected to have several morphological defects as 
RTKs are involved in a multitude developmental processes (Lemmon and 
Schlessinger, 2010; Schlessinger, 2000).  
STAT3 is a transcription factor and also an effector of RTK signalling 
after activation of JAKs. Embryos treated with STAT3 inhibitor showed no 
defects. Considering its promiscuity in the RTK pathway we would expect 
some developmental defects (Han et al., 2006; Shi et al., 2006). The lack of 
such, might be accounted for by either too low a dose or most probably to a 
difference in structure between species.  The same justification might explain 
why we saw no defects in Herbimycin A and Met inhibitor treatments. 
Herbimycin A is a generic RTK inhibitor. Neither Herbimycin A nor Met 
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inhibitor showed developmental defects. In the case of Met inhibitor this is 
most probably due to precipitation of the inhibitor. Met is involved in the 
development of hypaxial muscle, lateral line (Haines et al., 2004), and 
motoneurons (Tallafuss and Eisen, 2008); we saw no effects in muscle 
development, but we did not assess the later two for any defects. 
PDGFR inhibitor was the one that gave us the most severe effects. 
PDGFR inhibition showed several morphological defects including reduced 
head, eyes and ear, bent axis, heart oedemas and most prominently 
epidermis looking very deformed. Pigment cells were also affected, 
particularly melanophores looked compact and with impaired migration. 
PDGF signalling is required during gastrulation, and is also spatially 
restricted in premigratory neural crest cells, the placodes, somites and 
tailbud. PDGF signalling has also been involved in skin, CNS and skeleton 
development (Andrae et al., 2008; Ataliotis et al., 1995; Liu et al., 2002b; 
Nagel et al., 2004). Knockout mice have defects in NCC development, somite 
patterning, kidney development and haematological disorders (Gschwind et 
al., 2004). It is involved in vascular development and early haematopoiesis 
(Hellstrom et al., 1999; Liu et al., 2002a) and some work has already been 
done in zebrafish with the use of inhibitors to study vessel formation (Lee et 
al., 2002). PDGFR in zebrafish is structurally related to c-kit. C-kit is an RTK 
involved in melanophore development (Kelsh and Eisen, 2000; Parichy et al., 
1999), with mutants showing partial reduction in melanophore number 
(Cooper et al., 2009; Kelsh et al., 2000; Parichy et al., 1999). 
 
TAE684 A NOVEL LTK INHIBITOR 
When testing TAE684 against our injections of NPM-ALK we concluded 
that this compound was very efficient at inhibiting the extra and/or ectopic 
iridophores caused by the constitutively active kinase. This same result was 
observed when treating NPM-Ltk injected embryos with TAE684. Our results 
not only confirm the in vitro data for the TAE684 inhibition of NPM-ALK but 
also we used a similar concentration range (Galkin et al., 2007). Galkin et al. 
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report an IC50 values in cell culture between 2 and 10 nM whereas in our 
inhibition studies we have used 2 nM to 4 nM of TAE684. In addition to that 
previous reported by Galkin et al. (2007) we show here that TAE684 can also 
inhibit zebrafish Ltk as an off-target effect. We came to this conclusion since 
treatment with TAE684 in NPM-ALK injected embryos leads to a reduction in 
the number of iridophores. Lopes, et al, (2008) had previously shown that Ltk 
the most closely related RTK to ALK was crucial in iridophore development. 
We further confirmed this by inhibiting NPM-Ltk in vivo. 
Galkin et al. (2007) reported that TAE684 is highly specific for ALK 
when testing it against a panel of RTK. Ltk was not amongst the panel of 
RTK tested; nevertheless unpublished data by N.S. Gray indicates TAE684 
also inhibits human LTK (N. S. Gray, personal communication). This confirms 
our data for inhibition of Ltk by TAE684.  
When testing TAE684 against EML4-ALK lines, Koivunen et al. (2008) 
reported that inhibition of EML4-ALK with TAE684 did not lead to a reduction 
in STAT signalling, showing that EML4-ALK does not lead to STAT 
activation. Conversely Galkin et al. (2007) reported strong STAT inhibition in 
NPM-ALK lines treateted with TAE684. This interesting difference might 
explain why we could not get an effect when injecting EML4-ALK, if the 
pathway required for iridophore formation is STAT dependent. It would be 
interesting to test whether STAT signalling is required for Ltk signalling. 
NPM-ALK is expressed in nucleus, nucleolus and cytoplasm whereas EML4-
ALK is only expressed in the cytoplasm, this difference in subcellular 
localization might explain the lack of effect of injection of EML4-ALK. A way 
to test whether NPM-ALK is acting through the STAT3 pathways would be to 
generate a MO against STAT3 and see if we could get an iridophore 
phenotype; it should also be tested if it is possible to bypass the Ltk signalling 
by overexpressing a constitutively active STAT3 in NC. Alternatively injection 
of another fusion forms such as ATIC-ALK that has been show to produce 
high levels of phosphorilated STAT3 (Armstrong et al., 2004), could confirm 
these results. 
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ALK seems to work at least partially through the JAK/STAT pathway, it 
would have been interesting if inhibition of these had resulted in reduction of 
the number of iridophores, suggesting Ltk could work through the same 
pathway. 
 
DISSECTING EARLY AND LATE EFFECTS OF LTK IN IRIDOPHORE DEVELOPMENT 
When treating NPM-ALK injected embryos with TAE684, we noticed 
that not only the ectopic and/or extra iridophores caused by the constitutive 
kinases were inhibited, but also the endogenous iridophores. This suggested 
that TAE684 could also inhibit the closely related Ltk in zebrafish. This was 
later confirmed by inhibition of constitutive NPM-LTK by TAE684. We used 
this to our advantage and decided to study the effect of Ltk in iridophore 
development. 
We counted the number of individual spots of iridophores and number 
of clusters. We propose that ‘clusters’ are an agglomeration of several 
iridophores and propose that these reflect a proliferation of the iridophores. 
Here we show that when inhibiting Ltk at different time points it is indeed 
possible to distinguish functions of Ltk. The number of iridophores is more 
affected at early time points, whereas cluster number is affected by later 
treatment time windows. We also conclude that the 28 – 52 hpf period seems 
to be the most crucial to Ltk function in iridophore development has this had 
the lowest number of both iridophores and iridophore clusters. 
Previous experiments have shown that ltk is expressed early from 18 
hpf in a subset of premigratory NCCs. Ltk expression becomes progressively 
restricted to iridophore positions by 30 hpf where it is maintained up to 72 hpf 
(Lopes et al., 2008). Lopes et al. conclude that Ltk is responsible for 
iridophore specification from a multipotent NCC. Nevertheless the function of 
Ltk in the later stages of development remains unclear. Using our inhibitor 
experiments we confirm the early effect on iridophores specification by 
reduction of the numbers of iridophores in early time windows without greatly 
affecting the number of clusters. It is also possible that Ltk drives proliferation 
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of the early precursors as this would also affect the pool of iridophores and 
thus reduce the number of spots. In mammalian cell lines LTK has been 
show to activate IRS-1 and the Shc driving mitogenic signals driving 
proliferation (Ueno et al., 1995; Ueno et al., 1996). We propose based on the 
reduction of the number of clusters in the late time-window treatments that 
the late expression of Ltk in iridophores might be responsible for proliferation 
of these. 
 
Previous experiments have shown that evaluation of potential drugs can 
be fast and efficient in the zebrafish system (Chan et al., 2002). We confirm 
the use of zebrafish as a powerful tool for chemical screening and testing. 
Further we have shown that using zebrafish because it’s a whole organism, 
with its underlying complexity, allows us to look for off-target effects. This is a 
major advantage compared with in vitro systems that are normally composed 
of a single cell population with lower complexity. Nevertheless precaution 
should be taken when doing these studies, as like all models, there might be 
species-specific structural differences in the RTK that could affect the results. 
Zebrafish is a cheaper alternative to other animal models, ease of drug 
delivery, non-invasive method with the potential to obtain in vivo data at 
earlier stages of drug discovery reducing the number of licensed animals 
used, since we use embryos. We have developed a new in vivo assay for 
testing inhibitors for receptor tyrosine kinases. 
 
FUTURE WORK. 
In the future we should continue to develop this method, for example 
injection with different ALK fusion forms or injection of other constitutive 
RTKs. The range of inhibitors should also be broadened. 
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 APPENDICES 
APPENDIX 1 - MAP, FEATURES, RESTRICTION MAP AND SEQUENCE OF -
4725SOX10:CRE 
 Entire molecule length: 11499 bp 
 
 
  
-4725sox10:cre sequenced
11499 bp
Ampicillin
M13 reverse primer
M13 pUC rev primer
cre cyclization recombinase
sox10promoter end sequencing primer
-4725sox10
T3 promoter
AmpR promoter
f1 origin
cre 3' UTR
ApaI (8358)
EagI (8333)
HindIII (11110)
NcoI (3338)
NheI (3293)
Not I (8333)
Sca I (10131)
XbaI (8326)
BglI (9771)
BglI (11038)
EcoRI (6712)
EcoRI (11122)
NdeI (3698)
NdeI (7809)
Sac II (1207)
Sac II (8339)
SalI (8296)
SalI (11095)
SnaBI (7203)
SnaBI (7245)
SpeI (6688)
SpeI (8320)
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Feature Map 
 CDS (1 total) 
  Ampicillin 
   Start: 9577  End: 10437 (Complementary) 
   Original Location Description: 
      complement(9577..10437) 
 Misc. Feature (3 total) 
  cre cyclization recombinase 
   Start: 6728  End: 7759 
  M13 reverse primer 
   Start: 8412  End: 8430 (Complementary) 
   Original Location Description: 
      complement(8412..8430) 
  M13 pUC rev primer 
   Start: 8429  End: 8451 
   Original Location Description: 
      8429..8451 
 Primer Binding Site (1 total) 
  sox10promoter_end sequencing primer 
   Start: 6573  End: 6592 
 Promoter Eukaryotic (1 total) 
  -4725sox10 
   Start: 1     End: 6692 
   Original Location Description: 
      1..6692 
 Promoter Prokaryotic (2 total) 
  T3 promoter 
   Start: 8376  End: 8395 (Complementary) 
   Original Location Description: 
      complement(8376..8395) 
  AmpR promoter 
   Start: 10479  End: 10507 (Complementary) 
   Original Location Description: 
      complement(10479..10507) 
 Replication Origin (1 total) 
  f1 origin 
   Start: 10700  End: 11006 
   Original Location Description: 
      10700..11006 
 3' UTR (1 total) 
  cre 3' UTR 
   Start: 7760  End: 8289 
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Restriction/Methylation Map 
Enzyme # of cuts Positions 
AcuI 7 69 3423(c) 6945(c) 6952 8146 9306 10318(c)  
ApaI 1 8358  
ApoI 15 422 837 889 1012 2869 3755 3992 4656 4876 6639 6712 6755 
10595 10606 11122  
BamHI 4 1798 7084 8290 8314  
BglI 2 9771 11038  
BglII 3 4058 4774 6467  
BsaI 6 1391(c) 1432 1760(c) 4969(c) 9712(c) 11325(c)  
BsgI 4 1504 4326(c) 11177(c) 11369(c)  
BslI 25 952 953 1423 1762 2857 2888 2899 3136 4089 4136 6874 6881 
7267 7513 7709 8093 8606 8780 8798 8964 9243 10689 11015 
11098 11133  
BsmI 5 2276 2694 4280(c) 7917 7990  
BsrI 19 1125 2081(c) 3141(c) 4369 6551 7075 7390 8558(c) 9166 9179 
9291(c) 9697(c) 9815(c) 9858(c) 10127 10297(c) 10706(c) 
11092(c) 11234(c)  
ClaI 4 5838 6701 7535 11105  
EagI 1 8333  
EcoRI 2 6712 11122  
EcoRV 4 399 573 7280 11118  
HindIII 1 11110  
NcoI 1 3338  
NdeI 2 3698 7809  
NheI 1 3293  
NotI 1 8333  
PstI 7 124 2188 2686 3336 6722 8306 9379  
SacII 2 1207 8339  
SalI 2 8296 11095  
ScaI 1 10131  
SmaI 3 6080 6709 8310  
SnaBI 2 7203 7245  
SpeI 2 6688 8320  
XbaI 1 8326  
XmaI 3 6078 6707 8308  
 No cuts: SacI, SbfI, SciI, SfiI, XhoI 
 
  
 302 
Sequence 
     1 atcctataaa ctgcgcacaa cactaagcac cagcagtttt agtttgctga agcatcagtt tgtaacagaa 
taactcagcc tcctcatgat ctcctcttcg  
   101 ctgctcattc aggcaaaact gcagtttaaa agcgctgata aacaaaactc caactatggc acacacactc 
ccttgatcag agatgaattg atgaaattaa  
   201 ttatgttttt gtgtgcgtat ttctttatta aatcacgcag acgcgcgcag ttttatctct gcggtaatgc ggatcataat 
aaactcgtga ttaaaaaact  
   301 aattacactg tcgcacgaac atgcgcgcat taacaacgaa cacacgagtc atttcgataa atatacagct 
cagaaattac attaaacatt tataagatat  
   401 caaaaacggt caagagaaac gaatttattt atgtttttat aaagcgcatt tgcgagtcgc tcaaaaaact 
gtatagtatg aacataataa tgtttaaaaa  
   501 acacgaaata ctgatacaaa taatactgtt aataataaaa acattgttat ttgtattaaa tagcttgtgg 
atatccagaa ataatgcgta attctaaccg  
   601 acagatgatc taaaatcatt tcgtcagtct cttatttgat agactacaaa tgcataaaaa gtaaaacgcg 
ttttcgtatt tattaaattg gttttagttt  
   701 tttttaatta aattataata ttataataaa ataatcaatt gtatttttat tactgacatg cacgcataat 
aaacgcgcta tacaaatgcg catacacatt  
   801 acgcacctgc gcgtttgggt tatttccatt taaataaatt caactacaaa accccaaaac aaaaagttta 
aaaacatttt aatttctgaa tttaaaaaat  
   901 aaacaaaatc aatcatttaa aaattgtagg cagggttgta ttaacccaac gctgggtcaa atatggactc 
aaagtttttg catggcattt aaatatttaa  
  1001 tccgtctgct gaatttgtcc atatttgaca ataatacatc ccagctattt tagagcgcat ttctgatctc 
ttctttacca taaaaacgaa accccttgat  
  1101 aaagcagaat ggcattaaac tggaaattaa taataatgta aacaattaac taataacata tataaaacaa 
aacgatttac acaaatagcg caggacacat  
  1201 ttccgcggta taaaagaagc ctccctgttc tgacaggcga tgcgacacac ataacaaatc actcttctca 
agcagccaca ttaaataaca gaagaaacaa  
  1301 ttaacatgca cgcgcatact aaacagcaca cattaacaaa tgtccctcac tgacaaacac cccccagctt 
gatgtttatg tcctataaat gctcggagac  
  1401 cgagtgtcac tttctccaaa gcggggtctc ctccttccca aagcctccct aagagcaaca gggcaaaact 
cacatcaaag tgtgcagcag gcctcagatc  
  1501 cgcgcgcttt cccgtgtaca tccacagacc cgcgagaacc gagacatgtg tgcgtgtacg tttgaaggga 
caccgagaaa aagacgctct aaagagagac  
  1601 acacgtcttt tctcttttct tttctttttt tatatacaca gaactgcttt ttgttcctca ttttttcatt taagagggta 
atggaagggg ggtgttcgtt  
  1701 tgatcacatg attacaattc acctgagata aaacaaagga cgcaaagaaa ggagccgagc 
gccggagacc gagacagaga gatgctctca tggtcaggat  
  1801 ccccttatca gagtcaacat tcatggataa tgaaaaaggc aatgattttt ggcttgggtg ggggggccgt 
cgtgagatgg aaatacaaga ggttattgtt  
  1901 gaccagaaca gcgcgcgtgt ttgtgtgcgt ttggcccgtc gtttgcctct cttctcgtct ttctatattt 
tctactaaag ctgtttaaac gcgttaaatg  
  2001 cgctctctgt gtgtgtttat gcgcgctgat gcaattataa cactaacaca catagcgcga cacgatgcag 
gagttcattc cagtgctgcg ggcctgcgcg  
  2101 cgcagcatga acacaccact gcgagcaaat ctgcaatatt aatgaatata tataactaaa gtgtgcactt 
tctggtttat aactgcagca ccccgcatac  
  2201 accacagtat aaagtaatct acaatattaa tgaatataat aaacaagaat gttcactttt aggtttaaga 
atgcaggcct gcgcgcgcag catcccgcga  
  2301 gcacaacact agaaactaaa ctccaatatt agttaatata ttcaattaaa atgtacactt tctggtttaa 
aactgcaagt atgcgtgcgc agcatccgac  
  2401 atacccaaca ctagaaacta atctacaata tttatgaaag tattcaacta aaatgttcac tttctggttt 
aaaactgcaa gtatacgcgt gcgcagcatc  
  2501 cgacataccc aacactagaa attaatctaa attattaatt aaagtattca actgaattgt tcactttctg 
gtttaaaact gcaagtatgg gtgcgcagca  
  2601 taaaacatac ccaacactag aaactaatct acaatattaa tggatgtatt caactaaaat gttcactttc 
tggtttaaaa ctgcaggaat gcgcgcgcaa  
  2701 caccctgcgg ataactttaa aaacaattcc gcaatcagct aaaactgaaa agttcagttg attaatgaat 
gtaggcatgc gcaaaatatt ataaatgcgc  
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  2801 acacacatct atttaataca ttaaaactaa ggctaaatgt tcactttcac cattttgggg aaaatgaaaa 
ttcagtgtcc cccttaagtg gccagcttta  
  2901 gggcaatagg tgaccctcca taagtagcat aaaatcgtag gctattctgg gcaccctttg acatcgccac 
gcgttaaaca gagaatggag aggttattgc  
  3001 gcacagcagg tgcgcagagt cgcgtccgct aatggcgctg gagctgctga caggtccgct ggcgctctgc 
ggggtggaag cgctcgaaac cccgcacaac  
  3101 ccctgattca ccctgaggca cagccaggcc aacaacgggc cagtgtgatc ggaaaagagt 
tgaaagaatc tccgtgacac caatgaggag ccaaagacca  
  3201 cctgtgaaat acatcacatg tcagacaaaa gcatattaag ctgatcaaat attgcgtgca taaccgcatt 
acatcacaaa gaaaaacatt agctagctat  
  3301 gggtaactta ataagtgttc tacatttgca ctgcagccat ggttgtgagc cgaaaaggtt tgcgcaataa 
tattcacccc ccgagattta catttttttt  
  3401 ttgcggttct ctgatgtcga ttaatggcca cgtggccttc aggtaaacac atttaatatt taacttatgt 
gttttaatta gtgtgttccg aattattcgg  
  3501 ttatttttat ttaacatttt tattaattag cttaattctg atccactccc aactcttatt aacgaatcac aaatcaaatg 
gatagtttta attgcacaat  
  3601 tagcctgtca aaacttaact taaagctgtt aatgcactgc ttttaagttt gaaaaataaa gaaaaattat 
tagaaaactt aagattagat tttaacatat  
  3701 gttgaaatta tcaaatcggc atgtttatga taaaacaact ttacctaaaa ctaaaattca gatcaacaaa 
aacctaaatg aagttacata tatatatata  
  3801 tgtgtgtgtg tgtgtgtata tatatatata tatatatata tatatatata tatatatata tatatatata tatatatata 
taaatgtaag gcaaaggagg  
  3901 attatttaaa tagaatgtca tacacaatgg aaaatcaaag tgttttacat aaacaacaat aaaagaaaca 
taaataacaa gcgtaaaagc aaattcaaac  
  4001 tgaataataa aaaaataata aagttgaaga cacaaatgta tatttaaaaa agtttaagat ctgaattaaa 
agtaagatgc ccctgtgaga ggccaaatat  
  4101 tactgtcgtt gatttgcagc cgaaatcacc gccctctggg gcaaaactca gcagccaatc agagcgggac 
ccgacagggc tctgttgctc ctttaagaga  
  4201 tttttttcca tgaattgatt tttttctcgc tcttcacaca acggggctct ttaagcctcg acgcgcgaca 
cagagcaggc attcagagcg cgagcgaggg  
  4301 ggctgaaccg acggactctc gtgctgggcg ggcgacctgc tgcactgtaa agtaagtgca ttactggctt 
tctctctatc gcttactctg tgtgggaata  
  4401 tatacgccat tgcactgtct aacggagaaa cttttacatt tcttattagt aataatacta ctaataataa 
gcggtgcatt tataaacgac atctacttat  
  4501 tttggatttt tcggtttatg tattgatggg tttggtcgtg gataattgta atggagaagg tttttaattg aaatggatta 
aaggacgtct ttaaaagtgc  
  4601 aacttatcta atcttttggc gaaaggaaca cttaaagttg gtgtcacggg gcataaattt cgagatttgc 
gtgaatgtgt aaatcagaga cgtgttgggt  
  4701 taatctgtct taattggaaa gaacggctta atctatctgt gcacggacca cttgggatgt acatacactt 
ttagatcttt tagtaaatgt ttacagtccg  
  4801 ataaattata catttgaaca ctttaattcg aagtgaatca gtttttaaat agttttataa gaaataattt ttttaaattt 
aatcttctga gaagttttac  
  4901 ttgcgtaagg ctatttgtat atatcgccgt ctcttgccaa attgctcatg taaccaacgc aaagattaac 
aaagagacca aactttaaag tacacaattt  
  5001 ataatattgt ttatctacac atcctttcac aacaaatata acaggatcag aaaacttaag taaagtaaaa 
ctaactgaaa tgcacatttg tgtaagtttg  
  5101 aatcaaatgt ttgatacaat aataatctcc gcagattagt ttgaaaggtt tcattcgaat gagtttgtgt 
catttatgag ttttgtgttt tggcatgagt  
  5201 gaattagggg caaattattg ccaaaccagg cgttatgatc cgccctacag cagccaaaga tgaacccaat 
caaatctgaa caaataaagt ttacagcgga  
  5301 ggaaactcaa ataagcaaga gttgcgagca aagttaaaat gaatgagcat aaagtttata aaagtcctcc 
tgacagaaaa cagccgctga aatcttttcc  
  5401 ttaaaacaaa ataaacccag cagcgcaatt accgaaattg acggatacat ttgttagcta ctaaaacaaa 
ccaagtcttg tgcgatgctt tctttttcgt  
  5501 cccaaataaa ttggacaagt caaaccatta acgctttctg taggctatac atgtgattaa caaatgatca 
atgtgttaat gtgttttgta aggggtctac  
  5601 aagtagccat tcttggctaa ctctagcaca ttttacagta atgtttatta atgtgcattg accctgtaaa 
caaataaact aaacatggtt ctgctcatgt  
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  5701 gaagtcacct gtatcttaat taacactgct gttggatgct gtgtttttgt attcgggtta atattggatg 
tctgtaactc aagttcaagc tgacaggtcg  
  5801 catctcaaca gcttctgtcg catataaatt atttgatcga tttttctgta attggaccta gtcaaccaca 
tccactcgtt taattcacga ttacttcaca  
  5901 tttcagaaac acactgccat gactctcttg atttttttct tcttctgctg gttataagtc gtcgtttgtg ctttcaccaa 
caaacactgt gtaattcagc  
  6001 tgcccacggc agcgccgctc cgtgtttatc cagcagcgag gcggaatgaa gccggtatta ttccagcact 
ttctctcccg ggagcttgaa caaaccgcca  
  6101 aaccttcaac agtagcttgt tagcagaagt gaagctaaaa taacacacac acatatacac acaccgaggc 
ccactgacgc caccgtatga ttgcagcgct  
  6201 gccctggaaa aaggcgactt ctaaataaag tcaaagcctt agtgtttgta ggtttttcct gaacaggttt 
atcttgttca tgaggtgttc gggtgaacag  
  6301 caaaggggtt gtgcggtcat acagccaacc attaaaacga catattaatg ctattttata cattaggaag 
acatgctttg cagaagcaag ctgtttaata  
  6401 aaataataac aatgattatt ataactaata aattacctgt gtgtgtattt ttgtaggttt ccatcagatc 
tatatccaga ggaagacggc ggaaggattc  
  6501 cttcttacaa actcgaatta tataaaaaga actgttaagg tttcactgga tgatcttaaa taataaacaa 
aagcacaatt attttacaag aaaaaaacat  
  6601 ttgtaaagta taaattaata catttatatt taaaataaaa tttaagtgag gaaattaaac ctaccgaagt 
cacctgtggc cgcagaacta gtcatcccat  
  6701 cgattcccgg gaattcctgc agccgatatg tccaatttac tgaccgtaca ccaaaatttg cctgcattac 
cggtcgatgc aacgagtgat gaggttcgca  
  6801 agaacctgat ggacatgttc agggatcgcc aggcgttttc tgagcatacc tggaaaatgc ttctgtccgt 
ttgccggtcg tgggcggcat ggtgcaagtt  
  6901 gaataaccgg aaatggtttc ccgcagaacc tgaagatgtt cgcgattatc ttctatatct tcaggcgcgc 
ggtctggcag taaaaactat ccagcaacat  
  7001 ttgggccagc taaacatgct tcatcgtcgg tccgggctgc cacgaccaag tgacagcaat gctgtttcac 
tggttatgcg gcggatccga aaagaaaacg  
  7101 ttgatgccgg tgaacgtgca aaacaggctc tagcgttcga acgcactgat ttcgaccagg ttcgttcact 
catggaaaat agcgatcgct gccaggatat  
  7201 acgtaatctg gcatttctgg ggattgctta taacaccctg ttacgtatag ccgaaattgc caggatcagg 
gttaaagata tctcacgtac tgacggtggg  
  7301 agaatgttaa tccatattgg cagaacgaaa acgctggtta gcaccgcagg tgtagagaag gcacttagcc 
tgggggtaac taaactggtc gagcgatgga  
  7401 tttccgtctc tggtgtagct gatgatccga ataactacct gttttgccgg gtcagaaaaa atggtgttgc 
cgcgccatct gccaccagcc agctatcaac  
  7501 tcgcgccctg gaagggattt ttgaagcaac tcatcgattg atttacggcg ctaaggatga ctctggtcag 
agatacctgg cctggtctgg acacagtgcc  
  7601 cgtgtcggag ccgcgcgaga tatggcccgc gctggagttt caataccgga gatcatgcaa gctggtggct 
ggaccaatgt aaatattgtc atgaactata  
  7701 tccgtaacct ggatagtgaa acaggggcaa tggtgcgcct gctggaagat ggcgattagc cattaacgcg 
taaatgattg ctataattat ttgatattta  
  7801 tggtgacata tgagaaagga tttcaacatc gacggaaaat atgtagtgct gtctgtaagc actaatattc 
agtcgccagc cgtcattgtc actgtaaagc  
  7901 tgagcgatag aatgcctgat attgactcaa tatccgttgc gtttcctgtc aaaagtatgc gtagtgctga 
acatttcgtg atgaatgcca ccgaggaaga  
  8001 agcacggcgc ggttttgcta aagtgatgtc tgagtttggc gaactcttgg gtaaggttgg aattgtcgag 
gctgggtgtg gcggaccgct atcaggacat  
  8101 agcgttggct acccgtgata ttgctgaaga gcttggcggc gaatgggctg accgcttcct cgtgctttac 
ggtatcgccg ctcccgattc gcagcgcatc  
  8201 gccttctatc gccttcttga cgagttcttc tgaggggatc ggcaataaaa agacagaata aaacgcacgg 
gtgttgggtc gtttgttcgg atccgtcgac  
  8301 ctgcagcccg ggggatccac tagttctaga gcggccgcgg cgccaatgca ttgggcccgg tacccagctt 
ttgttccctt tagtgagggt taattgcgcg  
  8401 cttggcgtaa tcatggtcat agctgtttcc tgtgtgaaat tgttatccgc tcacaattcc acacaacata 
cgagccggga gcataaagtg taaagcctgg  
  8501 ggtgcctaat gagtgagcta actcacatta attgcgttgc gctcactgcc cgctttccag tcgggaaacc 
tgtcgtgcca gctgcattaa tgaatcggcc  
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  8601 aacgcgcggg gagaggcggt ttgcgtattg ggcgctcttc cgcttcctcg ctcactgact cgctgcgctc 
ggtcgttcgg ctgcggcgag cggtatcagc  
  8701 tcactcaaag gcggtaatac ggttatccac agaatcaggg gataacgcag gaaagaacat 
gtgagcaaaa ggccagcaaa aggccaggaa ccgtaaaaag  
  8801 gccgcgttgc tggcgttttt ccataggctc cgcccccctg acgagcatca caaaaatcga cgctcaagtc 
agaggtggcg aaacccgaca ggactataaa  
  8901 gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg accctgccgc ttaccggata 
cctgtccgcc tttctccctt cgggaagcgt  
  9001 ggcgctttct catagctcac gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt 
gtgcacgaac cccccgttca gcccgaccgc  
  9101 tgcgccttat ccggtaacta tcgtcttgag tccaacccgg taagacacga cttatcgcca ctggcagcag 
ccactggtaa caggattagc agagcgaggt  
  9201 atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac actagaagaa cagtatttgg 
tatctgcgct ctgctgaagc cagttacctt  
  9301 cggaaaaaga gttggtagct cttgatccgg caaacaaacc accgctggta gcggtggttt ttttgtttgc 
aagctgcaga ttacgcgcag aaaaaaagga  
  9401 tctcaagaag atcctttgat cttttctacg gggtctgacg ctcagtggaa cgaaaactca cgttaaggga 
ttttggtcat gagattatca aaaaggatct  
  9501 tcacctagat ccttttaaat taaaaatgaa gttttaaatc aatctaaagt atatatgagt aaacttggtc 
tgacagttac caatgcttaa tcagtgaggc  
  9601 acctatctca gcgatctgtc tatttcgttc atccatagtt gcctgactcc ccgtcgtgta gataactacg 
atacgggagg gcttaccatc tggccccagt  
  9701 gctgcaatga taccgcgaga cccacgctca ccggctccag atttatcagc aataaaccag ccagccggaa 
gggccgagcg cagaagtggt cctgcaactt  
  9801 tatccgcctc catccagtct attaattgtt gccgggaagc tagagtaagt agttcgccag ttaatagttt 
gcgcaacgtt gttgccattg ctacaggcat  
  9901 cgtggtgtca cgctcgtcgt ttggtatggc ttcattcagc tccggttccc aacgatcaag gcgagttaca 
tgatccccca tgttgtgcaa aaaagcggtt  
 10001 agctccttcg gtcctccgat cgttgtcaga agtaagttgg ccgcagtgtt atcactcatg gttatggcag 
cactgcataa ttctcttact gtcatgccat  
 10101 ccgtaagatg cttttctgtg actggtgagt actcaaccaa gtcattctga gaatagtgta tgcggcgacc 
gagttgctct tgcccggcgt caatacggga  
 10201 taataccgcg ccacatagca gaactttaaa agtgctcatc attggaaaac gttcttcggg gcgaaaactc 
tcaaggatct taccgctgtt gagatccagt  
 10301 tcgatgtaac ccactcgtgc acccaactga tcttcagcat cttttacttt caccagcgtt tctgggtgag 
caaaaacagg aaggcaaaat gccgcaaaaa  
 10401 agggaataag ggcgacacgg aaatgttgaa tactcatact cttccttttt caatattatt gaagcattta 
tcagggttat tgtctcatga gcggatacat  
 10501 atttgaatgt atttagaaaa ataaacaaat aggggttccg cgcacatttc cccgaaaagt gccacctaaa 
ttgtaagcgt taatattttg ttaaaattcg  
 10601 cgttaaattt ttgttaaatc agctcatttt ttaaccaata ggccgaaatc ggcaaaatcc cttataaatc 
aaaagaatag accgagatag ggttgagtgt  
 10701 tgttccagtt tggaacaaga gtccactatt aaagaacgtg gactccaacg tcaaagggcg aaaaaccgtc 
tatcagggcg atggcccact acgtgaacca  
 10801 tcaccctaat caagtttttt ggggtcgagg tgccgtaaag cactaaatcg gaaccctaaa gggagccccc 
gatttagagc ttgacgggga aagccggcga  
 10901 acgtggcgag aaaggaaggg aagaaagcga aaggagcggg cgctagggcg ctggcaagtg 
tagcggtcac gctgcgcgta accaccacac ccgccgcgct  
 11001 taatgcgccg ctacagggcg cgtcccattc gccattcagg ctgcgcaact gttgggaagg gcgatcggtg 
cgggcctctt cgctattacg ccagtcgacg  
 11101 gtatcgataa gcttgatatc gaattcccca cagcggacaa caggacaaaa cctctcactg ctacatgatc 
aatcctccac ccactgcccg ctgcacttcc  
 11201 tgtctcacac acacacacac acacaagcag agccagtgcc atcaggtgtg tgtgtgtgtg tgtgtcatgg 
gacatgcgtg tcctcctatt gaccttctga  
 11301 cctcacaaac atctttctct gacatcccag agaccatctc caacggcaac cagccacatc atcactgtca 
catgctgcat gactgcacac acacacacac  
 11401 acactttctc gctcacacaa acatattgat tcacatttat acacacattt aaacacacaa acacatttaa 
atacacacac acacacacac acacacatg   
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APPENDIX 2 - RECORD OF PROGENY (F1) OF EMBRYOS INJECTED WITH -
4725SOX10:CRE CROSSED WITH TG(EF1ALPHA:LOXP-EGFP-PA-LOXP-
DSRED-PA). 
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1 S1621 (F1918) 242 730 246 34% 0 0% 
2 S1621 (F1918) 177 579 225 39% 0 0% 
3 S1621 (F1918) 54 150 43 29% 0 0% 
4 S1621 (F1918) 472 682 210 31% 0 0% 
5 S1621 (F1918) 1303 2147 789 37% 3 0% 
6 S1621 (F1918) 74 273 55 20% 0 0% 
7 S1621 (F1918) 248 621 125 20% 0 0% 
8 S1621 (F1918) 187 634 156 25% 0 0% 
9 S1621 (F1918) 135 573 198 35% 0 0% 
10 S1621 (F1918) 90 803 360 45% 0 0% 
11 S1621 (F1918) 138 452 177 39% 0 0% 
12 S1621 (F1918) 103 433 227 52% 0 0% 
13 S1621 (F1918) 283 905 339 37% 0 0% 
14 S1621 (F1918) 170 300 64 21% 0 0% 
15 S1621 (F1918) 293 869 345 40% 0 0% 
16 S1621 (F1918) 237 531 168 32% 0 0% 
17 S1621 (F1918) 122 369 125 34% 0 0% 
18 S1621 (F4817) 265 801 271 34% 0 0% 
19 S1621 (F4817) 79 360 210 58% 0 0% 
20 S1621 (F4817) 230 604 145 24% 0 0% 
21 S1621 (F4817) 271 672 130 19% 0 0% 
22 S1621 (F4817) 58 463 347 75% 0 0% 
23 S1621 (F4817) 321 644 185 29% 0 0% 
24 S1621 (F4817) 267 651 271 42% 0 0% 
25 S1621 (F4817) 383 841 458 54% 0 0% 
26 S1621 (F4817) 770 1289 407 32% 0 0% 
27 S1621 (F4817) 61 289 159 55% 0 0% 
28 S1621 (F1918) 277 561 215 38% 0 0% 
29 S1621 (F1918) 128 630 373 59% 0 0% 
30 S1621 (F4817) 22 48 5 10% 0 0% 
31 S1621 (F4817) 306 861 249 29% 0 0% 
32 S1621 (F4817) 149 914 617 68% 0 0% 
33 S1621 (F4817) 505 1124 487 43% 0 0% 
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34 S1621 (F4817) 207 508 125 25% 0 0% 
35 S1621 (F4817) 245 713 224 31% 0 0% 
36 S1621 (F4817) 151 558 257 46% 0 0% 
37 S1621 (F4817) 91 513 331 65% 0 0% 
38 S1621 (F4817) 168 275 27 10% 0 0% 
39 S1621 (F4817) 134 327 59 18% 0 0% 
40 S1621 (F4817) 61 193 71 37% 0 0% 
41 S1621 (F4817) 35 431 36 8% 0 0% 
42 S1621 (F4817) 249 339 53 16% 0 0% 
43 S1621 (F4817) 108 590 374 63% 0 0% 
44 S1621 (F4817) 217 530 96 18% 0 0% 
45 S1621 (F4817) 131 362 100 28% 0 0% 
46 S1621 (F4817) 222 443 92 21% 0 0% 
47 S1621 (F4817) 179 452 183 40% 0 0% 
48 S1621 (F4817) 142 163 21 13% 0 0% 
49 S1621 (F4817) 0 0 0 0% 0 0% 
50 S1621 (F4817) 121 254 125 49% 0 0% 
51 S1621 (F4817) 133 633 378 60% 0 0% 
52 S1621 (F4817) 134 312 44 14% 0 0% 
53 S1621 (F4817) 144 402 114 28% 0 0% 
54 S1624 (F3414) 260 582 62 11% 0 0% 
55 S1624 (F3414) 263 662 136 21% 0 0% 
56 S1624 (F3414) 99 542 345 64% 0 0% 
57 S1624 (F3414) 247 609 116 19% 0 0% 
58 S1624 (F3414) 155 349 186 53% 0 0% 
59 S1624 (F3414) 15 301 275 91% 0 0% 
60 S1624 (F3414) 28 35 7 20% 0 0% 
61 S1624 (F3414) 22 49 5 10% 0 0% 
62 S1624 (F3414) 72 145 1 1% 0 0% 
63 S1624 (F3414) 64 189 61 32% 0 0% 
64 S1624 (F3414) 114 251 23 9% 0 0% 
65 S1624 (F3414) 122 323 79 24% 0 0% 
66 S1624 (F3414) 47 150 56 37% 0 0% 
67 S1624 (F3414) 47 93 46 49% 0 0% 
68 S1624 (F3414) 69 253 115 45% 0 0% 
69 S1624 (F3414) 36 78 6 8% 0 0% 
70 S1624 (F3414) 108 259 43 17% 0 0% 
71 S1624 (F3414) 113 288 63 22% 0 0% 
72 S1624 (F3414) 25 161 112 70% 0 0% 
73 S1624 (F3414) 151 387 85 22% 80 53% 
74 S1624 (F3414) 88 222 47 21% 26 30% 
75 S1624 (F3414) 76 359 210 58% 0 0% 
76 S1624 (F3414) 41 150 68 45% 0 0% 
77 S1624 (F3414) 29 340 110 32% 0 0% 
78 S1624 (F3414) 185 467 97 21% 0 0% 
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79 S1624 (F3414) 48 171 76 44% 0 0% 
80 S1624 (F3414) 65 184 54 29% 0 0% 
81 S1624 (F3414) 92 182 23 13% 0 0% 
82 S1624 (F3414) 113 398 173 43% 0 0% 
83 S1624 (F3414) 76 166 14 8% 0 0% 
84 S1624 (F3414) 104 138 34 25% 0 0% 
85 S1624 (F3414) 239 257 18 7% 0 0% 
86 S1624 (F3414) 118 144 26 18% 0 0% 
87 S1624 (F3414) 32 67 3 4% 0 0% 
88 S1624 (F3414) 56 117 5 4% 0 0% 
89 S1624 (F3414) 135 137 2 1% 0 0% 
90 (S1624) F3414 66 218 152 70% 0 0% 
91 (S1624) F3414 530 759 229 30% 0 0% 
92 (S1624) F3414 108 389 173 44% 0 0% 
93 (S1624) F3414 276 344 68 20% 0 0% 
94 (S1624) F3414 97 233 40 17% 0 0% 
95 (S1624) F3414 575 666 91 14% 0 0% 
96 (S1624) F3414 253 627 122 19% 0 0% 
97 (S1624) F3415 89 304 127 42% 0 0% 
98 (S1624) F3416 67 141 8 6% 0 0% 
99 (S1624) F3417 54 62 8 13% 0 0% 
100 (S1624) F3418 87 141 54 38% 0 0% 
101 (S1624) F3419 108 119 11 9% 22 20% 
102 (S1624) F3420 71 120 49 41% 0 0% 
103 (S1624) F3421 86 130 44 34% 0 0% 
104 (S1624) F3422 0 0 0 0% 0 0% 
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APPENDIX 3 - TIME LINE WITH COMPREHENSIVE DESCRIPTION OF CULTURE 
CONDITIONS USED. WHEN MAJOR CHANGES WERE INTRODUCED IN THE 
PROTOCOLS THEY ARE INDICATED AT THE TIME THEY WERE INITIATED. 
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APPENDIX 4 - MAP, FEATURES, RESTRICTION MAP AND SEQUENCE OF -
4725SOX10:EML4-ALK:IRES:GFP 
 Entire molecule length: 15075 bp 
 
 
 
  
-4725sox10:EML4-ALK:IRES:gfp
15075 bp
Ampicillin
EGFP
EML4-ALK
M13 reverse primer
M13 pUC rev primer
att2 shared
EMCV IRES AUG 11
att3 shared
SV40 late polyA (from pCS2+)
sox10promoter end sequencing prime
sox10
T3 promoter
AmpR promoter
f1 origin
attR2
attL3
EMCV IRES (A7)
CAAX box from Harvey ras NheI (3293)
SciI (7046)
SnaBI (11589)
SpeI (6688)
XhoI (7044)
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Feature Map 
 CDS (3 total) 
  EML4-ALK 
   Start: 6822  End: 9999 
  EGFP 
   Start: 10768  End: 11484 
  Ampicillin 
   Start: 13153  End: 14013 (Complementary) 
   Original Location Description: 
      complement(9577..10437) 
 Misc. Feature (5 total) 
  att2_shared 
   Start: 10160  End: 10175 
  EMCV IRES AUG 11 
   Start: 10768  End: 10770 
  att3 shared 
   Start: 11789  End: 11803 
  M13 reverse primer 
   Start: 11988  End: 12006 (Complementary) 
   Original Location Description: 
      complement(8412..8430) 
  M13 pUC rev primer 
   Start: 12005  End: 12027 
   Original Location Description: 
      8429..8451 
 PolyA Signal (1 total) 
  SV40 late polyA (from pCS2+) 
   Start: 11592  End: 11787 
 Primer Binding Site (1 total) 
  sox10promoter_end sequencing primer 
   Start: 6573  End: 6592 
 Promoter Eukaryotic (1 total) 
  sox10 
   Start: 1     End: 6692 
   Original Location Description: 
      1..6692 
 Promoter Prokaryotic (2 total) 
  T3 promoter 
   Start: 11952  End: 11971 (Complementary) 
   Original Location Description: 
      complement(8376..8395) 
  AmpR promoter 
   Start: 14055  End: 14083 (Complementary) 
   Original Location Description: 
      complement(10479..10507) 
 Replication Origin (1 total) 
  f1 origin 
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   Start: 14276  End: 14582 
   Original Location Description: 
      10700..11006 
 Misc. Recombination (2 total) 
  attR2 
   Start: 10021  End: 10177 
  attL3 
   Start: 11789  End: 11884 
 Misc. Structure (2 total) 
  EMCV IRES (A7) 
   Start: 10180  End: 10764 
  CAAX box from Harvey ras 
   Start: 11500  End: 11562 
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Restriction/Methylation Map 
Enzyme # of cuts Positions 
AcuI 12 69 3423(c) 7008 8483 8619 9270 10627 10922 10966(c) 11165 
12882 13894(c)  
ApaI 3 9999 10299 11934  
ApoI 21 422 837 889 1012 2869 3755 3992 4656 4876 6639 6817 7242 
7381 8166 8192 8657 10016 11672 14171 14182 14698  
BamHI 2 1798 9620  
BglI 4 9379 10484 13347 14614  
BglII 4 4058 4774 6467 11495  
BsaI 10 1391(c) 1432 1760(c) 4969(c) 8739(c) 8762(c) 9421 9526 
13288(c) 14901(c)  
BsgI 10 1504 4326(c) 8219 8804(c) 9280(c) 10897(c) 10994 11318 
14753(c) 14945(c)  
BslI 45 952 953 1423 1762 2857 2888 2899 3136 4089 4136 8294 8295 
8300 8467 8496 8497 8578 8712 8924 9307 9397 9555 9598 
9645 9659 9742 9904 9941 10282 10445 10465 10635 10717 
10938 11101 11451 12182 12356 12374 12540 12819 14265 
14591 14674 14709  
BsmI 11 2276 2694 4280(c) 7321 8210(c) 8556 9575(c) 10328(c) 10367 
11648 11741(c)  
BsrI 29 1125 2081(c) 3141(c) 4369 6551 7110(c) 7608 7804 8012 8242 
8628 9014(c) 9168(c) 9784 10215 10533(c) 11380(c) 12134(c) 
12742 12755 12867(c) 13273(c) 13391(c) 13434(c) 13703 
13873(c) 14282(c) 14668(c) 14810(c)  
ClaI 2 5838 14681  
EagI 3 6748 9546 11909  
EcoRI 3 6817 10016 14698  
EcoRV 3 399 573 14694  
HindIII 2 10406 14686  
NcoI 4 3338 8509 10767 11892  
NdeI 5 3698 6807 7615 7989 10067  
NheI 1 3293  
NotI 2 6748 11909  
PstI 9 124 2188 2686 3336 7459 7887 8361 9517 12955  
SacI 3 8733 10014 11891  
SacII 3 1207 8477 11915  
SalI 2 6791 14671  
ScaI 3 6871 7701 13707  
SciI 1 7046  
SmaI 2 6080 6814  
SnaBI 1 11589  
SpeI 1 6688  
XbaI 2 10006 11564  
XhoI 1 7044  
XmaI 2 6078 6812  
 No cuts: SbfI, SfiI 
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Sequence 
     1 atcctataaa ctgcgcacaa cactaagcac cagcagtttt agtttgctga agcatcagtt tgtaacagaa 
taactcagcc tcctcatgat ctcctcttcg  
   101 ctgctcattc aggcaaaact gcagtttaaa agcgctgata aacaaaactc caactatggc acacacactc 
ccttgatcag agatgaattg atgaaattaa  
   201 ttatgttttt gtgtgcgtat ttctttatta aatcacgcag acgcgcgcag ttttatctct gcggtaatgc ggatcataat 
aaactcgtga ttaaaaaact  
   301 aattacactg tcgcacgaac atgcgcgcat taacaacgaa cacacgagtc atttcgataa atatacagct 
cagaaattac attaaacatt tataagatat  
   401 caaaaacggt caagagaaac gaatttattt atgtttttat aaagcgcatt tgcgagtcgc tcaaaaaact 
gtatagtatg aacataataa tgtttaaaaa  
   501 acacgaaata ctgatacaaa taatactgtt aataataaaa acattgttat ttgtattaaa tagcttgtgg 
atatccagaa ataatgcgta attctaaccg  
   601 acagatgatc taaaatcatt tcgtcagtct cttatttgat agactacaaa tgcataaaaa gtaaaacgcg 
ttttcgtatt tattaaattg gttttagttt  
   701 tttttaatta aattataata ttataataaa ataatcaatt gtatttttat tactgacatg cacgcataat 
aaacgcgcta tacaaatgcg catacacatt  
   801 acgcacctgc gcgtttgggt tatttccatt taaataaatt caactacaaa accccaaaac aaaaagttta 
aaaacatttt aatttctgaa tttaaaaaat  
   901 aaacaaaatc aatcatttaa aaattgtagg cagggttgta ttaacccaac gctgggtcaa atatggactc 
aaagtttttg catggcattt aaatatttaa  
  1001 tccgtctgct gaatttgtcc atatttgaca ataatacatc ccagctattt tagagcgcat ttctgatctc 
ttctttacca taaaaacgaa accccttgat  
  1101 aaagcagaat ggcattaaac tggaaattaa taataatgta aacaattaac taataacata tataaaacaa 
aacgatttac acaaatagcg caggacacat  
  1201 ttccgcggta taaaagaagc ctccctgttc tgacaggcga tgcgacacac ataacaaatc actcttctca 
agcagccaca ttaaataaca gaagaaacaa  
  1301 ttaacatgca cgcgcatact aaacagcaca cattaacaaa tgtccctcac tgacaaacac cccccagctt 
gatgtttatg tcctataaat gctcggagac  
  1401 cgagtgtcac tttctccaaa gcggggtctc ctccttccca aagcctccct aagagcaaca gggcaaaact 
cacatcaaag tgtgcagcag gcctcagatc  
  1501 cgcgcgcttt cccgtgtaca tccacagacc cgcgagaacc gagacatgtg tgcgtgtacg tttgaaggga 
caccgagaaa aagacgctct aaagagagac  
  1601 acacgtcttt tctcttttct tttctttttt tatatacaca gaactgcttt ttgttcctca ttttttcatt taagagggta 
atggaagggg ggtgttcgtt  
  1701 tgatcacatg attacaattc acctgagata aaacaaagga cgcaaagaaa ggagccgagc 
gccggagacc gagacagaga gatgctctca tggtcaggat  
  1801 ccccttatca gagtcaacat tcatggataa tgaaaaaggc aatgattttt ggcttgggtg ggggggccgt 
cgtgagatgg aaatacaaga ggttattgtt  
  1901 gaccagaaca gcgcgcgtgt ttgtgtgcgt ttggcccgtc gtttgcctct cttctcgtct ttctatattt 
tctactaaag ctgtttaaac gcgttaaatg  
  2001 cgctctctgt gtgtgtttat gcgcgctgat gcaattataa cactaacaca catagcgcga cacgatgcag 
gagttcattc cagtgctgcg ggcctgcgcg  
  2101 cgcagcatga acacaccact gcgagcaaat ctgcaatatt aatgaatata tataactaaa gtgtgcactt 
tctggtttat aactgcagca ccccgcatac  
  2201 accacagtat aaagtaatct acaatattaa tgaatataat aaacaagaat gttcactttt aggtttaaga 
atgcaggcct gcgcgcgcag catcccgcga  
  2301 gcacaacact agaaactaaa ctccaatatt agttaatata ttcaattaaa atgtacactt tctggtttaa 
aactgcaagt atgcgtgcgc agcatccgac  
  2401 atacccaaca ctagaaacta atctacaata tttatgaaag tattcaacta aaatgttcac tttctggttt 
aaaactgcaa gtatacgcgt gcgcagcatc  
  2501 cgacataccc aacactagaa attaatctaa attattaatt aaagtattca actgaattgt tcactttctg 
gtttaaaact gcaagtatgg gtgcgcagca  
  2601 taaaacatac ccaacactag aaactaatct acaatattaa tggatgtatt caactaaaat gttcactttc 
tggtttaaaa ctgcaggaat gcgcgcgcaa  
  2701 caccctgcgg ataactttaa aaacaattcc gcaatcagct aaaactgaaa agttcagttg attaatgaat 
gtaggcatgc gcaaaatatt ataaatgcgc  
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  2801 acacacatct atttaataca ttaaaactaa ggctaaatgt tcactttcac cattttgggg aaaatgaaaa 
ttcagtgtcc cccttaagtg gccagcttta  
  2901 gggcaatagg tgaccctcca taagtagcat aaaatcgtag gctattctgg gcaccctttg acatcgccac 
gcgttaaaca gagaatggag aggttattgc  
  3001 gcacagcagg tgcgcagagt cgcgtccgct aatggcgctg gagctgctga caggtccgct ggcgctctgc 
ggggtggaag cgctcgaaac cccgcacaac  
  3101 ccctgattca ccctgaggca cagccaggcc aacaacgggc cagtgtgatc ggaaaagagt 
tgaaagaatc tccgtgacac caatgaggag ccaaagacca  
  3201 cctgtgaaat acatcacatg tcagacaaaa gcatattaag ctgatcaaat attgcgtgca taaccgcatt 
acatcacaaa gaaaaacatt agctagctat  
  3301 gggtaactta ataagtgttc tacatttgca ctgcagccat ggttgtgagc cgaaaaggtt tgcgcaataa 
tattcacccc ccgagattta catttttttt  
  3401 ttgcggttct ctgatgtcga ttaatggcca cgtggccttc aggtaaacac atttaatatt taacttatgt 
gttttaatta gtgtgttccg aattattcgg  
  3501 ttatttttat ttaacatttt tattaattag cttaattctg atccactccc aactcttatt aacgaatcac aaatcaaatg 
gatagtttta attgcacaat  
  3601 tagcctgtca aaacttaact taaagctgtt aatgcactgc ttttaagttt gaaaaataaa gaaaaattat 
tagaaaactt aagattagat tttaacatat  
  3701 gttgaaatta tcaaatcggc atgtttatga taaaacaact ttacctaaaa ctaaaattca gatcaacaaa 
aacctaaatg aagttacata tatatatata  
  3801 tgtgtgtgtg tgtgtgtata tatatatata tatatatata tatatatata tatatatata tatatatata tatatatata 
taaatgtaag gcaaaggagg  
  3901 attatttaaa tagaatgtca tacacaatgg aaaatcaaag tgttttacat aaacaacaat aaaagaaaca 
taaataacaa gcgtaaaagc aaattcaaac  
  4001 tgaataataa aaaaataata aagttgaaga cacaaatgta tatttaaaaa agtttaagat ctgaattaaa 
agtaagatgc ccctgtgaga ggccaaatat  
  4101 tactgtcgtt gatttgcagc cgaaatcacc gccctctggg gcaaaactca gcagccaatc agagcgggac 
ccgacagggc tctgttgctc ctttaagaga  
  4201 tttttttcca tgaattgatt tttttctcgc tcttcacaca acggggctct ttaagcctcg acgcgcgaca 
cagagcaggc attcagagcg cgagcgaggg  
  4301 ggctgaaccg acggactctc gtgctgggcg ggcgacctgc tgcactgtaa agtaagtgca ttactggctt 
tctctctatc gcttactctg tgtgggaata  
  4401 tatacgccat tgcactgtct aacggagaaa cttttacatt tcttattagt aataatacta ctaataataa 
gcggtgcatt tataaacgac atctacttat  
  4501 tttggatttt tcggtttatg tattgatggg tttggtcgtg gataattgta atggagaagg tttttaattg aaatggatta 
aaggacgtct ttaaaagtgc  
  4601 aacttatcta atcttttggc gaaaggaaca cttaaagttg gtgtcacggg gcataaattt cgagatttgc 
gtgaatgtgt aaatcagaga cgtgttgggt  
  4701 taatctgtct taattggaaa gaacggctta atctatctgt gcacggacca cttgggatgt acatacactt 
ttagatcttt tagtaaatgt ttacagtccg  
  4801 ataaattata catttgaaca ctttaattcg aagtgaatca gtttttaaat agttttataa gaaataattt ttttaaattt 
aatcttctga gaagttttac  
  4901 ttgcgtaagg ctatttgtat atatcgccgt ctcttgccaa attgctcatg taaccaacgc aaagattaac 
aaagagacca aactttaaag tacacaattt  
  5001 ataatattgt ttatctacac atcctttcac aacaaatata acaggatcag aaaacttaag taaagtaaaa 
ctaactgaaa tgcacatttg tgtaagtttg  
  5101 aatcaaatgt ttgatacaat aataatctcc gcagattagt ttgaaaggtt tcattcgaat gagtttgtgt 
catttatgag ttttgtgttt tggcatgagt  
  5201 gaattagggg caaattattg ccaaaccagg cgttatgatc cgccctacag cagccaaaga tgaacccaat 
caaatctgaa caaataaagt ttacagcgga  
  5301 ggaaactcaa ataagcaaga gttgcgagca aagttaaaat gaatgagcat aaagtttata aaagtcctcc 
tgacagaaaa cagccgctga aatcttttcc  
  5401 ttaaaacaaa ataaacccag cagcgcaatt accgaaattg acggatacat ttgttagcta ctaaaacaaa 
ccaagtcttg tgcgatgctt tctttttcgt  
  5501 cccaaataaa ttggacaagt caaaccatta acgctttctg taggctatac atgtgattaa caaatgatca 
atgtgttaat gtgttttgta aggggtctac  
  5601 aagtagccat tcttggctaa ctctagcaca ttttacagta atgtttatta atgtgcattg accctgtaaa 
caaataaact aaacatggtt ctgctcatgt  
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  5701 gaagtcacct gtatcttaat taacactgct gttggatgct gtgtttttgt attcgggtta atattggatg 
tctgtaactc aagttcaagc tgacaggtcg  
  5801 catctcaaca gcttctgtcg catataaatt atttgatcga tttttctgta attggaccta gtcaaccaca 
tccactcgtt taattcacga ttacttcaca  
  5901 tttcagaaac acactgccat gactctcttg atttttttct tcttctgctg gttataagtc gtcgtttgtg ctttcaccaa 
caaacactgt gtaattcagc  
  6001 tgcccacggc agcgccgctc cgtgtttatc cagcagcgag gcggaatgaa gccggtatta ttccagcact 
ttctctcccg ggagcttgaa caaaccgcca  
  6101 aaccttcaac agtagcttgt tagcagaagt gaagctaaaa taacacacac acatatacac acaccgaggc 
ccactgacgc caccgtatga ttgcagcgct  
  6201 gccctggaaa aaggcgactt ctaaataaag tcaaagcctt agtgtttgta ggtttttcct gaacaggttt 
atcttgttca tgaggtgttc gggtgaacag  
  6301 caaaggggtt gtgcggtcat acagccaacc attaaaacga catattaatg ctattttata cattaggaag 
acatgctttg cagaagcaag ctgtttaata  
  6401 aaataataac aatgattatt ataactaata aattacctgt gtgtgtattt ttgtaggttt ccatcagatc 
tatatccaga ggaagacggc ggaaggattc  
  6501 cttcttacaa actcgaatta tataaaaaga actgttaagg tttcactgga tgatcttaaa taataaacaa 
aagcacaatt attttacaag aaaaaaacat  
  6601 ttgtaaagta taaattaata catttatatt taaaataaaa tttaagtgag gaaattaaac ctaccgaagt 
cacctgtggc cgcagaacta gttctagctc  
  6701 gccgcagccg aaacgaccga gcgcagcgag tcagtgagcg aggaagcggc cgcataactt 
cgtatagcat acattatacg aagttatcag tcgacggtac  
  6801 cggacatatg cccgggaatt cgatggacgg tttcgccggc agtctcgatg atagtatttc tgctgcaagt 
acttctgatg ttcaagatcg cctgtcagct  
  6901 cttgagtcac gagttcagca acaagaagat gaaatcactg tgctaaaggc ggctttggct gatgttttga 
ggcgtcttgc aatctctgaa gatcatgtgg  
  7001 cctcagtgaa aaaatcagtc tcaagtaaag gccaaccaag ccctcgagca gttattccca tgtcctgtat 
aaccaatgga agtggtgcaa acagaaaacc  
  7101 aagtcatacc agtgctgtct caattgcagg aaaagaaact ctttcatctg ctgctaaaag tggtacagaa 
aaaaagaaag aaaaaccaca aggacagaga  
  7201 gaaaaaaaag aggaatctca ttctaatgat caaagtccac aaattcgagc atcaccttct ccccagccct 
cttcacaacc tctccaaata cacagacaaa  
  7301 ctccagaaag caagaatgct actcccacca aaagcataaa acgaccatca ccagctgaaa 
agtcacataa ttcttgggaa aattcagatg atagccgtaa  
  7401 taaattgtcg aaaatacctt caacacccaa attaatacca aaagttacca aaactgcaga caagcataaa 
gatgtcatca tcaaccaaga aggagaatat  
  7501 attaaaatgt ttatgcgcgg tcggccaatt accatgttca ttccttccga tgttgacaac tatgatgaca 
tcagaacgga actgcctcct gagaagctca  
  7601 aactggagtg ggcatatggt tatcgaggaa aggactgtag agctaatgtt taccttcttc cgaccgggga 
aatagtttat ttcattgcat cagtagtagt  
  7701 actatttaat tatgaggaga gaactcagcg acactacctg ggccatacag actgtgtgaa atgccttgct 
atacatcctg acaaaattag gattgcaact  
  7801 ggacagatag ctggcgtgga taaagatgga aggcctctac aaccccacgt cagagtgtgg gattctgtta 
ctctatccac actgcagatt attggacttg  
  7901 gcacttttga gcgtggagta ggatgcctgg atttttcaaa agcagattca ggtgttcatt tatgtgttat 
tgatgactcc aatgagcata tgcttactgt  
  8001 atgggactgg cagaggaaag caaaaggagc agaaataaag acaacaaatg aagttgtttt 
ggctgtggag tttcacccaa cagatgcaaa taccataatt  
  8101 acatgcggta aatctcatat tttcttctgg acctggagcg gcaattcact aacaagaaaa cagggaattt 
ttgggaaata tgaaaagcca aaatttgtgc  
  8201 agtgtttagc attcttgggg aatggagatg ttcttactgg agactcaggt ggagtcatgc ttatatggag 
caaaactact gtagagccca cacctgggaa  
  8301 aggacctaaa gtgtaccgcc ggaagcacca ggagctgcaa gccatgcaga tggagctgca 
gagccctgag tacaagctga gcaagctccg cacctcgacc  
  8401 atcatgaccg actacaaccc caactactgc tttgctggca agacctcctc catcagtgac ctgaaggagg 
tgccgcggaa aaacatcacc ctcattcggg  
  8501 gtctgggcca tggcgccttt ggggaggtgt atgaaggcca ggtgtccgga atgcccaacg acccaagccc 
cctgcaagtg gctgtgaaga cgctgcctga  
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  8601 agtgtgctct gaacaggacg aactggattt cctcatggaa gccctgatca tcagcaaatt caaccaccag 
aacattgttc gctgcattgg ggtgagcctg  
  8701 caatccctgc cccggttcat cctgctggag ctcatggcgg ggggagacct caagtccttc ctccgagaga 
cccgccctcg cccgagccag ccctcctccc  
  8801 tggccatgct ggaccttctg cacgtggctc gggacattgc ctgtggctgt cagtatttgg aggaaaacca 
cttcatccac cgagacattg ctgccagaaa  
  8901 ctgcctcttg acctgtccag gccctggaag agtggccaag attggagact tcgggatggc ccgagacatc 
tacagggcga gctactatag aaagggaggc  
  9001 tgtgccatgc tgccagttaa gtggatgccc ccagaggcct tcatggaagg aatattcact tctaaaacag 
acacatggtc ctttggagtg ctgctatggg  
  9101 aaatcttttc tcttggatat atgccatacc ccagcaaaag caaccaggaa gttctggagt ttgtcaccag 
tggaggccgg atggacccac ccaagaactg  
  9201 ccctgggcct gtataccgga taatgactca gtgctggcaa catcagcctg aagacaggcc caactttgcc 
atcattttgg agaggattga atactgcacc  
  9301 caggacccgg atgtaatcaa caccgctttg ccgatagaat atggtccact tgtggaagag gaagagaaag 
tgcctgtgag gcccaaggac cctgaggggg  
  9401 ttcctcctct cctggtctct caacaggcaa aacgggagga ggagcgcagc ccagctgccc caccacctct 
gcctaccacc tcctctggca aggctgcaaa  
  9501 gaaacccaca gctgcagagg tctctgttcg agtccctaga gggccggccg tggaaggggg 
acacgtgaat atggcattct ctcagtccaa ccctccttcg  
  9601 gagttgcaca aggtccacgg atccagaaac aagcccacca gcttgtggaa cccaacgtac ggctcctggt 
ttacagagaa acccaccaaa aagaataatc  
  9701 ctatagcaaa gaaggagcca cacgacaggg gtaacctggg gctggaggga agctgtactg 
tcccacctaa cgttgcaact gggagacttc cgggggcctc  
  9801 actgctccta gagccctctt cgctgactgc caatatgaag gaggtacctc tgttcaggct acgtcacttc 
ccttgtggga atgtcaatta cggctaccag  
  9901 caacagggct tgcccttaga agccgctact gcccctggag ctggtcatta cgaggatacc attctgaaaa 
gcaagaatag catgaaccag cctgggccca  
 10001 gctttctaga gctcgaattc tacaggtcac taataccatc taagtagttg attcatagtg actgcatatg 
ttgtgtttta cagtattatg tagtctgttt  
 10101 tttatgcaaa atctaattta atatattgat atttatatca ttttacgttt ctcgttcaac tttcttgtac aaagtggccg 
cccctctccc tccccccccc  
 10201 ctaacgttac tggccgaagc cgcttggaat aaggccggtg tgcgtttgtc tatatgttat tttccaccat 
attgccgtct tttggcaatg tgagggcccg  
 10301 gaaacctggc cctgtcttct tgacgagcat tcctaggggt ctttcccctc tcgccaaagg aatgcaaggt 
ctgttgaatg tcgtgaagga agcagttcct  
 10401 ctggaagctt cttgaagaca aacaacgtct gtagcgaccc tttgcaggca gcggaacccc ccacctggcg 
acaggtgcct ctgcggccaa aagccacgtg  
 10501 tataagatac acctgcaaag gcggcacaac cccagtgcca cgttgtgagt tggatagttg tggaaagagt 
caaatggctc tcctcaagcg tattcaacaa  
 10601 ggggctgaag gatgcccaga aggtacccca ttgtatggga tctgatctgg ggcctcggta cacatgcttt 
acatgtgttt agtcgaggtt aaaaaaacgt  
 10701 ctaggccccc cgaaccacgg ggacgtggtt ttcctttgaa aaacacgatg ataatatggc cacaaccatg 
gtgagcaagg gcgaggagct gttcaccggg  
 10801 gtggtgccca tcctggtcga gctggacggc gacgtaaacg gccacaagtt cagcgtgtcc 
ggcgagggcg agggcgatgc cacctacggc aagctgaccc  
 10901 tgaagttcat ctgcaccacc ggcaagctgc ccgtgccctg gcccaccctc gtgaccaccc tgacctacgg 
cgtgcagtgc ttcagccgct accccgacca  
 11001 catgaagcag cacgacttct tcaagtccgc catgcccgaa ggctacgtcc aggagcgcac catcttcttc 
aaggacgacg gcaactacaa gacccgcgcc  
 11101 gaggtgaagt tcgagggcga caccctggtg aaccgcatcg agctgaaggg catcgacttc 
aaggaggacg gcaacatcct ggggcacaag ctggagtaca  
 11201 actacaacag ccacaacgtc tatatcatgg ccgacaagca gaagaacggc atcaaggtga 
acttcaagat ccgccacaac atcgaggacg gcagcgtgca  
 11301 gctcgccgac cactaccagc agaacacccc catcggcgac ggccccgtgc tgctgcccga 
caaccactac ctgagcaccc agtccgccct gagcaaagac  
 11401 cccaacgaga agcgcgatca catggtcctg ctggagttcg tgaccgccgc cgggatcact ctcggcatgg 
acgagctgta caagggagga ggaagatcta  
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 11501 agctgaaccc tcctgatgag agtggccccg gctgcatgag ctgcaagtgt gtgctctcct gatctagaac 
tatagtgagt cgtattacgt agatccagac  
 11601 atgataagat acattgatga gtttggacaa accacaacta gaatgcagtg aaaaaaatgc tttatttgtg 
aaatttgtga tgctattgct ttatttgtaa  
 11701 ccattataag ctgcaataaa caagttaaca acaacaattg cattcatttt atgtttcagg ttcaggggga 
ggtgtgggag gttttttcca actttattat  
 11801 acaaagttgg cattataaaa aagcattgct tatcaatttg ttgcaacgaa caggtcacta tcagtcaaaa 
taaaatcatt atttggagct ccatggtagc  
 11901 gttaacgcgg ccgcggcgcc aatgcattgg gcccggtacc cagcttttgt tccctttagt gagggttaat 
tgcgcgcttg gcgtaatcat ggtcatagct  
 12001 gtttcctgtg tgaaattgtt atccgctcac aattccacac aacatacgag ccgggagcat aaagtgtaaa 
gcctggggtg cctaatgagt gagctaactc  
 12101 acattaattg cgttgcgctc actgcccgct ttccagtcgg gaaacctgtc gtgccagctg cattaatgaa 
tcggccaacg cgcggggaga ggcggtttgc  
 12201 gtattgggcg ctcttccgct tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt 
atcagctcac tcaaaggcgg taatacggtt  
 12301 atccacagaa tcaggggata acgcaggaaa gaacatgtga gcaaaaggcc agcaaaaggc 
caggaaccgt aaaaaggccg cgttgctggc gtttttccat  
 12401 aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag gtggcgaaac 
ccgacaggac tataaagata ccaggcgttt ccccctggaa  
 12501 gctccctcgt gcgctctcct gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg 
aagcgtggcg ctttctcata gctcacgctg  
 12601 taggtatctc agttcggtgt aggtcgttcg ctccaagctg ggctgtgtgc acgaaccccc cgttcagccc 
gaccgctgcg ccttatccgg taactatcgt  
 12701 cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac tggtaacagg attagcagag 
cgaggtatgt aggcggtgct acagagttct  
 12801 tgaagtggtg gcctaactac ggctacacta gaagaacagt atttggtatc tgcgctctgc tgaagccagt 
taccttcgga aaaagagttg gtagctcttg  
 12901 atccggcaaa caaaccaccg ctggtagcgg tggttttttt gtttgcaagc tgcagattac gcgcagaaaa 
aaaggatctc aagaagatcc tttgatcttt  
 13001 tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt ggtcatgaga ttatcaaaaa 
ggatcttcac ctagatcctt ttaaattaaa  
 13101 aatgaagttt taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag 
tgaggcacct atctcagcga tctgtctatt  
 13201 tcgttcatcc atagttgcct gactccccgt cgtgtagata actacgatac gggagggctt accatctggc 
cccagtgctg caatgatacc gcgagaccca  
 13301 cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc cgagcgcaga 
agtggtcctg caactttatc cgcctccatc cagtctatta  
 13401 attgttgccg ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctac 
aggcatcgtg gtgtcacgct cgtcgtttgg  
 13501 tatggcttca ttcagctccg gttcccaacg atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa 
gcggttagct ccttcggtcc tccgatcgtt  
 13601 gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact gcataattct cttactgtca 
tgccatccgt aagatgcttt tctgtgactg  
 13701 gtgagtactc aaccaagtca ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaat 
acgggataat accgcgccac atagcagaac  
 13801 tttaaaagtg ctcatcattg gaaaacgttc ttcggggcga aaactctcaa ggatcttacc gctgttgaga 
tccagttcga tgtaacccac tcgtgcaccc  
 13901 aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa aacaggaagg caaaatgccg 
caaaaaaggg aataagggcg acacggaaat  
 14001 gttgaatact catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg 
atacatattt gaatgtattt agaaaaataa  
 14101 acaaataggg gttccgcgca catttccccg aaaagtgcca cctaaattgt aagcgttaat attttgttaa 
aattcgcgtt aaatttttgt taaatcagct  
 14201 cattttttaa ccaataggcc gaaatcggca aaatccctta taaatcaaaa gaatagaccg agatagggtt 
gagtgttgtt ccagtttgga acaagagtcc  
 14301 actattaaag aacgtggact ccaacgtcaa agggcgaaaa accgtctatc agggcgatgg 
cccactacgt gaaccatcac cctaatcaag ttttttgggg  
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 14401 tcgaggtgcc gtaaagcact aaatcggaac cctaaaggga gcccccgatt tagagcttga 
cggggaaagc cggcgaacgt ggcgagaaag gaagggaaga  
 14501 aagcgaaagg agcgggcgct agggcgctgg caagtgtagc ggtcacgctg cgcgtaacca 
ccacacccgc cgcgcttaat gcgccgctac agggcgcgtc  
 14601 ccattcgcca ttcaggctgc gcaactgttg ggaagggcga tcggtgcggg cctcttcgct attacgccag 
tcgacggtat cgataagctt gatatcgaat  
 14701 tccccacagc ggacaacagg acaaaacctc tcactgctac atgatcaatc ctccacccac tgcccgctgc 
acttcctgtc tcacacacac acacacacac  
 14801 aagcagagcc agtgccatca ggtgtgtgtg tgtgtgtgtg tcatgggaca tgcgtgtcct cctattgacc 
ttctgacctc acaaacatct ttctctgaca  
 14901 tcccagagac catctccaac ggcaaccagc cacatcatca ctgtcacatg ctgcatgact gcacacacac 
acacacacac tttctcgctc acacaaacat  
 15001 attgattcac atttatacac acatttaaac acacaaacac atttaaatac acacacacac acacacacac 
acatg  
